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ABSTRACT
Background: During the last two decades, several international studies of women in preterm labor
(PTL) and preterm pre-labor rupture of the membranes (pPROM) have shown a significant association
between microbial invasion of the amniotic cavity (MIAC), some cytokines and chemokines and
preterm birth (PTB). These studies have been performed in countries with much higher incidence of
PTB than that in Sweden. Cerebral palsy (CP) has also been shown to be associated with infectious
and inflammatory mechanisms in several international epidemiological studies. Our aim was to
examine the role of inflammatory mechanisms in PTB and CP in a setting with a low incidence of
preterm birth and perinatal infections.
Material and Methods: In order to examine PTB mechanisms, amniotic fluid (AF) was retrieved
transabdominally from 61 patients in PTL and 47 patients with pPROM, before 34 weeks of gestation
in both groups. Forty-five women at term (≥ 37 weeks) were included. These women were scheduled
for elective cesarean section after uncomplicated pregnancies. Cervical fluid was obtained from the
external cervical os in all patients in PTL and in all term patients. Polymerase chain reaction analyses
for Ureaplasma urealyticum and Mycoplasma hominis and culture for aerobic and anaerobic bacteria
were performed. Interleukin (IL)-6, IL-8, IL-18 and monocyte chemotactic protein (MCP)-1 were
analyzed with enzyme-linked immunosorbent assay.
In order to examine inflammatory mechanisms in CP, a population-based series of 148 preterm infants
with spastic CP, born 1983-90, were included and matched with a control group (n=296). Subgroup
analyses of patients with spastic diplegia and hemiplegia and those born at <32 and ≥32 weeks were
performed.  Maternal, antenatal and intrapartal variables were retrieved from obstetric records.
Results: MIAC was detected in 16% of women in PTL and 25 % of women with pPROM.  Patients in
PTL with MIAC had significantly elevated levels of IL-6, IL-8 and IL-18. The levels of IL-6, IL-8 and
MCP-1 were elevated in MIAC cases in women with pPROM. There was also a significant association
between elevated levels of IL-6, IL-8, IL-18 and MCP-1 and short amniocentesis-delivery interval (≤ 7
days) and preterm birth (< 34 weeks) in women in PTL, whereas this association was less evident in
women with pPROM. A receiver-operator-characteristic curve was used to identify the best cut-off
levels of IL-6 and IL-8 in AF for delivery within 7 days. This value was used to define an
inflammatory response. The inflammatory response rate was 46 % in the PTL group and 51% in the
pPROM group. Elevated IL-18 and MCP-1 were related to an inflammatory response in the women in
PTL. MCP-1 was also related to an inflammatory response in women with pPROM.
There were higher levels of IL-18 and MCP-1 in the cervical fluid of women in PTL, compared with
non-laboring women at term. There were elevated levels of MCP-1 in the cervical fluid of women in
PTL who gave birth within 7 days or before 34 weeks of gestation, who had MIAC or had intra-
amniotic inflammation.
In the epidemiological study of CP, clinical chorioamnionitis/pyelonephritis, long interval between
rupture of membranes and birth, admission-delivery interval <4 hours and Apgar scores of <7 at 1
minute just significantly increased the risk of CP. Apgar scores of <7 at 5 and 10 minutes were
strongly associated with an increased CP risk. Abruptio placentae, Apgar scores <7 at 1 minute and
pathological non-stress test (reason for delivery) were significant risk factors for CP only in the
moderately preterm and hemiplegic groups, whereas fever prior to delivery was a significant risk
factor in the very preterm and spastic diplegic groups. Antibiotics administered during pregnancy only
constituted a risk factor in the spastic diplegic CP group.
Conclusion: The occurrence of intra-amniotic microbial invasion and inflammation in this
population of Swedish women in PTL and pPROM was similar to that reported in data from
populations with a higher incidence of preterm delivery. In addition, our data support an association
between antenatal infection/inflammation and CP.
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1. General introduction
Preterm birth (PTB) remains one of the main
causes of perinatal mortality and long-term
morbidity (1). The US incidence of PTB in
2000, 11.6 % (2), was double that in Sweden,
5.6% (3). There has been a slight increase
during the last decades in the USA (1, 2) and
Canada (4). In the USA, the PTB rate has risen
steadily from 9.4 % in 1981, to 10.6 % in 1990
and 11.6 % in 2000 (2). Among the non-
Hispanic white population, the PTB rate has
risen from 8.5 % in 1990 to 10.4 % in 2000,
but there has been a slight reduction in the black
population from 18.9 % in 1991 to 17.3 % in
2000 (2). In Sweden, the incidence has been
stable since 1973 with a slight increasing
tendency in the beginning of the 1980s and
subsequently then stabilizing (Fig. 1) (3). Two
exceptions from the stable or increased PTB
rate are France (5, 6) and Finland (7) that have
reported decreasing incidence of PTB.
Although all births before 37 weeks of gestation
are considered preterm according to the World
Health Organization’s definition, births before
32 weeks of gestation account for most neonatal
deaths and disorders (1). Sweden and the USA
also differ when it comes to the rate of births
occurring < 32 weeks of gestation, 0.85 % and
1.93 % respectively (2, 3). PTB accounts for
75 % of the total perinatal mortality and over
two thirds of this emanates from the 30-40%
of preterm infants who are born before 32
weeks of gestation (8). Although major efforts
have been made to reduce the incidence of PTB
in industrialized countries, they have so far not
yielded any tangible effect (1).
PTB is also a leading cause of long-term
neurological morbidity (1, 9, 10). An increasing
prevalence of cerebral palsy (CP) has been
observed since the mid-seventies, especially
among very and extremely preterm children (9).
During the last four decades, there has been a
successive decrease in perinatal mortality and
Fig. 1. Incidence of preterm birth (< 37 weeks of gestation) in Sweden between 1973 – 2000. (From Medical Birth
Registration in 2000: Swedish National Board of Health and Welfare; 2002).
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a parallel increase in the potential for survival
at ever lower gestational ages, which might
explain the increased prevalence of CP (9, 11).
The live birth prevalence in Sweden of CP
during the period 1991-94 was 2.12 per 1000
and is inversely correlated with gestational age,
with a 60-70 times higher rate at a gestational
age less than 28 weeks, compared to term
delivery (9). The risk of developing CP related
to gestational age is shown in Fig. 2 (9). The
prevalence of CP was 8.6 % in children born
before 28 weeks, 6 % between 28 and 31 weeks,
0.6% between 32 and 36 weeks and 0.13% in
those born at term (9).
Preterm children are also at increased risk of
developing cognitive and behavioral
abnormalities and of achieving poorly in
educational situations (12), problems which
persist until adulthood (13, 14). Non-
retinopathy-related visual abnormalities are
also seen in extremely preterm children (15,
16).
Against this background, it is understandable
that the economic costs for PTB are
considerable, related both to the initial
hospitalization in the neonatal intensive care
unit and to the long-term consequences of PTB.
However, comparatively little research has
been devoted to measuring the economic costs
of preterm delivery, especially the combination
of the short-term and long-term costs (17). One
study has estimated the magnitude of the
additional costs attributable to low birth weight
at 35 % of all health care costs for infants (< 1
year) and 10 % of all health care costs for
children (18). This is equivalent to the cost of
unintentional injuries, the leading cause of
death for children after infancy (17). It has been
shown that a collaborative quality improvement
of the neonatal care of very preterm infants can
quickly and substantially reduce the costs of
care (19). This implies that preventive measures
aimed at reducing the incidence of PTB will
immediately release economic resources, and
Fig. 2. Prevalence of CP per 1000 live births according to gestational age. (From data in Hagberg B, Hagberg G,
Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year
period 1991-94. Acta Paediatr 2001;90(3):271-7).
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in the long run, reduce human suffering from
life-long disabilities.
2. Preterm birth
2.1 Sub-grouping of preterm birth
The possibility that the clinical consequences
of prematurity for the infant could vary
according to causal mechanism has led to a
subdivision of PTB into sub-groups (20). One
classification of PTB is based on the manner
in which the patients presents, i.e. spontaneous
preterm labor (PTL), preterm prelabor rupture
of membranes (pPROM) and elective induction
or cesarean section (CS) (usually due to a
complication of pregnancy), respectively (20).
The first two groups are often combined and
called spontaneous PTB, in contrast to
indicated PTB. This subdivision has been
questioned but is still the one in most common
use (21). All studies related to this issue are
hospital-based.
The proportion of preterm deliveries resulting
from PTL varies in different studies from 18 to
64 % (22-24), while that resulting from
pPROM is reported at between 7 and 51% (25-
27). The proportion of preterm deliveries
classified as indicated varies between 18 and
38% (23, 25, 28).
2.2 Spontaneous preterm birth
Since the beginning of the eighties a compelling
amount of evidence has been presented,
suggesting a strong association between
microbial invasion of the amniotic cavity
(MIAC), PTL and pPROM. MIAC and the
presence of pro-inflammatory cytokines in the
amniotic fluid (AF), the intra-amniotic
inflammatory response, are known to induce
the release of uterotonic substances such as
prostaglandins from gestational tissue, thereby
causing uterine contractions and labor (29).
Infection may cause up to 30% of PTL cases
and may either be clinically evident or, more
often, subclinical (30).  At any rate, the etiology
of PTB is multifactorial and the exact cause in
each case can rarely be identified.
Evidence of activation of the fetal
hypothalamic-pituitary-adrenal axis in relation
to preterm delivery has also been presented
(31). Spontaneous parturition in primates is
characterized by fetal adrenal synthesis of C19
androgens which, in turn are aromatized by the
placenta into estrogens, including estrone,
estradiol and estriol. Among non-human
primates, a rise in AF concentration of estrone
precedes or coincides with increases in AF
prostaglandin concentrations, which begin to
rise several days before parturition (32). In
humans, placental corticotropin releasing
hormone (CRH) (33, 34),  maternal salivary
estradiol (35) and maternal plasma estradiol
concentrations all increase before spontaneous
preterm parturition (31). In contrast to
infection-associated parturition, spontaneous
parturition at term is associated either with no
increase or minor increases in AF
concentrations of cytokines (36, 37).
2.3 Animal models for studying
spontaneous preterm birth associated
with infection and inflammation
Several animal models have been developed
in order to study further the role of infection
and inflammation in PTB. Some investigators
have used a mouse model for studies of
infection- and inflammation-associated PTB
(38-41). Lipopolysaccharide (LPS) and pro-
inflammatory cytokines have been injected in
pregnant mice (day 12-14 of 19-day pregnancy)
and preterm delivery has been observed within
24 hours.
Others have used a rabbit model (42-47);
Dombroski et al have, for instance, shown that
bacterial inoculation via the vagina results in
PTB (46). There is also a primate model;
pregnant rhesus monkeys (36, 48) can be
infected (day 130 of 167 day pregnancy) which
will cause PTB (36).
3. Cerebral palsy in preterm infants
CP is defined as a group of non-progressive,
but often changing, motor impairment
syndromes, secondary to lesions or
abnormalities of the brain, and arising in the
16
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early stages of development (49). CP diagnosed
in the first two years of life may resolve during
early childhood, especially when functional
impairment is mild (50-52). Mild CP had
resolved in 72% of the cases on reexamination
at age seven in one study (50). Nonetheless,
children with resolved CP were almost 10 times
more likely to be mentally retarded, which
indicates that the neurological abnormalities
observed were a valid indication of antecedent
brain damage rather than a variation of the
normal (50, 53). This indicates that the child
must be at least 4 or 5 years old before a reliable
diagnosis can be made (9).
CP is associated to cerebral white matter
damage. The classical neuropathological white
matter damage findings associated to CP
include periventricular leukomalacia (PVL)
and periventricular hemorrhagic infarction (54-
56). A diffuse white matter injury with
widespread gliosis and hypomyelination is also
commonly seen (57, 58). The motor function
impairment may be explained by the observed
white matter damage (59). Cranial
ultrasonography is therefore one of the most
important examinations for predicting the
development of CP (60, 61). Periventricular
echodensities are the cranial ultrasound finding
that most often predicts CP, followed by
echolucency and ventricular enlargement (due
to loss of white matter).  Echolucencies have
been the most studied and presumably the most
specific cranial ultrasound finding (62). Very
preterm neonates with this finding have a CP
risk of 59 %, about 20 times higher than very
preterm neonates without these findings (53,
62). Conversely, only 3 % of infants with
normal cranial ultrasound scans developed CP
(62). The diffuse white matter injury is more
easily seen with magnetic resonance imaging
(63, 64).  The strong association between
cranial ultrasound findings indicative of white
matter damage and CP suggest that etiologic
studies of white matter damage may provide
information about the etiology of CP.
3.1 Epidemiological studies (different
etiologies)
As an effect of the success of newborn intensive
care during the last three decades ensuring an
increasing survival of children born very and
extremely preterm, the prevalence of CP among
preterm children has risen (9, 65). The etiology
of CP is still poorly understood. Since CP is
not a disease but a symptom complex, clinically
defined at 4-5 years of age, it is not surprising
that there are considerable problems associated
with epidemiological studies of CP etiology:
the long time-lag between recognition of CP
and the presumed brain damage, disagreements
among examiners about clinical findings in
patients and changes in clinical findings over
time and, due to the lack of a definitive test for
CP, multiple and different possible causes (53).
Some risk factors have been repeatedly
observed to be related CP: low gestational age
(9, 53), low Apgar scores (66), male gender
(53), multiple gestation (67), intrauterine viral
infections (e.g. rubella, cytomegalovirus) (68-
70), iodine deficiency (71), exposure to methyl
mercury during pregnancy (69, 72) and
maternal thyroid abnormalities (69, 73). The
higher risk of CP in multiple births is apparently
related to prematurity or to antenatal death of
a co-twin or co-triplet (67, 74, 75) .
Intrapartal factors producing asphyxia have
traditionally been assumed to be the principal
cause of CP, but this assumption has been
reconsidered during the 80- and 90-ties. Today,
intrapartal asphyxia is still believed to account
for a relatively large proportion of CP in term
and near-term born infants, around 10 % (53);
some researchers feel that this figures is too
low (9). There is consensus that intrapartal
asphyxia seems to be of less importance for
the development of CP in very preterm infants.
Birth asphyxia is a poorly defined term relating
to a sequence initiated by hypoxia (76). There
is no definitive test for asphyxia and the clinical
signs are not specific (53). Using indirect signs
of birth asphyxia, recent studies suggest that
1) birth asphyxia may not be such an important
cause of CP as was previously assumed, but it
may sometimes constitute one element of a
multifactorial cause, 2) neonatal signs
17
Bo Jacobsson
associated with birth asphyxia may be early
manifestations of CP from a variety of causes,
of which birth asphyxia is only one, 3) the
majority of pathways to CP commence pre-
delivery (53, 73, 76-78).
The proportion of CP acquired post-neonatally
varies from 8 to 18 %; the causes are mainly
infectious, anoxic and traumatic (53).
4. Infectious and inflammatory mechanisms
in preterm birth and cerebral palsy
4.1 General inflammatory mechanisms
4.1.1 Inflammatory cells
Maternal and fetal inflammatory responses
include the involvement of cytokines,
chemokines, adhesion molecules, extracellular
matrix proteins with adhesive properties and
matrix metalloproteinases. All five of these
groups facilitates the transendothelial migration
of cells out of the circulation and into adjacent
organ parenchyma, which is essential for the
inflammatory process (79). When it comes to
PTB, nearly all of the disparate maternal and
fetal cell types in the uteroplacental unit are
integrated into the cytokine network. The
highly versatile macrophage, abundant in
uteroplacental tissues, has turned out to be a
potential pivotal cell type in this context (80).
The polymorphonuclear leukocytes found in
AF are of fetal origin in the majority of cases
(81). These data have raised the question of how
the fetal leukocytes might gain access to the
AF; via extravasation from the umbilical cord,
from chorionic vessels, from the chorionic plate
of the placenta or from fetal endothelium in
vessels in the alveolar space of the lung (81).
A primate model has been developed to study
this (82) but results have not yet been published.
The brain was previously thought to be
protected by the blood-brain-barrier, but it has
been established that the brain can no longer
be described as an immune-privileged organ
devoid of the capacity to initiate an
inflammatory response (83). The blood-brain
barrier is relatively ineffective in preterm
infants (84). It has been hypothesized that
cytokines and chemokines activate endothelial
cells and leukocytes in the circulation, diminish
the effectiveness of the blood-brain barrier (85)
and gain access to and activate microglia and
astrocytes, which in turn produce chemokines
and more cytokines (79). The chemokines
function as chemo-attractants for activated
inflammatory cells, including those in the
circulation (79).
The immediate response of the brain to a variety
of insults is characterized by the proliferation
and hypertrophy of microglia cells (the resident
inflammatory cells). The process of gliosis is
accompanied by the infiltration of activated
inflammatory cells derived from the periphery,
the inflammatory products of which act in
consort with centrally derived mediators in
eliciting a response to the injury (83). Although
some monocytes, macrophages and microglia
in the brain are derived from resident cells,
others are derived from the circulation (86).
4.1.2 Pro-inflammatory cytokines
The concept of pro-inflammation is based on
the genes coding for the synthesis of small
mediator molecules that are up-regulated
during inflammation. Type II phospholipase
A2, cyclooxygenase (COX)-2 and inducible
nitric oxide (NO) synthase are examples of
these genes. These genes code for enzymes that
increase the synthesis of platelet activating
factor and leukotrienes, prostanoids and NO.
Pro-inflammatory cytokine-mediated
inflammation does not normally occur in
healthy individuals (87). Interleukin (IL)-1 and
tumor necrosis factor (TNF)-α are considered
to be the prototypic pro-inflammatory
cytokines.  Although inflammatory products
such as endotoxins act as triggers, the cytokines
IL-1 and TNF-α are particularly effective and
act synergistically in the process of activating
the inflammatory genes (87). Interferon (IFN)-
γ, IL-6 and IL-18 are other cytokines
considered to possess pro-inflammatory
properties. Genes coding for chemokines are
also considered to be pro-inflammatory (87).
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IL-6
IL-6 is a protein consisting of 185 amino acids
and glycosylated at positions 73 and 172. It is
synthesized as a precursor protein consisting
of 212 amino acids. Monocytes express at least
five different molecular forms of IL-6 with
molecular masses of 19-26 kDa. It maps to
human chromosome 7p21-p14.
The IL-6 gene promoter contains many
different regulatory elements allowing the
induction of gene expression by various stimuli,
including glucocorticoids and cAMP. The
nuclear factor kappa B (NF-κB) binding site is
responsible for the induction of IL-6 production
in non-lymphoid cells, so NF-κB is considered
to be an important transcription factor for IL-6
(88).
IL-6 is a cytokine with pro-inflammatory and
immunomodulatory properties, produced by
many cell types including activated phagocytes,
macrophages, monocytes and endothelial cells.
IL-6 functions in both innate and specific
immunity and stimulates the synthesis of acute
phase proteins by hepatocytes as well as the
growth of antibody-producing B lymphocytes
(88). TNF-α and IL-1 stimulate the
transcription of IL-6 which acts synergistically
with these two cytokines in many situations
(87). IL-6 is known to be a multifunctional
cytokine that regulates immune response,
hematopoesis, the acute phase response and
inflammation (88).
IL-18
IL-18 is a recently described member of the
IL-1 cytokine family (due to its structure,
receptor family and signal transduction
pathways) and was initially defined as an IFN-
γ inducing factor (89, 90). IL-18 is synthesized
as a precursor, requiring caspase-1 for cleavage
into the active form (90). Human pro-IL-18
contains 193 amino acids and has a molecular
mass of 24 kDa (91). Activated IL-18 cytokine
has a molecular weight of 18kDa (92). It maps
to human chromosome 11q22 (90). The
intracellular signal pathway includes the
transcription factor NF-κB which up-regulates
transcription of the IL-18 gene (92).
IL-18 is a cytokine with pro-inflammatory and
pro-apoptotic properties. It is mainly
synthesized by macrophages, monocytes and
keratinocytes, but can also be produced by
epithelial cells (93-97). IL-18 enhances the
inflammatory process by stimulating the
production of INF-γ and TNF-α and IL-1β (91).
IL-12 can act synergistically with IL-18 to
provoke a T helper 1 response (97, 98).
4.1.3 Chemokines
Chemokines (short for chemoattractive
cytokines) are small (8-10 kDa) inducible
proteins (99, 100). Chemokines have the
capacity to activate leukocytes and mediate
inflammatory reactions. These proteins are
involved in diverse immune responses to which
they recruit various leukocytes (99). Four
classes of chemokines have been described,
based on the conserved cysteine residues on
the mature protein: α-chemokines, β-
chemokines, γ-chemokines and fractalkine or
neurotactin (101). The two major sub-families
are: C-X-C chemokines (α-chemokines) which
have an amino acid between two cysteines, and
C-C chemokines (β-chemokines), which have
two adjacent cysteines. α-chemokines possess
potent chemoattractive properties, mostly for
neutrophils; β-chemokines exert their effect on
monocytes, lymphocytes, eosinophils and mast
cells, but not on neutrophils (88, 99, 100).
IL-8
IL-8 is the prototypic α-chemokine, previously
called neutrophil attractant/activating peptide-
1. IL-8 is produced by the processing of a
precursor protein consisting of 99 amino acids.
Processing of this precursor by specific
proteases yields N-terminal variants of IL-8.
IL-8 contains 72-77 amino acids (no
glycosylated sites) and has a molecular weight
of 8-11 kDa. The IL-8 gene maps to human
chromosome 4q12-q21.  NF-κB is an important
transcription factor for IL-8 as well (88, 99).
IL-8 is produced by monocytes, macrophages,
fibroblasts, endothelial cells, keratinocytes,
melanocytes, hepatocytes, chondrocytes, and
a number of tumor cell lines in many different
cell types (88, 99). The synthesis of IL-8 is
strongly stimulated by IL-1 and TNF-α in many
cell types (88, 99). IL-8 is thought to be the
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primary regulatory molecule of acute
inflammatory states, because of its potent
neutrophil chemotactic effect (99) . Neutrophil
migration into the inflamed peritoneal cavity
is severely inhibited in IL-8 transgenic mice
(102).
Monocyte chemotactic protein - 1
Monocyte chemotactic protein (MCP)- 1 is the
prototypic β-chemokine. MCP-1 is produced
by the processing of a precursor protein
consisting of 99 amino acids. MCP-1 contains
76 amino acids (one glycosylated site) and has
a molecular weight of 11-15 kDa. The MCP-1
gene maps to human chromosome 17(q12-q21)
(88, 99). NF-κB is also an important
transcription factor for MCP-1 (99).
A great deal of research has identified the
chemoattractants and activators responsible for
neutrophil and lymphocyte traffic but less is
known about the molecules regulating
monocyte migration (103). Certain
chemokines, such as MCP-1, have been
demonstrated to recruit monocytes into foci of
active inflammation (103).  MCP-1 is produced
in a great variety of cells, including monocytes
and macrophages. There are indications that
MCP-1 is uniquely essential for monocyte
recruitment in several inflammatory models in
vivo (104).
4.2 Infectious and inflammatory
mechanisms in preterm delivery
One reason for the lack of progress in reducing
PTB is the poor understanding of the
pathophysiological process related to PTL and
pPROM (30). Pathologic processes implicated
in the etiology of the preterm labor syndrome
include infection, uteroplacental ischemia,
uterine overdistension, abnormal allograft
recognition, allergic phenomena and cervical
disease (105, 106). Over the past two decades,
the important concept has emerged that PTL
most likely represents a heterogeneous
syndrome characterized by uterine contractility,
cervical ripening, and/or membrane rupture
(105). Inflammatory responses can be initiated
by any foreign stimulus, from foreign bodies
to specific bacterial pathogens (105). As only
a minority of PTL cases can be attributed to a
clinically evident intra-uterine infection, most
PTL cases secondary to infection are likely to
be the result of an inflammatory response in
the maternal and fetal gestational tissue
generated in response to these pathogens. This
inflammatory process is mediated by cytokine
production and ultimately results in
prostaglandin production, an important cascade
in the onset and propagation of myometrial
contractility and subsequent labor and birth
(107).
4.2.1 Microbial invasion of the amniotic
cavity
Microorganisms may gain access to the
amniotic cavity by the following pathways: 1)
ascending from the vagina and cervix; 2)
hematogenic dissemination through the
placenta (trans-placental); 3) retrograde seeding
from the peritoneal cavity through the fallopian
tubes; 4) accidental introduction at the time of
invasive procedures such as amniocentesis,
percutaneous fetal blood sampling or chorionic
villous sampling (107). Several lines of
evidence support the idea of the ascending route
as the most common (29, 106, 107):
histological chorioamnionitis is more common
and severe at the membranes rupture sites than
in other parts of the membranes (108), bacteria
identified in cases of congenital infections are
similar to those found in the lower genital tract
(106, 107, 109), inflammation of the chorionic
membranes is present in most cases of
congenital pneumonia (stillbirth or neonatal),
the membranes of the first twin more often has
signs of inflammation in twin gestations and
signs of inflammation  have not been observed
exclusively in the second twin in the absence
of such signs in the first twin (106, 107, 110).
A four-stage process leading to intrauterine
infection has been proposed (111). Stage I: an
overgrowth of facultative organisms or the
presence of pathological organisms in the
vagina. Bacterial vaginosis may be one of the
manifestations at this stage. Stage II: the
microorganisms ascend, gain access to the
uterine cavity and then reside in the decidua.
Stage III: a localized inflammatory reaction
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leads to deciduitis which extends into
chorionitis, leading to choriovasculitis (fetal
vessels inflammation) and, via the amnion
membrane (amnionitis), into the amniotic
cavity resulting in intra-amniotic infection.
Stage IV: once in the amniotic cavity, the
bacteria may gain access to the fetus by
different routes of entry: aspiration, otitis,
conjunctivitis and omphalitis. Seeding from
any of these sites to the fetal circulation leads
to bacteremia and sepsis (111, 112).
The bacteria isolated from the upper genital
tract among women who have had PTB are all
microorganisms generally believed to be of low
virulence, typically representative of the normal
microbial flora in the cervix and vagina (113,
114). The timing of the upper genital tract
infection is not completely understood but most
evidence indicates that bacterial ascension from
the lower to the upper genital tract occurs earlier
rather than later in gestation (114, 115).
Regardless of when or how they arrive in the
upper genital tract, these bacteria may reside
in the chorio-decidual interface, where they are
associated with chronic low-grade
inflammation for many weeks before resulting
in spontaneous labor or rupture of the
membranes (114). Activation of the host
response as early as mid-trimester by elevated
levels of AF IL-6 at amniocentesis in a subset
of women that later had a late pregnancy loss
or an early spontaneous preterm delivery serves
as evidence of this process (116, 117). There is
also data available to support the possibility that
upper genital tract microbial colonization and
inflammation may be present prior to
conception (118). If Ureaplasma urealyticum
is detected at a mid-trimester amniocentesis,
the patient is likely to give birth at around 24
weeks of gestation (119, 120). Viral infections
seem to be of less importance related to late
fetal loss or early preterm delivery (116).
In summery, it is an established fact that
clinically silent upper genital tract infection and
inflammation are strongly associated with an
increased risk of spontaneous PTB (29, 106,
107, 111, 114, 120). The proportion of women
with MIAC is much greater in women whose
pregnancies have been the object of sampling
and delivery at earlier gestational age (115, 121,
122). However, although infection may only
account for perhaps 20–25% of all PTB and
although intra-amniotic inflammation (IAI)
may account for a similar proportion. Infection
and inflammation may account for the majority
of the early spontaneous PTB and thus the
majority of infant morbidity and mortality (115,
122).
4.2.2 The inflammatory process within the
uterine cavity
The main hypothesis on how ascending bacteria
can lead to spontaneous PTB is as follows:
bacterial invasion of the chorio-decidual space
activates monocytes both in the decidua and
the fetal membranes to produce a number of
pro-inflammatory cytokines. Some
combinations of these cytokines stimulate
prostaglandin synthesis and release and initiate
a sequence of neutrophil chemotaxis,
infiltration, and activation, culminating in the
synthesis and release of a number of
metalloproteases. The cytokines and
prostaglandins stimulate contractions, while the
proteases attack the chorioamniotic
membranes, leading to rupture of membranes.
Various proteases also remodel cervical
collagen, resulting in cervical ripening (120).
An overview is presented in Fig. 3.
Macrophages seem to play a pivotal role in the
defense against microbial invasion of the
uterine cavity by phagocytosis and by synthesis
and secretion of large amounts of cytokines and
other regulatory molecules. Macrophages are
a major cell type in both the maternal and fetal
compartments of the uteroplacental unit. They
are abundant in the decidua and in fibrous
tissues near the placenta. In the placenta,
macrophages can be isolated in the
mesenchymal stroma. In the extraplacental
membranes, fetal macrophages populate the
mesenchymal stroma between the amnion and
chorion layers (80).
The bacteria invading the choriodecidual
interface release endotoxins and exotoxins that
activate the decidua and the fetal membranes.
Several studies have shown that phospholipase
A2 and C and LPS are capable of stimulating
production of prostaglandins by the amnion and
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decidua in vitro (123). Phospholipase A2 can
cleave and release arachidonic acid, which can
be metabolized to prostaglandins, leukotrienes
and epoxides. Substantial evidence supports the
critical role of prostaglandins in the preterm
and term labor process by inducing
myometrical contractility, as well as, changes
in the extracellular matrix metabolism
associated with cervical ripening; they are also
presumed to be involved in decidual and fetal
membrane activation (114, 123).
Until recently it was thought that bacteria alone
were responsible for various clinical and
metabolic derangements seen with infection,
but today we know that host immune responses
and endogenous products precipitated by
bacterial endotoxins are, to a large extent
responsible for the deleterious effects of the
infection (123).  There is a growing body of
evidence that PTB may, in the presence of
bacterial invasion or infection, be caused by
the host-mediated response through activation
of the macrophage-monocyte system by
bacterial products and tissue injury. Pro-
inflammatory cytokines and chemokines (TNF-
α, IL-1α, IL-1β, IL-6, IL-8 and granulocyte-
colony stimulating factor (G-CSF)) are released
on activation of these cells by microbial
products (114, 123). The release of these pro-
inflammatory cytokines and exotoxins create
a positive feedback loop which recruits more
monocytes and macrophages to the infected
area, sustaining the host-mediated response
(123).
Other pathways may play a role as well. In
chorionic tissue, prostaglandin dehydrogenases
normally inactivate the prostaglandins
produced in the amnion, preventing them from
reaching the myometrium and causing
contractions. If the chorionic membrane is
infected the dehydrogenase activity decreases,
allowing increasing quantities of
prostaglandins to reach the myometrium (124,
125) and uterine contractions.
Fig. 3. Mechanisms of preterm labor due to infection (Modified from Goldenberg RL, Hauth JC, Andrews WW.
Intrauterine infection and preterm delivery. N Engl J Med 2000;342(20):1500-7).
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Recent evidence suggests that infection may,
in many cases, involve the fetus. A fetal host-
response is induced with increased levels of
plasma cytokines. This is the background of
the concept of fetal inflammatory response
syndrome (FIRS) (123, 126, 127). In fetuses
with infection, increases in both the fetal
hypothalamic and placental production of
corticotropin-releasing hormone cause an
increase in fetal corticotropin secretion. This
results in fetal adrenal production of cortisol,
which in turn increases the production of
prostaglandins (114).
An alternative hypothesis has recently been
suggested, i.e. that the main event actually
happens in the choriodecidual interface and that
localized inflammation here is actually a
sufficient cause of preterm delivery.
Choriodecidual inflammatory syndrome
implies that this inflammatory process and its
effects, rather than a silent infection in the
amniotic cavity, are the main issues in the
pathogenesis of PTL (128). This hypothesis
does not explain the strong association between
intra-amniotic cytokines and preterm delivery.
4.2.3 Fetal inflammatory response syndrome
FIRS is thought to represent an acute-phase
response resembling that seen in adult patients
with septic chock, systemic inflammatory
response syndrome (SIRS). This syndrome
apparently includes aberrations in multiple
organ systems (e.g. hematological, endocrine,
connective tissue and cardiovascular) (129).
FIRS was launched as a concept based on
studies of cytokines from cordocentesis and
umbilical cord blood from neonates. Proof has
accumulated of fetal capability to initiate an
inflammatory response to microorganisms that
have gained access to fetal circulation. FIRS
was originally defined in 1998 by relating IL-
6 levels in cord plasma to severe neonatal
morbidity (respiratory distress syndrome,
proven or suspected sepsis, intraventricular
hemorrhage, PVL, necrotizing enterocolitis,
bronchopulmonary dysplasia) (126, 127). An
IL-6 fetal plasma level above 11 pg/mL is a
major independent risk factor for developing
severe neonatal morbidity. These data suggest
that the pathophysiological derangements
responsible for some neonatal complications
may begin before birth rather than merely being
attributable to immaturity.
MIAC has been associated with a fetal plasma
IL-6 level > 11 pg/mL, suggesting that fetal
exposure to bacteria may result in elevation of
plasma IL-6 (127). Fetal bacteremia has been
demonstrated, by cordocentesis, in 30 % of
patients with MIAC and pPROM (130).
However, the mode of bacterial entry, into the
fetus from the AF is unknown. It has been
suggested that the fetal lung represents the route
of entry into the fetal compartment after MIAC
(43) and results of another study supports this
idea (131). Large doses of intra-amniotic
endotoxin do not cause fetal death or abortion
(132, 133) but much smaller doses administered
intramuscularly or into the peritoneal cavity do
result in fetal death (133, 134).  These findings
suggest that intra-amniotic endotoxin does not
tend to enter the fetal circulation rapidly. About
one week after intra-amniotic endotoxin
administration, fetal white blood cell counts
increase (132, 135, 136), but only if the contents
of the amniotic sac can gain access to the lungs
(131). Concentrations of inflammatory
cytokines are also increased in the umbilical
arterial blood of sheep days after intra-amniotic
endotoxin administration (135). Other routes
of entry are possible as well, e.g. other mucosa
in contact with AF or the placenta.
It has been proposed that onset of labor has a
survival value and is initiated when the
intrauterine environment is so hostile that it
threatens the survival of the fetal-maternal pair.
Elevated IL-6 in cord plasma from
cordocentesis in patients with pPROM without
contractions is associated with impeding the
onset of spontaneous preterm delivery (126).
This indicates that pro-inflammatory cytokines
are involved in the initiation of labor since the
elevation occurs before the clinical onset of
labor (126). Another pro-inflammatory
cytokine, IL-1β, did not have this relation to
impeding delivery, which might be due to the
time span of the IL-1β elevation and the sample
size in the study (137).
Several observations support the notion that an
inflammatory process already present in
23
Bo Jacobsson
umbilical cord blood at birth, may mediate
short- and long-term complications of
prematurity. Elevated umbilical cord IL-6 is
associated with development of cerebral white
matter lesions and congenital neonatal sepsis
(138, 139). Elevated IL-18 in umbilical cord
blood was found to be associated with PVL and
CP (140).
Studies of SIRS in children and adults (129)
may provide valuable information about FIRS.
SIRS was initially viewed as a predominantly
inflammatory phenomenon with increased
levels of so-called pro-inflammatory cytokines
in the blood and increased activation of
endothelial cells and leukocytes. These pro-
inflammatory mediators might be implicated
in the multiple organ dysfunction and increased
mortality in patients who develop SIRS (141-
143). Today SIRS is regarded as having both
an inflammatory and an anti-inflammatory
component simultaneously. The anti-
inflammatory phenomena in SIRS usually
include both proteins (e.g. anti-inflammatory
cytokines such as IL-10) and cells (monocyte
deactivation) (144).The parallel (or, less likely,
sequential) anti-inflammatory phenomena
appear to explain the increased risk of infection
seen in people with this disorder.
On the protein level, the anti-inflammation pro-
cess often consists of increased plasma levels
of cytokines that block the binding of pro-
inflammatory cytokines to their cell surface
receptors (interleukin-1 receptor antagonist,
soluble TNF receptors) or induce the synthesis
and release of so-called anti-inflammatory
cytokines (IL-10, transforming growth factor-
b) (144). On the cellular level, in blood, the
anti-inflammation process is expressed as
monocyte deactivation by disabling monocytes
from processing antigen (characterized most
commonly by reduced HLA-DR expression)
and disabling polymorphonuclear leukocytes
from up-regulating in response to inflammatory
stimuli. People who have such defects are at
increased risk of death due to overwhelming
infection (144). There is one published study
regarding the anti-inflammatory phenomena in
FIRS (145). The soluble TNF-α receptors are
increased in fetal plasma in FIRS (145).
Further observations on FIRS have been made
lately. Funisitis and chorionic vasculitis seem
to be the histological counterpart of this
condition (146, 147). Neonates born to mothers
with clinical chorioamnionitis had higher
concentrations of umbilical plasma IL-6 than
those born to women without clinical signs of
infection. A fetal origin of the excess plasma
IL-6 was suggested by the arteriovenous gra-
dient observed in the group with
chorioamnionitis (148). Also metalloproteinase
8 levels in AF have been related to funisitis,
the histological hallmark of FIRS (149).
It has been a common misconception that fetu-
ses and neonates are immunologically naive.
However, neonatal human T-cells proliferate
in response to an array of antigens, auto-
antigens and allergens. Nevertheless, fetuses
have a limited ability, both in quantitative and
qualitative terms, to initiate immune responses,
compared to adults and probably also to neona-
tes (150). Some research findings suggest that
preterm neonates are less able to initiate a
vigorous inflammatory response than term
counterparts (151-153). However, some
findings support the view that very preterm
neonates can initiate a more vigorous systemic
inflammatory response than their term peers
(152, 154-157). One study revealed that lower
gestational age is associated with an increased
ability to secrete proteins that can block pro-
gression of the inflammatory response (156).
Other reports support the view that very pre-
term neonates are less able to initiate a vigorous
systemic anti-inflammatory response than term
neonates (158-160).
The concept of FIRS relates to the idea that
plasma content is of fetal origin and mirrors
the fetal response to certain stimuli. But data
obtained from fetal plasma and umbilical cord
blood must be interpreted with caution
concerning to what extent the content is totally
of fetal origin.  Despite the fetal and maternal
circulations being physically separated by
villous trophoblast layers of the placenta, blood
cells move from one circulation to the other.
The proportion of neonates with maternal cells
in their umbilical cord blood varies
considerably (1-100% of neonates) (161-164).
In a recent publication, unique maternal DNA
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sequences were found in 43 of 57 (75%) cord
plasma samples (165).
4.2.4 Sources of cytokines in the amniotic
fluid
The suggested main possible sources of
cytokines within the AF are decidua, fetal
membranes, maternal circulation and possibly
the fetus itself. The relative contribution of the
maternal and fetal compartments to the overall
inflammatory response is unknown (114).
There are different cell types within the decidua
that can act as sources of different cytokines,
e.g. activated resident macrophages located
throughout the reproductive tract, or
macrophage-like decidual cells released in
response to bacterial products (80, 111, 166).
The idea of an extra-amniotic source of intra-
amniotic cytokines, is contradicted by a study,
the findings of which indicate that, AF does
not reflect the cytokines produced by the
decidua in case with intact and non-inflamed
fetal membranes (80). The fetal membranes
have been shown to be important producers of
cytokines, which are probably released into the
AF to some extent. Different layers in the
membranes are involved in cytokine production
in different ways (Table I).  IL-6 and IL-8 are
produced by both layers of the membrane (167-
170). IL-18 is produced by the chorion
membrane but not by the amnion (171). IL-1β
is probably produced mostly in the chorion
(168).
Maternal circulation can be another source but
few reports have studied this issue. Researchers
in one study proposed that IL-8 does not cross
the placenta in either direction by simple
diffusion. Likewise, no evidence of active
transfer processes for IL-8 was found (172).
This implies that activation and chemotactic
effects of chorionic and amniotic IL-8 on
neutrophil granulocytes appears to be limited
to the fetal compartment (172).
The fetus itself could be a source of the
cytokines in the AF. Many different cytokines
and chemokines have been identified in
umbilical blood from newborns, e.g. IL-6, IL-
8 and IL-18. IL-6 has been identified in
umbilical cord blood obtained by cordocentesis
and in some of those cases with high intra-
amniotic levels the blood levels are also
increased (127).
4.2.5 Cytokines in amniotic fluid
The traditional view on the onset of parturition
in the presence of infection has been that the
bacteria or their products (endotoxins) directly
stimulate prostaglandin biosynthesis. As
knowledge has accumulated and understanding
of the concept has changed, it has become
obvious that there was an overlap between labor
Table I. The expression of mRNA (detected by in-situ hybridization) and cytokine peptides (detected by
immunohistochemistry or by ELISA) in cultured amnio-chorion. 
Amnion 
membrane
Chorion  
membrane
Decidua
mRNA protein mRNA protein mRNA protein
IL-1β         (168) - ? + +
IL-6           (168) + + + +
IL-8           (167, 169) + + + + +
IL-18         (171) - - + + + +
MCP-1      (167) - + +
RANTES  (167) - + +
IL-10         (167) - + +
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and non-laboring groups regarding the presence
of endotoxins; a link was missing (173).  After
re-consideration the concept emerged that
infection (but also other triggering agents)
induced stimulation of immune cells to produce
cytokines and the subsequent synthesis and
release of prostaglandin E2 and prostaglandin
F2α, which have been shown to induce cervical
ripening, uterine contractions and labor at term
(174-177). Cytokines also have been implicated
in the physiological mechanisms of term labor
and pathophysiological mechanisms of PTL
(173). The association between several AF
cytokines has been evaluated in relation to
different preterm outcome variables (173). It
has been proven that several cytokines in AF
are increased in cases of MIAC e.g. TNF-α
(176, 178), IL-1 (176, 179, 180), IL-6 (176,
179-189), IL-8 (190, 191), IL-18 (192),
granulocyte colony stimulating factor (G-CSF)
(191), macrophage inflammatory protein-1α
(MIP-1α) (193) and growth related protein
(GRO-α) (194, 195).
4.2.6 Intra-amniotic inflammation
The gold standard for the diagnosis of infection
in clinical medicine is the isolation and
identification of the microorganism from body
fluid or tissue. However, microbial culture may
take days, and results are often not available in
time for important clinical decisions. This is in
contrast to the diagnosis of inflammation that
is more easily arrived at (e.g. blood cell count,
cytokine determination). Therefore the
prevalence and outcome of IAI has attracted
interest. IAI is more common than MIAC and
is associated with adverse maternal and
neonatal outcome (122). The maternal and
neonatal outcome  of patients with only IAI
does not differ from that of MIAC (122). IAI
seems to be twice as common as MIAC (122,
185). These studies have been performed in
patients with PTL. IAI in women with pPROM
has not been studied to the same extent as in
women in PTL, but there is one study that has
provided indirect information regarding this
issue (196). Without calling the condition IAI,
the authors actually defined the condition
similarly by drawing a receiver-operation-
characteristic (ROC) curve for both cervical
fluid and AF IL-6 in relation to MIAC and they
found the same cut-off level (0.35 ng/mL) for
both fluids. IAI in pPROM is also related to
delivery within 7 days and significant neonatal
morbidity (196). IAI seems to have different
characteristics in women with pPROM (197).
IAI without MIAC, may nonetheless be a
bacterial reason for the inflammatory reaction.
Studies using polymerase chain reaction (PCR)
to detect bacteria in the AF have been able to
demonstrate that the sensitivity for detecting
MIAC is much higher with this technique than
with standard procedures (198, 199). Another
subgroup of IAI without MIAC is cases with
extra-amniotic (between the amniotic and
chorionic membranes) detectable bacteria.
Previous studies have demonstrated that AF IL-
6 may be elevated in these patients (185), but
still IAI might nonetheless also have a non-
bacterial cause.
4.3 Infectious and inflammatory
mechanisms in cerebral palsy
Evidence suggests that 70-80 % of CP cases
are due to prenatal factors and that birth
asphyxia plays a relatively minor role (76, 200).
The inflammatory/cytokine hypothesis, one of
the important prenatal hypotheses, proposed
initially by Leviton and Adinolfi, according to
which a maternal infection may lead to elevated
fetal blood and brain cytokine levels, which
may result in central nervous damage and
subsequent CP (201-203). Leviton also
extended the hypothesis, suggesting that
cytokines such as TNF-α, produced in response
to MIAC, contributed to both PTB and
periventricular white matter damage (203).
Dammann and Leviton argued further for this
hypothesis by finding support for four other
sub-hypotheses: 1) Cytokines are present in all
three relevant compartments (i.e. uterus, fetal
circulation and brain), 2) cytokines are present
in or may cross boundaries (placenta and blood
brain barrier), 3) cytokines may contribute to
the occurrence of intraventricular hemorrhage,
4) cytokines may be involved in the induction
of white matter damage (204). An overview is
presented in Fig.4.
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An important study has shown that blood
inflammatory cytokine levels were
significantly higher in full term infants that
developed CP than in controls (205).
In a preterm population, an association between
pro-inflammatory cytokines such as IL-6 and
IL-8 in AF and CP has been observed (206).
IL-6 in AF is also related to intraventricular
hemorrhage and elevated IL-6, IL-1β and TNF-
α are associated with PVL (196, 207, 208).
Intraventricular hemorrhage and PVL are
associated with the development of CP.
Fig. 4. Possible relationship between pre-conceptional uterine colonization, intra-uterine infection/inflammation,
periventricular leukomalacia and cerebral palsy (Modified from Dammann et al  Dev Med Child Neurol 1997;39:836-
40).
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The main aim of this thesis was to investigate
infectious and inflammatory mechanisms
related to PTB and CP in a Scandinavian
population with a low incidence of PTB.
Specific aims
1. To examine the relationship between
the existence of intra-amniotic
microorganisms and the levels of IL-6
and IL-8, and their relationship to PTB
(delivery within 7 days and delivery at
< 34 weeks of gestation, respectively)
in a Swedish population of women in
PTL (Paper I) and in women with
pPROM (Paper II).
2. To investigate (Papers III and IV) how
IL-18 and MCP-1 levels in cervical
fluid and AF in PTL and in AF in
pPROM are affected by microbial
invasion of the AF, preterm delivery (<
34 weeks, ≤ 7 days) and IAI. We also
compare the intra-amniotic IL-18 level
in PTL with that in pPROM, as IL-18-
induced apoptosis has been suggested
to be important in the rupture of
membranes. In addition, the levels of
IL-18 and MCP-1 in cervical fluid and
AF in women in PTL and in non-
laboring women at term were
compared.
3. To evaluate (Paper V) maternal,
antenatal and intrapartal risk factors for
spastic CP in preterm children,
especially those factors related to feto-
maternal infections. We also examine
the risk factors for the subtypes of CP.
The very preterm group (<32 weeks)
and the moderately preterm group (32-
36 weeks) were analyzed separately, as
infection is considered to be a more
common cause of very PTB.
OBJECTIVES
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1.Patients
1.1 Cohort study of PTL patients (I, part of
III and IV)
A total of 66 patients were recruited at the
Department of Obstetrics and Gynecology at
Sahlgrenska University Hospital in Göteborg,
Sweden, between 1996 and 2001. The majority
of the patients (n=59) were recruited  at
Sahlgrenska University Hospital/East (1997-
2001) and some patients (n=7) were recruited
at Sahlgrenska Hospital in the beginning of the
study (1996-1997). Inclusion criteria were:
women with a singleton pregnancy in PTL with
altered cervical status (see below) and a
gestational age of 22 - 34 weeks. PTL was
defined as regular uterine contractions (at least
2 uterine contractions/10 minutes during ≥ 30
minutes) in combination with cervical
alterations: 1) ≤ 2 cm length + ≥ 1 cm dilatation;
2) ≤ 2 cm length + cervical softening; 3) ≥ 1
cm dilatation + cervical softening; 4) cervical
length <30 mm at endovaginal ultrasound.
Exclusion criteria were: known uterine
abnormalities, fetal malformations, significant
vaginal bleeding, imminent delivery or fetal
distress.
Gestational age was determined in all patients
except three by routine ultrasound in the second
trimester (16 to 19 weeks of gestation). Date
of last menstrual period was used for gestational
length determination when a routine ultrasound
was not available. Tocolytic therapy
(intravenous terbutaline and/or indomethacin,
the latter, if the pregnancy was < 28 weeks of
gestation) was administrered according to the
department protocol.
1.2 Cohort study of pPROM patients (II,
part of III and IV)
Fifty-eight women with singleton pregnancies
and pPROM were recruited. The women
presented at 2 delivery wards in Göteborg
(Sahlgrenska Hospital (1996-1997; n=14) and
Sahlgrenska University Hospital/East (1997-
2001; n=44)). pPROM was defined as
amniorrhexis (diagnosed by a speculum
examination confirming pooling of AF in the
vagina) before the onset of spontaneous labor.
Digital examination was not performed.
Women with contractions before rupture of
membranes, known uterine abnormalities, fetal
malformations, significant vaginal bleeding,
imminent delivery or fetal distress were not
included.
1.3 Cohort study of IL-18 and MCP-1 in
PTL, pPROM and term patients (III
and IV)
The PTL groups in these studies consisted of
87 patients in the IL-18 study and 75 patients
in the MCP-1 study. These are partly the same
patients as in paper I. The pPROM-group
consists of the same patients as in paper II.
Twenty-eight women at term (≥ 37 weeks) were
also included in the IL-18 study and forty-five
were included in the MCP-1 study. These
women were scheduled for an elective CS with
the following indications: psychosocial, breech
presentation or two previous CS.  None of the
term patients had contractions or rupture of
membranes prior to surgery.
1.4 Case-control study (V)
The population-based western Swedish CP-
project was the case identification source (9,
209-213). When the case-control study started
we used the two last four-year cohorts (birth
years 1983-1986 and 1987-1990) (211, 212).
Since then, another four-year cohort report has
been published (9). The register is population-
based in the sense that it includes all children
born in Sweden and living in the study area on
the date when the youngest child in the
population is 4 years old. This date was
December 31st, 1990 for the birth years 1983-
MATERIAL AND METHODS
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1986 and December 31st, 1994 for the birth
years 1987-1990. The general methodology has
been described in detail elsewhere (210, 213).
All children with spastic CP were included
(n=152), but not children with non-spastic CP
(dyskinetic CP without spasticity and simple
ataxia) (n=7). Children with an obvious
postnatal (> 28 days after delivery) cause of
CP were also excluded.
The controls were selected using the Swedish
Medical Birth Register (MBR). The MBR is
administrated by The National Board of Health
and Welfare in Sweden. It contains
prospectively collected medical record data
from antenatal care, delivery and pediatric
examination of neonates. The MBR is
population-based, covers 98-99% of deliveries
in Sweden and has been validated (214). The
controls were matched for gestational age,
gender, multiple gestation and delivery ward,
all known risk factors for CP (9, 215-217). The
births that met the criteria, occurring most
closely before and after the case birth were
chosen as controls.
2 Methods
2.1 Cohort studies (I, II, III, IV)
An ultrasound-guided transabdominal
amniocentesis, at which 30-50 ml of AF was
aspirated, was performed under antiseptic
conditions within 12 hours after admission. In
women at term, AF was retrieved during CS. A
catheter was introduced into the amniotic cavity
and 50 mL of AF was aspirated prior to opening
the membranes. After retrieval, the AF was
immediately placed in a refrigerator  (+4°C)
and was centrifuged within 5 hours of sampling
for 10 minutes at 855 g in +4°C. The
supernatant was stored at –80°C until analysis.
Cervical fluid was obtained with a Cytobrush
(Cytobrush Plus GT, Medscan Medical AB,
Malmö, Sweden) from the external cervical os
of PTL and term patients. The cervical mucus
was weighed and kept in a refrigerator (+4°C)
until processed within 5 hours. The Cytobrush
with the cervical mucus was submerged in 1.0
mL NaCl, shaken for 30 minutes at +4°C,
followed by centrifugation at 855 g at +4°C
for 10 minutes and stored at –80°C until
analysis.
2.1.1 Bacterial analyses
A sample of uncentrifuged AF was immediately
transported to the microbiological laboratory
for PCR analysis of Ureaplasma urealyticum
and Mycoplasma hominis and for aerobic and
anaerobic culture. Microbial invasion was
defined as positive PCR and/or growth of any
bacteria in the AF, except coagulase negative
Staphylococcus (CoNS), which was considered
to be a skin contamination. Bacterial isolates
were characterized biochemically by using the
API Rapid ID32STREP, Rapid ID32A,
ID32STAPH, ID32E, API ZYM, API Coryne,
API50CHL, ID32C according to the
manufacturer’s instructions (API bioMérieux).
These systems identified anaerobes,
coryneform bacteria, yeasts, streptococci,
Enterobacteriaceae and other Gram-negative
rods, the Staphylococcus and Micrococcus
genera and the Lactobacillus genus and related
organisms. PAGE analysis of whole-cell
proteins was performed as described by Pot et
al (218) . The GelCompar 4.1 software package
(Applied Maths) was used for densitometric
analysis, normalization and interpretation of
protein patterns. Anaerobic bacteria were
further analyzed by fatty acid analysis using
the MIDI specifications (219). Some of the
difficult bacterial isolates were identified by
DNA sequencing. The 16S rRNA genes in the
isolates were amplified by PCR and directly
sequenced by using the Big dye terminator
cycle sequencing kit (Applied Biosystems) and
an automatic DNA sequencer (model 310,
Applied Biosystems).
2.1.2 Cytokine analyses
IL-6, IL–8, IL-18 and MCP-1 in AF and
cervical fluid were analyzed by enzyme-linked
immunosorbent assay (ELISA). Commercially
available paired antibodies and standards (from
R&D Systems, Minneapolis, Minn, USA) were
used in a sandwich ELISA setup. The samples
were diluted 1:5, 1:20 and 1:100 and run in
duplicates, except the MCP-1 samples which
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were diluted 1:2, 1:3 and 1:6. The inter-assay
variation was calculated at < 10% for IL-6 and
IL-8 and at <25% for IL-18, based on analyses
of several samples on three separate occasions.
The coefficient of variation (29-76%) were
higher for low values (≤ 700 pg/mL for IL-6
and IL-8 and ≤ 400 pg/mL for IL-18) The
ELISA detection limit was 30 pg/mL for IL-6,
IL-8 and IL-18, but the lower limit of detection
in these studies were 150 pg/mL because the
samples were run at a 1:5 dilution.
Comments:
Cytokines are considered to be stable at –80°C
but a recent study showed that a partial
degradation occurs even under these
circumstances (220, 221). IL-6 seems to be
most sensitive to higher temperatures (220,
221). No studies are available concerning the
handling of AF before freezing but informa-
tion on handling of blood samples indicates that
AF should promptly be placed in a refrigerator
(+4°C) and be centrifuged within 6 hours (222,
223). At any rate, the most important
recommendation is that all samples be hand-
led and frozen under identical conditions (222).
2.2 Case-control study (V)
This was designed as a case-control study,
focusing on the infectious and inflammatory
mechanisms that can be related to the
development of spastic CP.
2.2.1 Variables studied
The primary variables in focus were those
related to maternal infectious morbidity during
pregnancy and delivery: clinical
chorioamnionitis, histological
chorioamnionitis, pyelonephritis, fever before/
during/after delivery, postpartum endometritis,
use of antibiotics during pregnancy. The
secondary variables studied were complications
related to pregnancy and delivery: second and
third trimester bleeding, abruptio placentae,
umbilical cord complications. Several
descriptive variables were also collected. The
reason to preterm delivery were classified:
spontaneous, indicated – bleeding, indicated –
hypertensive disease, indicated – pathological
non-stress test, indicated – severe abdominal
pain, indicated – suspected or clinical
chorioamnionitis or other severe infections. A
total of 154 variables categorized as maternal
(40), antenatal (63), intrapartal or immediately
postpartal (51) were investigated in this study.
A database was constructed and tested in a pilot
study by scrutinizing 48 medical records at
Sahlgrenska University Hospital/Sahlgrenska.
After analyzing the database function
modifications were made and the records were
re-scrutinized. One investigator, unaware of the
pediatric outcome, examined all records.
3 Ethical considerations
Approval for the studies was obtained from the
Ethics Committee at Göteborg University.
3.1 Cohort studies (I, II, III, IV)
In studies I-IV, the women gave informed
consent before enrollment. The main ethical
consideration in these studies was if the
amniocentesis could in any way affect the
pregnancy outcome. A review of the literature
pertaining to this issue is presented in the
Discussion section.
3.2 Case-control study (V)
A database was constructed using the collected
data available only to the datacompiler. This
database was protected by a user ID and a
personalized password. The database was de-
personalized before the basic analysis. The
majority of the records were scrutinized at the
archives; a minority (from small hospitals
outside the region) were requested and sent by
mail.
4 Statistics
4.1 Cohort studies (I, II, III, IV)
Continuous variables were analyzed with the
Mann-Whitney U test and proportions were
compared using Fisher’s exact test. Spearman’s
rank correlations test was used for analysis of
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correlation between continuous variables. We
selected the best cut-off level for cytokines and
chemokines, relating to different outcome
variables of interest, from a receiver-operator
characteristic (ROC) curve, in order to
minimize the sum of type I and type II errors.
Using this level to define the risk group, we
compared time to delivery through a survival
analysis. The risk ratio was calculated by using
relative risk (RR) and 95% confidence interval
(CI). A p-value < 0.05 was considered
statistically significant, as was a CI not
including 1.
Calculations were made using the computer
programs StatView 5.01 (SAS Institute Inc,
Cary North Carolina, USA) and InStat 2.01
(Graph Pad Software, San Diego California,
USA).
Comments:
As these are prospective cohort studies RR is
appropriate when calculating risk ratio.
4.2 Case-control study (IV)
Univariate logistic regression was used to esti-
mate the odds ratio (OR) with a 95% CI for
correlation between one factor and the
outcome. Statistical significance was conside-
red to exist if the 95 % CI did not include 1.
Proportions were compared using Fisher’s
exact test. Wilcoxon’s rank-sum test was used
to test continuous variables for differences
between two groups.  A p-value < 0.05 was
considered to be statistically significant.
Calculations were made using SAS (SAS In-
stitute Inc, Cary North Carolina, USA) and
InStat 2.01 (Graph Pad Software, San Diego,
California, USA ).
Comments:
In a prospective study, groups of subjects with
different characteristics are followed up to
explore whether an outcome of interest occurs
and whether it is possible to calculate a risk
ratio for that outcome. This study is a case-
control study in which the subjects are selected
according to outcome. This means that we
cannot estimate the risk ratio by comparing the
risk of the outcome in those with and without
the characteristic.  It is possible to obtain any
risk ratio by varying the number of studied
cases and controls. Therefore, in order to
estimate a risk ratio in a case-control study, a
comparison within the characteristic groups and
an OR is calculated (224, 225).
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1. Cohort studies (I, II, III, IV)
1.1 General description
1.1.1 PTL
Sixty-six patients underwent amniocentesis. In
five women, no AF or an inadequate amount
was obtained and no analyses could be
performed. In one patient, the AF was only
analyzed with PCR for Ureaplasma
urealyticum and Mycoplasma hominis, leaving
60 patients with a sufficient amount of AF to
allow the complete set of analyses. In the PTL
group, 44.3% (27/61) delivered before 34
weeks and 63.9% (39/61) before 37 weeks of
gestation (Fig. 5). Twelve patients were given
antibiotics before or during delivery. Two
patients were treated with antibiotics as
prophylaxis, and 3 patients were treated
because of bacteria in the AF. No patient was
taking antibiotics at amniocentesis. Fourteen
patients were given corticosteroids before
amniocentesis, thirty-six patients after
amniocentesis and eleven were not receiving
any corticosteroids at all. In the PTL group, 18
% (11/61) of the patients were of non-Swedish
origin according to their antenatal records: (Iran
(n=3), Bolivia (n=2), Chile (n=1), China (n=1),
Hungary (n=1), Lebanon (n=1), Somalia (n=1)
and Turkey (n=1)). Labor did not begin
spontaneously in five patients. Three of the
inductions were at term (week 38, 40, 40) and
two were preterm, the letter because of severe
preeclampsia (week 32) and painful
contractions (week 35), respectively. None of
the inductions were undertaken within 7 days
after amniocentesis.
1.1.2 pPROM
Fifty-eight patients with pPROM, before
uterine contractions started, underwent
amniocentesis. In five patients, no AF or an
inadequate amount was obtained and no
analyses could be performed. In another six
patients, the AF was only analyzed for bacteria
with PCR and culture, leaving 47 patients with
a sufficient amount of AF to allow a complete
set of analyses. In the pPROM-group, 70.2%
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Fig. 5. Gestational age at inclusion and birth in the preterm labor group.
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(33/47) delivered before 34 weeks and 89.4%
(42/47) before 37 weeks of gestation (Fig. 6).
Contractions began prior to amniocentesis in
seven cases of pPROM. Thirteen patients were
given antibiotics before or during delivery, two
of which because of bacteria in the AF. No
patient was taking antibiotics at amniocentesis.
All but two patients were treated with
corticosteroids, eleven before amniocentesis.
In the pPROM-group, 23 % (11/47) were of
non-Swedish origin according to their antenatal
records: (Iraq (n=2), Turkey (n=2), Bosnia-
Herzegovina (n=1), El Salvador (n=1), Iran
(n=1), Poland (n=1), Romania (n=1), Somalia
(n=1) and Yugoslavia (n=1)). Delivery did not
begin spontaneously in twelve patients. Labor
was induced in eight patients (week 33, 33, 33,
34, 34, 34, 38, 38) and 4 had CS before onset
of delivery (week 29, 32, 34, 40). Indication
for the preterm inductions were prolonged
pPROM, with fever as additional indication in
one case, vaginal bleeding in another and in
three cases that the gestational age exceeded
week 34. The indications for the three preterm
CS were fever (week 29), suspected abruptio
placentae (week 32) and transverse lie (week
34). Three of the inductions and none of the
CS occurred within 7 days after amniocentesis.
The indications for the three inductions were:
passed 34 weeks (week 34, 34) and vaginal
bleeding (week 33). There were three
inductions before 34 weeks, the indications for
which were low platelets (week 33), fever
(week 33) and vaginal bleeding (week  33),
respectively .
1.2 Microbial invasion of the amniotic cavity
MIAC is examined in papers I and II and the
relevant bacteria are presented in Table 2 in
both papers. The prevalence of MIAC was 16%
in women in PTL and 25% in women with
pPROM. We found bacteria that have been
identified in AF before, except for one case of
Sneathia sanguinegens.  CoNS was considered
to be contamination.
Comments:
We have identified 36 amniocentesis sampling
studies, all non-Scandinavian, in which the
prevalence of MIAC in women in PTL was
reported (108, 110, 121, 127, 176, 181, 182,
184, 186, 199, 226-250). It is difficult to
compare these studies, because of differences
in study design, inclusion criteria, bacterial
identification technique and frequency of
Fig. 6. Gestational age at inclusion and birth of the women in the preterm pre-labor rupture of
membrane
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amniocentesis in eligible patients. However,
according to these studies, 13% (415/3108) of
successful amniocenteses were culture or PCR
positive (Fig. 7).
With a slightly different spelling one study have
previously reported a case of Actinomyces
odontolyticus in AF (228). CoNS has both been
reported as a contamination, as we have done,
and as an infection causing microorganism in
the literature (122, 184, 199, 226, 227, 232, 239,
240).
The prevalence of MIAC was 25 % in the
pPROM study. We have identified 18 studies
(127, 130, 198, 229, 248, 251-262) that report
the prevalence of MIAC in women in pPROM
(all non-Scandinavian, two European (England,
Italy)). According to these studies, culture or
PCR from 34 % (509/1512) of successful
amniocentesis have had a positive bacterial
culture (Fig. 8). At any rate, with the limitations
mentioned above, our results are comparable
to those of others. The use of PCR to identify
the Ureaplasmas might have yielded a
comparatively higher level of MIAC. The use
of culture for detection of the Ureaplasmas
might give false negative results. Among the
43 patients with a positive PCR for Ureaplasma
urealyticum, AF culture was negative in 42%
(18/43) (198). CoNS has both been reported as
a contamination, as we have done, and as an
infection causing microorganism in the
literature (196, 198, 254).
In international studies, more than one
microorganism is isolated from AF in fifty
percent of patients with MIAC (107). In these
two studies, we found only two patients (2/23)
with two types of bacteria in the AF. The fact
that Ureaplasma urealyticum and certain
anaerobes predominate in our patients with
pPROM must affect the choice of antibiotic if
amniocentesis is not performed in the clinical
situation (is most often the case in Sweden).
1.3 IL-6
ELISA for IL-6 in AF was performed in 61
patients in the PTL group and in 47 patients in
the pPROM group. IL-6 was detectable in the
Fig. 7. The prevalence of microbial invasion of the amniotic cavity in women in preterm labor. Modified from  Goncalves
LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev
2002;8(1):3-13.
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amniotic samples in 80% (49/61) of the women
in PTL and in 79% (37/47) of the women with
pPROM.
In the PTL group, AF IL-6 was related to
MIAC, delivery within 7 days and delivery <
34 weeks. In the pPROM group, AF IL-6 was
related to MIAC and delivery within 7 days
but not to delivery < 34 weeks. Three patients
in the pPROM group underwent induction of
labor within 7 days from amniocentesis, and
the cases might therefore be misclassified as
spontaneous delivery within 7 days. Exclusion
of these patients did not alter results. There were
also 3 inductions and 2 CS before the onset of
contractions in the pPROM group, so they
could be misclassified as spontaneous delivery
< 34 weeks. Exclusion of these patients did not
alter the results either.
Comments:
IL-6 in AF of patients in PTL or with pPROM
has well-documented relations to MIAC (176,
179-189), histological chorioamnionitis (176,
182, 183, 189, 263-266), PTB (176, 182-184,
186) and significant neonatal morbidity and
mortality (183, 266). Our results concur with
those in the literature.  This indicates that IL-6
follows the same pattern in a Scandinavian
population with its low incidence of PTB as in
populations with higher incidences of PTB. We
found that nearly 80% of women in PTL
leading to PTB had elevated IL-6 levels (≥1.5
ng/mL), compared to 11% of those that did not
deliver preterm. Our data support the concept
that intra-amniotic IL-6 is one of the best
predictors of PTB (186).
1.4  IL-8
ELISA for IL-8 in AF was performed in 61
patients in the PTL group and in 47 patients in
the pPROM group. IL-8 was detectable in the
amniotic samples in 64% (39/61) of the women
in PTL and in 66% (31/47) of women with
pPROM.
In the PTL group, AF IL-8 was related to
MIAC, delivery within 7 days and delivery <
34 weeks. In the pPROM group, AF IL-8 was
Fig. 8
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related to MIAC and delivery < 34 weeks but
not to delivery within 7 days. Three patients in
the pPROM group underwent an induction of
labor within 7 days and these cases might be
misclassified as spontaneous delivery within 7
days. If these patients are excluded, a
significant relationship was also found between
IL-8 and delivery within 7 days. The cut-off
level for IL-8 in defining IAI was not altered
by these exclusions. There were also 3
inductions and 2 CS before the onset of
contractions in the pPROM group, which might
be misclassified as spontaneous delivery < 34
weeks. Exclusion of these patients did not alter
results.
Comments:
IL-8 in AF in patients in PTL or with pPROM
is related to MIAC (190, 191, 195), PTB (267),
histological chorioamnionitis (267) and
bronchopulmonary dysplasia (268). We found
that the alpha chemokine IL-8, which induces
neutrophil attractant and activating responses,
was highly expressed in the AF both in the PTL
and pPROM cases. Our results concur with
those in the literature. Previous studies have
shown that pPROM is associated with a
cytokine response including expression of IL-
1, IL-6, IL-8 and TNF-α (123).
1.5 Intra-amniotic inflammation
IAI seems to be twice as common as MIAC in
women in PTL (122, 185). In our study, the
frequency of IAI in women in PTL actually
approached three times the MIAC rate, which
might be partly due to the fact that we used a
combination of IL-6 and IL-8 levels to define
the condition. An inflammatory response,
defined in our study as IL-6 ≥ 1.5ng/mL and/
or IL-8 ≥ 1.3 ng/mL, was found in 45.9 % (28/
61) of the patients. Other researchers have
found the best cut-off level for IL-6 in AF to
be 2.6 ng/mL (122) or 2.0 ng/mL (109). Our
cut-off levels for IL-6 in defining IAI in both
the PTL and the pPROM groups, is in
accordance with other studies, even if the
definitions differ (122, 196). Other
investigators have made their calculations in
relation to different outcome variables
(microbes present in the AF (122) and IL-6 ele-
vation over the 70th percentile (109),
respectively).
Only half of the patients with an inflammatory
response, as defined above, in the PTL group
and only 37 % (10/27) of the patients with
pPROM, defined as IL-6 ≥ 0.80 ng/mL or IL-8
≥ 0.42 ng/mL, had detectable microorganism
levels in the AF despite PCR being used for
detection of Ureaplasma urealyticum and
Mycoplasma hominis (198). This concurs with
previous reports (122), and probably indicates
that some microorganisms cannot be detected
with the techniques used or that PTB can result
from non-infectious inflammation.
1.6 IL-18
The PTL group in this study consisted of 87
patients. ELISA for IL-18 was performed in
cervical fluid (n=87) and in AF (n=59). In the
patients with accessible AF, IL-6 and IL-8
levels were available from the previous studies.
The pPROM group included 47 patients with
available IL-18, IL-6 and IL-8 samples from
AF. IL-18 was detectable in the cervix in 60%
(52/87) of women with PTL and in 11% (3/28)
of women at term. IL-18 was detectable in the
amniotic samples in 73% (43/59) of the women
in PTL and in 70% (33/47) of the women with
pPROM. IL-18 was detectable in AF in 11%
(3/28) of the term cases.
There were higher levels of IL-18 in cervical
fluid of women in PTL, compared with non-
laboring women at term. The patients with IAI
were excluded in order to facilitate assessment
of the influence of gestational age on the IL-
18. The levels of IL-18 in cervical fluid in
women in PTL were still higher than in non-
laboring women at term (PTL: IL-18 0.41 ng/
mL; term: median 0.15 ng/mL; p<0.001). No
correlation was seen between gestational age
at sampling and IL-18 levels in cervical fluid.
In AF there were also higher levels of IL-18 of
women in PTL, compared with non-laboring
women at term. The patients with IAI were
excluded in order to facilitate assessment of the
influence of gestational age on the IL-18 level
in AF. The IL-18 levels in the AF of women in
PTL were still higher than compared with non-
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laboring women at term (median IL-18 0.38
ng/mL; median IL-18 0.15 ng/mL; p<0.001).
No correlation was seen between gestational
age at sampling and IL-18 levels in AF.
IL-18 levels were studied in AF in women in
PTL; MIAC, delivered within 7 days after
amniocentesis or before 34 completed weeks
as well as IAI had significantly increased levels
in this group. In women with pPROM, these
associations were not significant. No difference
was found between IL-18 levels in the PTL and
pPROM groups.
Comments:
IL-18 in cervical fluid and AF is of great interest
when it comes to the outcome of PTB,
especially since IL-18 has been proven to affect
long-term neurological outcome of preterm
children (140). No study concerning IL-18 in
cervical fluid is available, but two previous
studies have presented data regarding IL-18 in
AF (171, 192). Both Pacora et al and Menon et
al were able to detect IL-18 in all their samples.
We detected IL-18 in 71.8 % of our samples.
We found IL-18 levels similar to those reported
by Menon et al and 10-100 times higher than
those found by Pacora et al (Table 2). Menon’s
and our study were performed with antibody
from the same provider (R&D Systems), but
Pacora used an antibody from another provider.
The IL-18 antibody from R&D System is
directed towards an epitope on the active part
of IL-18.
IL-18 levels in both cervical fluid and AF seems
to decrease with increasing gestational age.
This relationship is consistent if patients with
IAI are excluded. This is new information as is
the fact that IL-18 in cervical fluid is related
neither to MIAC, PTB nor IAI. This result
contradicts results obtained by Pacora et al who
found a significant increase with gestational
age.
MIAC was associated with increased AF IL-
18 in PTL but not in pPROM cases. Bacteria
previously identified in AF, e.g.
Corynebacteria, Pseudomonas aeruginosa,
Haemophilus influenzae and Chlamydia
tracomatis, have been shown to provoke an IL-
18 response in vivo in other compartments of
the human body (90). It is also important to
note that the amniotic concentrations of IL-18
in patients with pPROM and MIAC were not
higher than in cases of pPROM with sterile AF.
This does not apply to IL-6 and IL-8, levels of
which were higher in patients with microbial
invasion both in the PTL and pPROM groups.
These data suggest that IL-18 plays different
roles in PTL and pPROM. A similar dichotomy
between PTL and pPROM has previously been
observed when it comes to TNF-α and IL-1α
(180, 192).
Table II. IL-18 levels detected in amniotic ﬂ uid in the three published studies on this subject . 
Data are given in ng/mL.
Pacora et al (192) Menon et al (171) Jacobsson et al (III)
PTL ~ 0.016 (0.004-0.28) 0.92 (0.1-2.7) 0.59 (0.15 – 6.7)
pPROM ~ 0.014 (0.004-0.34) 1.86 (0.3 – 15.2) 0.35 (0.15 – 3.4)
term ~ 0.019 (0.006-0.14) 0.16  (0.1-1.2) 0.15 (0.15 – 0.79)
(median and range)
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Women in PTL who gave birth within 7 days
(or <34 weeks) had higher levels of IL-18 in
the AF than those who delivered after 7 days
(or ≥34 weeks). This relationship between IL-
18 and interval to delivery was not found by
Pacora et al (192), a discrepancy that might be
due to differing gestational age (<34 weeks vs.
<37 weeks, respectively) (12), since
inflammation may be more important at low
gestational ages (122). In women with pPROM,
the opposite relationship was found, i.e. high
IL-18 levels were associated with longer
interval to delivery; this should, however, be
interpreted with caution since few patients (8/
47) had high levels ≥ 1.0 ng/mL.
1.8 MCP-1
There were higher levels of MCP-1 in cervical
fluid and AF in women in PTL compared with
non-laboring women at term.
There were higher levels of MCP-1 in the
cervical mucus in women in PTL who gave
birth within 7 days than in those with a longer
sample-delivery interval. Women in PTL who
gave birth within 7 days after amniocentesis
had significantly higher levels of MCP-1 in AF
than those who gave birth after 7 days. In the
pPROM group, the levels of MCP-1 in patients
that delivered in ≤ 7 days did not differ from
those with an interval > 7 days. Three patients
were allocated to the spontaneously delivered
group despite labor being induced. However,
the results were not affected by exclusion of
these cases. We performed a log rank survival
analysis of the best MCP-1 cut-off level in AF
(≥ 2.0 ng/mL) for delivery within seven days
of women in pPROM, with censor of patients
with induction of labor or CS before onset of
delivery (n=12). A significant difference
between the two groups regarding long interval
to delivery was found, in contrast to short
interval to delivery (Fig. 3 in article IV).
In AF there were higher levels of MCP-1 in
PTL women who gave birth before 34 weeks
of gestation than in those who delivered at ≥
34 weeks of gestation). In women with
pPROM, there was no association between AF
MCP-1 and delivery < 34 weeks. There were 3
inductions and 2 CS before the onset of labor;
these cases might be misclassified as
spontaneous delivery < 34 weeks. Exclusion
of these patients did not affect the results.
MCP-1 levels were higher in cervical mucus
in women in PTL with MIAC than in those with
sterile AF. In AF, the levels of MCP-1 were not
significantly higher in women in PTL with
MIAC than in those with sterile AF. In women
with pPROM, the levels of MCP-1 in AF were
higher in women with than in those without
MIAC.
There were also higher levels of MCP-1 in the
cervical mucus in women in PTL who had IAI.
MCP-1 in AF correlated to general IAI both in
women in PTL and in women with pPROM.
MCP-1 in cervical fluid predicted PTB and
MIAC with a high negative but low positive
predictive value. The AF levels of MCP-1 also
predicted MIAC and IAI in patients with
pPROM.
A correlation was seen between MCP-1 in
cervical fluid and AF (r=0.35 and p=0.02).
There was a high degree of correlation between
MCP-1, IL-8 and IL-6 in AF in both the PTL
(IL-8 r=0.74 and p<0.001; IL-6 r=0.70,
p<0.001) and the pPROM groups (IL-8 r=0.64,
p<0.001; IL-6 r=0.41, p=0.005).
Comments:
MCP-1 is the prototypic β-chemokine. It
recruits and activates monocytes and
macrophages. The macrophages in the decidua
and membranes are presumed to play a critical
role in the preterm labor syndrome. It is thus
most interesting that MCP-1 seems to be
associated with MIAC and IAI both at the
cervical and amniotic level.
Cervical ripening has been described as an
inflammatory process (269). The infiltration of
white blood cells (both neutrophils and
macrophages) into the cervix is known to occur
in women at term (270). Neutrophils are
responsible for most of the connective tissue
changes that take place during cervical
ripening, but macrophages are also involved,
although their specific role is still unclear (271).
There is a tenfold increase in macrophages in
cervical tissue from early to late pregnancy
(270) and another increase in number during
the final cervical ripening at birth (272).
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Chemokines have been proposed to be involved
in cervical ripening via their chemoattractant
and activating effects on neutrophils and
monocytes (273). Although functional
redundancy exists with other chemokines in
vitro, MCP-1 is exclusively responsible for
mononuclear cell infiltration in several
inflammatory animal models in vivo (104). It
is thus possible that MCP-1 is also involved in
the cervical ripening process via activation and
recruitment of monocytes and macrophages.
Monocytes and macrophages play a critical role
in the immune response, both by being potent
producers of pro-inflammatory cytokines,
matrix metalloproteinases and prostaglandins
and by processing and presenting antigens to
T-cells for recognition. In that sense, they
regulate both the innate and the specific
immune systems. It has been proposed that the
β-chemokines are likely to induce chemotaxis
of monocytes and macrophages into the
amniotic cavity and activate them (274). β-
chemokines may be involved in the host
defense against MIAC and in IAI. It was not
surprising that there was a significant
association between MCP-1 and MIAC in
women with pPROM, which is in accordance
with preliminary data reported by Esplin et al.
(275). MCP-1 is thus the third β-chemokine
(MIP-1α, RANTES) that has been shown to
increase in response to MIAC (193, 274).
The poor correlation between the levels of
MCP-1 in cervical fluid and AF in our study
may indicate different production sites. MCP-
1 is known to be produced by term placenta,
decidua and chorion and, to a lesser extent, by
the amniotic epithelium (167). It has been
shown that cell cultures of cervical fibroblasts
can produce MCP-1 (276) and
immunohistologically stained cervical biopsies
from pregnant women are positive for MCP-1
(277). MCP-1 is probably produced locally by
cervical tissue. However, the decidua and
membranes can be an alternative source of
MCP-1 as the inflammatory process leads to
disruption of the chorio-decidual interface,
leading to its possible release into the cervical
fluid (278). Kent et al found that AF does not
reflect the cytokines produced by the decidua
in cases with intact and non-inflamed fetal
membranes (279). Thus, and since the amniotic
epithelium appears to be a minor producer of
MCP-1, the fetus itself may be a source of
MCP-1. There are no reports of MCP-1 levels
Table III. Distribution of 148 preterm spastic CP cases according to 
type and gestational age 
Type of CP < 32 w
n           %
≥ 32 w
n           %
Total
n           %
Spastic diplegia 60            66% 28          49% 88       59.5%
Spastic hemiplegia 11            12% 20          35% 31          21%
Ataxic-spastic diplegia 11            12% 4             7% 15          10%
Spastic tetraplegia 9              10% 5              9% 14         9.5%
Total 91 57 148
w = weeks of gestation
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in umbilical cord blood but MCP-1 is present
in dried neonatal blood spots obtained from 3-
day-old neonates (205) and the respiratory tract
of the preterm baby is a known producer of
MCP-1 (280). Further studies are required to
determine the source of MCP-1 in cervical fluid
and AF.
MCP-1 is also part of the IAI in both PTL and
pPROM. However, in contrast to the findings
in the PTL group, we found no correlation
between MCP-1 in AF and delivery within 7
days or before 34 weeks of gestation in patients
with pPROM. Similar results were recently
pertaining to IL-18 (281), supporting the idea
that IAI has different characteristics and
outcome in pPROM and PTL, respectively
(282).
The levels of MCP-1 in cervical fluid and AF
were higher in women in PTL than in non-
laboring women at term. MCP-1 in AF
probably reflects the feto-placental
inflammatory response, whereas cervical MCP-
1 reflects both inflammation related to cervical
ripening and the generalized feto-placental
inflammatory response.
2. Case-control study (V)
All medical records including all documents
required for the study were available. Two cases
and their controls were excluded because the
correct gestational age was ≥ 259 days. Two
cases were excluded together with their controls
due to unequivocal perinatal cytomegalovirus
infection. One hundred and forty-eight cases
and 296 controls were included in the final
analysis. The distribution of sub-types of CP
and gestational age is described in Table III.
The MBR was used to match the controls and
cases. In certain cases, in which the MBR did
not contain correct information about the
Table IV.  Clinical chorioamnionitis and CP. 
Modiﬁ ed from Wu Y W. Systematic review of chorioamnionitis and 
cerebral palsy. Ment Retard Dev Disabil Res Rev 2002;8(1):25-9 and 
Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: 
A meta-analysis. JAMA 2000;284(11):1417-24.
Study design Risk ratio
Allan et al cohort 2.6 (1.2-5.9)
Gray et al cohort 1.2 (0.1-10.2)
Kim et al cohort 2.3 (0.5-10.7)
Neson and Ellenberg cohort 3.4 (1.6-7.4)
Yoon et al cohort 2.5 (0.3-26.0)
Cooke case-control 3.3 (1.2-8.9)
Grether et al case-control 0.95 (0.5-2.0)
Grether and Nelson case-control 1.2 (0.8-1.8)
Jacobsson et al case-control 1.8 (0.9-3.6)
O’Shea et al case-control 2.5 (0.9-6.9)
Wilson-Costello et al case-control 2.1 (0.7-6.1)
Summary 1.9 (1.4-2.5)
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matching variables, the next patient with
correct matching variables was chosen.
The matching was complete for gestational age,
gender, single and multiple pregnancy.
Matching for delivery ward was complete in
only 84.5%, as controls could not always be
recruited from small units. In these cases,
controls were recruited from another unit of
similar level and size.
2.1 Infection related variables
Clinical chorioamnionitis/pyelonephritis (OR
2.02 (1.02-3.99)), histological chorioamnionitis
(OR 3.61 (1.16-12.1)) and long duration of
pPROM were associated with an increased risk
of CP, whereas treatment with anti-
inflammatory corticosteroids was associated
with a significantly lower risk (OR 0.42 (0.20-
0.90)). Fever before onset of delivery was of
borderline significance (OR 2.30 (0.99-5.17)).
Fever during delivery and postpartum
endometritis were not associated with CP
(Table 3 in paper V).
In the sub-group analysis, infectious indicators
such as administered antibiotics during
pregnancy (OR 2.39 (1.12—5.09)) and fever
before the onset of delivery (OR 3.10 (1.14-
8.44)), but not histological chorioamnionitis
(OR 2.80 (0.76-10.3) were associated with
diplegic CP. Fever before onset of delivery was
also an antecedent of CP in the very preterm
(<32 weeks)  (Table 4 in paper V).
Comments:
Clinical chorioamnionitis and pyelonephritis
were grouped together since severe infections
outside the genital tract have also been shown
to be associated with perinatal brain damage
(283). There were no cases of appendicitis or
any other abdominal cavity infection in the
study, but there were two cases of severe
pyelonephritis; both those children developed
CP. Appendicitis and pyelonephritis are rare
conditions in pregnancy and calculation, when
testing the infectious/inflammation hypothesis
requires that they be grouped together in
compiled diagnosis, even in a large case-control
study as ours. Clinical chorioamnionitis may
expose the fetus to infectious material more
directly than pyelonephritis. The incidence of
clinical chorioamnionitis in the case group was
10.8 % (16/148) and 6.4 % (19/296) in the
control group (OR 1.77 (0.88-3.55)). The OR
in this study, whether pyelonephritis cases are
excluded or not, is close to the OR that Wu et
al found in their meta-analysis (OR 1.9 (1.5-
2.5)) (284, 285) (Table IV).
Table V.  Histological chorioamnionitis and CP.
Modiﬁ ed from Wu YW. Systematic review of chorioamnionitis and 
cerebral palsy. Ment Retard Dev Disabil Res Rev 2002;8(1):25-9 
and Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral 
palsy: A meta-analysis. JAMA 2000;284(11):1417-24.. 
Study design Risk ratio
Yoon et al cohort 7.6 (0.9-66.6)
Grether and Nelson case-control 1.2 (0.7-2.0)
Jacobsson et al case-control 3.9 (1.2-14.0)
O’Shea et al case-control 1.3 (0.3-5.1)
Redline et al case-control 1.2 (0.5-2.8)
Summary 1.5 (1.5-2.5)
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The histological chorioamnionitis factor might
be burdened with selection bias since only 73
of 444 placentas were analyzed, but the
proportion of analyzed placentas was the same
in both groups (18.9% cases, 15.2% controls;
p=0.69). Since so few placentas were analyzed
in the different sub-groups there might be
power problems in the analysis. According to
two recent meta-analyses, eight studies (206,
207, 284, 286-291) examine the relationship
between histological chorioamnionitis and CP
(284, 285). These studies were found to be
somewhat heterogeneous in design; it was only
in our study and one other that a significant
association was found (Table V). In another
population-based control study of the etiology
of CP from the USA, they examined factors
that influence whether placentas were
submitted for pathologic examination (292).
Within birth weight groups the main
determinant of placental submission was
surgical delivery. Maternal and infant
conditions had little influence on the
submission rate. Whether this is applicable to
Swedish conditions is unknown.
There might also be a selection bias towards
less infectious cases, when it comes to
corticosteroids since corticosteroids were not
a part of the clinical routine during the study
period due to concerns about increasing the risk
of severe infection. If all patients at less than
34 weeks of gestation would have been
considered eligible for corticosteroid treatment,
then only 13.9 % (47/345) were actually
treated.
2.2 Other variables
Hypertensive disease (OR  0.54 (0.28-0.99)),
cervical insufficiency (OR 0.85 (0.70-0.98) and
iatrogenic reason to delivery (OR  0.54 (0.28-
0.99)) were all associated with a lower
occurrence of CP, whereas no difference was
found between cases and controls with regard
to spontaneous onset of labor (pPROM and
PTL) (Table 4 in paper V). Decreased viability
at birth (low Apgar scores at 1, 5 and 10 min)
was associated with higher occurrence of CP.
The OR was higher the later after birth the child
had a low Apgar score (Table 5 in paper V).
No case of hypothyroidism and only one case
of thyrotoxicosis (control) were diagnosed in
the study.
Risk factors for CP were also analyzed
separately for very and moderately preterm
infants, as well as for spastic diplegic and
hemiplegic forms of CP (Table 6, paper IV).
Abruptio placentae and low Apgar scores were
associated with a higher risk of CP, especially
in the hemiplegic and moderately preterm (32-
36 weeks) group.
Comments:
Hypertensive disease and iatrogenic reason to
delivery are partly found in the same group of
patients. Several studies have indicated that
preeclampsia and/or hypertensive disease
might be related to a decreased risk of
developing CP (293-295). This has raised
concerns about preeclampsia as a potential
confounder, raising the estimated degree of
association between chorioamnionitis and CP
(284).
We confirmed the fact that Apgar scores are
related to CP (66), especially after 5 and 10
minutes. In the subgroup analysis it is possible
to observe that a Apgar score < 7 yielded a
higher OR for CP in the moderately preterm
group and in the hemiplegic group.
In the case of cervical insufficiency, it is of
course difficult to ascertain, in a retrospective
study, whether the diagnostic criteria were met.
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patients with positive PCR for Ureaplasma
urealyticum (2/10), but it might have led to a
false high level of MIAC in the pPROM group
in which Ureaplasma urealyticum (n=9) is the
most frequent bacterium. But on the other hand,
only 37 % (10/27) of the patients with IAI had
detectable bacteria in AF, even less than in the
PTL group. However, as mentioned in Results,
it is difficult to compare the data on MIAC from
different studies, since they differ to such an
extent. Bearing this limitation in mind a Scan-
dinavian population apparently has the same
prevalence of MIAC as a USA population,
although just half of the PTB incidence. This
is somewhat surprising as Sweden also has low
incidence of perinatal infections.  Several lines
of evidence, reviewed in a number of articles,
indicate that MIAC is involved in the
pathogenesis of PTL, leading to PTB (29, 106,
107, 111, 112). In three studies (study I, II, III)
we have designated CoNS a skin contamination
but we had from study IV, and in the future,
considered CoNS to be MIAC  if accompanied
by IAI (PTL, n=1; pPROM n=1). This means
that one of the four CoNS found in the PTL
study were regarded as MIAC in the MCP-1
study (IV). At present, MIAC is not the opti-
mal marker for the intra-amniotic situation, as
it requires an invasive amniocentesis and
because of the low sensitivity of the technique
used. Sensitivity can be improved by the use
of broad-spectrum bacterial rDNA PCR (16S
rDNA) (199), but test results are not available
for days in current clinical practice.
IL-6 and IL-8 have turned out to be the most
AF valuable markers of MIAC and PTB, no
other pro-inflammatory cytokines have been
studied with such consistent results. IL-6 and
IL-8 levels are also increased in term normal
labor but to a lesser extent (303).
There is a need for clinical studies of patients
in PTL and with pPROM, stratified according
to presence/absence of IAI. The identification
of patients with the most substantial risk of
adverse outcome would have important clinical
implications. It is possible that delivery is
1. Preterm birth
It is currently acknowledged that genital tract
infection can occur in a subset of pregnant
women and persist in a chronic and subclinical
state, eventually resulting in spontaneous PTB
(115). This type of infection may also have
additional negative effects on the neonate,
including adverse neurological outcomes such
as CP (204).  The majority of these children
belong to a small proportion of children born
after spontaneous onset of labor before 32
weeks of gestation (<1%). Sweden has a much
lower incidence of PTB than the USA (1, 3).
Also, the incidences of perinatal infections in
Sweden and the USA/North America differ:
clinical chorioamnionitis in patients with
pPROM: 0.8% vs. 6.7 % (296, 297);
endometritis in patients with pPROM; 0.3 %
vs. 8.3 % (297, 298); neonatal infection in cases
of pPROM: 1.9% vs. 2.4 % (296, 299). This
difference had led us to speculate on infection
related spontaneous PTB as an explanation for
the differences in the incidence of PTB.
An appropriate preventive strategy directed at
this group of high-risk pregnancies might entail
a major opportunity to reduce the prevalence
of CP and the perinatal mortality rate. Several
preventive strategies have been attempted
without any substantial success (1). One main
issue in understanding these issues and
suggesting effective preventive strategies is the
lack of basic knowledge regarding the
protection of the fetus from the bacterial
hazards surrounding it – proximity to the
bacteria in the vagina and rectum – and how
the fetal immune system actually deals with
invading bacteria. Recent discoveries in
immunology suggest that the powerful innate
immune system is an important contributor to
the epithelial defense (300-302).
The prevalence of MIAC in our studies
approximate the median in studies based on
amniocentesis (Fig. 7 and 8). The use of PCR
is probably not the explanation for this data in
the PTL group since there were only two
GENERAL DISCUSSION
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preferable to tocolysis and/or antibiotics for
patients with IAI (or infection). On the other
hand, if individual fetal genetic constitution is
not disposed toward initiation of inflammatory
response, the risk of intra-uterine fetal death
or bad neonatal outcome may be even higher.
There is a need for randomized controlled
studies in order to clarify whether a fetus should
be kept in an inflamed/infected uterine
environment by the use of tocolytic and
antibiotic treatment. All future studies
concerning tocolytic and antibiotic treatment
of patients with pPROM or PTL should provide
information on IAI, as it is probably one of the
most important confounders of different
outcome variables of interest. Tocolytic and
antibiotic studies should provide information
(primary outcome variables) on short-term and
long-term infant morbidity outcome rather than
interval to delivery. A study, results of which
indicate that a certain treatment prolongs
pregnancy one week, is of little importance
without information on the intra-amniotic
environment during this week, as well as the
short-term and long-term outcomes for the
children in both treatment and non-treatment
groups. Information on the intra-amniotic
situation might be obtainable with a cervical
test, although the optimal cervical/vaginal test
is yet not available.
2. CP
The diversity of the CP diagnosis and etiology
is one of the major challenges in the study of
its etiology. Since CP is not defined according
to etiology or pathology, it is not surprising that
it is etiologically and pathological diverse.
There are several known antenatal causes of
CP: developmental, vascular, infective, genetic,
metabolic and toxic (304). Thus, it seems that
a variety of clinical pictures can arise from a
single cerebral pathology and that many
different clinical cerebral pathologies can result
in similar clinical entities (10). Adverse
antenatal events may either cause brain damage
themselves or make the infant more vulnerable
to the normal asphyxiating events during
delivery (10).  Experimental animal studies
indicate that bacterial endotoxin sensitizes the
immature brain to the effect of an asphyxiating
event (305). There are indications in the results
of clinical studies, that maternal infections may
increase the effect of asphyxia (306).
For a long time, AF infection was thought to
primarily represent a maternal condition, while
it may instead actually primarily be of fetal
origin (307). However, there are no possibilities
to study the AF in large retrospective case-
control studies, necessitating the interpretation
of fetal infections based on maternal symptoms
and signs. Several studies focus on maternal
infections and CP; as described above, maternal
infection moderately increases the RR of CP.
Our study agrees with the meta-analysis
presented by Wu et al (285). Only one major
study of term infants (>2500g) has been
presented and the results indicate that maternal
infections (excluding TORCH infections) at
delivery are a major risk factor (OR 9.3) for
development of unexplained spastic CP (308).
Hypothetically, if maternal infection was a
sufficient cause of CP, then the estimated
etiologic proportion attributable to this
diagnosis of total spastic CP in term children
would be 12 % (95% CI, 4-20%). In other
subgroups of CP, this percentage would be even
higher (unexplained spastic quadriplegia)
according to the same study (308).
There is no international consensus on the de-
finition of clinical chorioamnionitis; a variety
of definitions have been applied in the past.
Fever, maternal tachycardia, fetal tachycardia,
uterine tenderness, malodorous AF and
maternal leukocytosis in various combinations
are the most commonly used.  The cut-off
temperature was 37.8˚C in study I-IV because
that is the most common definition in studies
of AF infection/inflammation based on Gibbs
et al. (309, 310). We believed that it was
important to be able to compare our results to
previously published data. In the case-control
study of preterm children with CP, a slightly
higher cut-off temperature, 38.0˚C, was chosen
in order to allow comparison with most other
studies in that particular area (285, 308).
Many studies define chorioamnionitis or
intrauterine infection as described above. These
signs, chosen for their relationship with
maternal sepsis, are not sensitive indicators for
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infections with non-purulent agents common
to the genital tract, such as Mycoplasma and
Ureaplasma. Moreover, these signs are not
specific to intrauterine infection, because some
of them can result from pharyngitis, urinary
tract infection, dehydration or prolonged
epidural anesthesia. This terminology requires
improvement but today there is no widely
accepted alternative (311).
Fever before the onset of delivery and
antibiotics during pregnancy might indicate a
longer-lasting and more intense infectious and/
or inflammatory intrauterine environment (47).
Fever during delivery might be confounded by
increased temperature due to physical exertion
during delivery, epidural analgesia and thus
fetal exposure to a hostile intrauterine
environment might be shorter and less intense
in cases of intrauterine infection. Another
infectious variable of interest is the use of
antibiotics during pregnancy or delivery. There
are indications that this variable can serve as
not only an indicator of ongoing or previous
infection, but also of prolonged intrauterine
exposure to bacteria, bacterial products and
cytokines (42).
3. Amniocentesis in clinical practice and
safety
Amniocentesis in the third trimester is quite
common in an international context but more
rarely used in the Nordic countries. Indications
for this procedure are assessment of fetal lung
maturity before delivery, sampling AF for
karyotype analysis in cases of severe
intrauterine growth retardation,
isoimmunization and evaluation of intrauterine
conditions in patients with PTL and pPROM.
Complications to third trimester amniocentesis
have been discussed; e.g. need of urgent
delivery, rupture of membranes, shorter latency
to delivery, fetal injury, feto-maternal bleeding
and contamination of the amniotic cavity by
skin bacteria. Most studies on the safety of
third-trimester amniocentesis have been
performed before the era of ultrasound-guided
punctures and complications were than indeed
common (252, 312-314). When the first
ultrasound guided amniocenteses were
performed, an AF pool was located by
ultrasound examination and then a blind
puncture was performed.
Yeast et al studied 91 patients with pPROM
using ultrasound for identification of an AF
pool but performing punctures without
ultrasound guidance. They did not find any
shortening of the latency period but they used
patients with oligohydramnios (insufficient AF
for amniocentesis) as a control group which
might have influenced the results (315). There
were no fetal or cord complications in this study
but there was one maternal abdominal wall
hematoma (315).
In another study, a protocol entailing
continuous CTG monitoring of the fetal heart
rate for at least one hour after amniocentesis,
resulted in detection of six cases of urgent fetal
jeopardy, making appropriate interventions
possible. The amniocenteses were performed
without ultrasound guidance in this study (313).
Piiroinen et al performed 501 diagnostic
amniocenteses in order to assess pulmonary
maturity or to enable spectrophotometric
analysis of the AF in cases of isoimmunization.
In 92 patients, the procedure was repeated 2-5
times. An ultrasound examination preceded
amniocentesis which was performed without a
real-time examination. In nine cases (1.8%),
the membranes ruptured within 24 hours of the
puncture although it is unclear if these
particular women were subjected to more than
one puncture (314).
Only three studies, published during the last 5
years, have studied modern ultrasound-guided
amniocentesis (316-318). Ultrasound-guided
amniocentesis with real-time observation of
needle passage has a high success rate (98-
99%) and is considered to be a safe procedure
with a complication rate of less than 1 % (316-
318). Stark et al studied 913 amniocenteses,
indications for which were assessment of the
fetal lung maturity, with a focus on
complications necessitating urgent delivery. Six
cases required urgent delivery (five emergency
CS and one vaginal induced delivery that ended
in CS). Complications included fetal heart rate
abnormalities (n=3), placental bleeding (n=1),
abruptio placentae (n=1) and uterine rupture
(n=1). Four of the six complications were
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associated with two punctures, bloody fluid was
withdrawn in two of six procedures and two
were unsuccessful. The uterine rupture
occurred in a patient with a former classic
cesarean incision (316). Spontaneous labor did
not contribute to any complication requiring
immediate delivery or that led to the decision
to deliver before the results of the maturity
studies were available (316). In this study, 3%
had transient amniotic leakage after the
procedure (5 minutes to 8 hours). Haeusler et
al also found amniocentesis (192 procedures),
performed under continuous ultrasound
guidance, to be a safe procedure (318). They
also studied the acceptance of third trimester
amniocentesis and found that the expectations
of procedure–related pain were generally
higher than the experienced pain, the degree
of which was low (318). Gordon et al found a
high success rate (99.2%) and a low risk of
complications (0.7%) in their recently
published study. The complications were
rupture of membranes (n=1), PTL (n=1), feto-
maternal bleeding (n=1) and placental
abruption (n=1) and no subject required an
emergency CS (317). Transplacental needle
passage had occurred in the case of placental
abruption and was unclear in the other cases
(317). In this study, 50 patients required more
than one puncture (9%) and eight patients
(1.4%) required more than two. Bloody fluid
was obtained in 55 of the procedures (10%)
(317).
Most studies are performed with patients
undergoing amniocentesis for reasons other
than PTL or pPROM. A review of the role of
amniocentesis in the diagnosis of subclinical
infections has recently been published (319),
according to which amniocentesis plays a
potential role in the  management of PTL and
pPROM, and its results may offer guidance for
administration of appropriate antibiotics to
mother and neonate. Amniocentesis may also
provide information on IAI, as a basis for
decisions on withdrawal of tocolytics, timing
of corticosteroid administration and delivery.
The authors argue that there is enough evidence
at present (in comparison to other obstetric
routines in clinical practice) to use
amniocentesis in the context of threatening
PTB, but they also say that there is a critical
need for a well-designed randomized trial of
amniocentesis in the handling of pPROM and
PTL (319).
According to our protocol, we checked the fetal
heart rate with ultrasound immediately after the
invasive procedure and CTG was performed
for 30-60 minutes after the procedure. We tried
to avoid more than one puncture. No maternal
complications were registered in our study. No
fetal complications of amniocentesis were
registered in the PTL group, but an urgent CS
was performed in the pPROM group due to
fetal bradycardia. This occurred in the
beginning of the study period; the patient had
oligohydramnios and the neonatal outcome was
good.
Although a third trimester amniocentesis is
considered to be a relatively safe and well
accepted procedure in a modern context (316-
318), the procedure should be performed under
ideal conditions and the procedure should be
restricted to one puncture (316). A third
trimester amniocentesis should be performed
in a hospital-based environment with access to
operation facilities and a strict surveillance
scheme should be applied after the puncture
(316-318). If puncture occurs under ultrasound
surveillance and passing the needle though the
placenta is avoided, the success rate is increased
(316, 317) and it may be a safer procedure (316,
317). Since only three studies have been
performed under modern conditions with
continuous ultrasound surveillance, the power
is too low to detect if the skill of the operator is
significant (317).
Amniocentesis has been used internationally
for several decades to handle patients with
threatening PTB. Nevertheless, no clinical
study has shown that amniocentesis and
analysis of AF lead to improvement of the
neonatal outcome.  However, amniocentesis
may serve as an important research tool, e.g.
to identify different sub-groups of PTL that may
have different etiologies. Division of patients
with threatening PTB into different subgroups
is urgently required in treatment studies of
tocolysis and antibiotics (122).
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Preterm birth is related to microbial invasion
of the amniotic cavity and measurable
inflammation in the AF. Although the
Scandinavian countries have a low incidence
of preterm delivery, the prevalence of microbial
invasion of the amniotic cavity is comparable
to that in populations with higher incidence of
preterm birth.
IL-6 and IL-8 are related to microbial invasion
of the amniotic cavity and preterm delivery
(delivery within 7 days or < 34 weeks) in
patients with preterm labor also in a
Scandinavian population. The prevalence of
intra-amniotic inflammation found in a
population with a low incidence of preterm
labor seems to be comparable to that found in
other populations. Intra-amniotic inflammation
was three times more common than microbial
invasion of the amniotic cavity in women in
preterm labor.
IL-6 and IL-8 are also related to microbial
invasion of the amniotic cavity in patients with
preterm prelabor rupture of membranes.
IL-18 in cervical fluid is not related to microbial
invasion of the amniotic cavity, intra-amniotic
inflammation or preterm delivery.
IL-18 in AF in patients in PTL is related to
microbial invasion of the amniotic cavity, intra-
amniotic inflammation and preterm delivery.
IL-18 seems to be part of the intra-amniotic
inflammation process in women in preterm
labor.  These associations were not found in
the pPROM group.
MCP-1 in cervical fluid is related to microbial
invasion of the amniotic cavity, intra-amniotic
inflammation and preterm delivery.
MCP-1 in AF in patients in PTL is related to
microbial invasion of the amniotic cavity, intra-
amniotic inflammation and preterm delivery.
MCP-1 was associated to microbial invasion
of the amniotic cavity and intra-amniotic
inflammation in the pPROM group, but not to
preterm delivery. MCP-1 appears to be part of
the intra-amniotic inflammation both in women
in preterm labor and in those with preterm
prelabor rupture of membranes.
Antenatal infections marginally increased the
risk of CP concurring with data from
populations with higher incidences of perinatal
infections and preterm birth. Low Apgar score
and abruptio placentae were associated with CP,
especially in moderately preterm infants with
hemiplegic CP.
CONCLUSIONS
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Errata paper I:
page 122, par 10, line 22 should be :  AF, IL-6 (≥ 1.5 ng/mL) and IL-8 (≥
1.3 ng/mL) in .....
page 122, par 11, line 2-3 should be :  ≥ 1.5 ng/mL, ≥ 1.3 ng/mL
page 122, par 11, line 6 should be:  ≥ 1.3 ng/mL
page 123, Table I, line 2 should be ≤ 7 days
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Microbial invasion and cytokine response
in amniotic fluid in a Swedish population
of women in preterm labor
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Background. Previous studies indicate an association between intra-amniotic microbial
invasion and/or inflammation and spontaneous preterm birth, but there is a limited
amount of data available from Europe. The aim of this study was to investigate the
occurrence of intra-amniotic microorganisms and cytokines (interleukin-6 and interleu-
kin-8) in a Swedish population of women in preterm labor and their correlation with
preterm birth.
Methods. Amniotic fluid was retrieved transabdominally from 61 patients in preterm
labor before 34weeks of gestation. Polymerase chain reaction analyses for Ureaplasma
urealyticum andMycoplasma hominis and culture for aerobic and anaerobic bacteria were
performed. Interleukin-6 and interleukin-8 were analyzed with enzyme-linked immuno-
sorbent assay.
Results. Microorganisms in amniotic fluid were detected in 10 patients (16%). Patients with
detected bacteria in the amniotic fluid had significantly higher levels of interleukin-6 and
interleukin-8. There was also an association between interleukin-6/-8, the amniocentesis-
delivery interval ( 7 days) and preterm birth (<34weeks). An amniotic fluid con-
centration of interleukin-6 1.5 ng/mL or interleukin-8 1.3 ng/mL was associated with
an increased risk of delivery within 7 days (interleukin-6: relative risk 7.3; 95% confidence
interval: 2.8–19; sensitivity 83%, specificity 87%; interleukin-8: relative risk 14, 95%
confidence interval: 3.6–55, sensitivity 91%, specificity 87%).
Conclusions. The occurrence of intra-amniotic microbial invasion and inflammation in
this population of Swedish women in preterm labor was similar to data reported from
populations with a higher incidence of preterm delivery. Amniotic interleukin-6 and
interleukin-8 correlated with the presence of microorganisms and with preterm birth.
Keywords: interleukin-6, interleukin-8, microbial invasion, preterm birth, preterm labor
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Preterm birth (PTB) is still a major unresolved
problem in modern obstetrics. It is related to
increased perinatal mortality and morbidity,
including cerebral palsy and suboptimal school
achievement (1–4). The incidence of PTB has not
decreased over the last decades, despite new
pharmacological therapies and prevention pro-
grams (5). In Sweden, the incidence of PTB has
been approximately 5% since the beginning of
the 1970s (2). In the United States and many
other countries, the incidence of PTB is signiﬁ-
cantly higher (12%) and has increased slightly
Abbreviations:
AF: amniotic ﬂuid; ELISA: enzyme-linked immunosorbent
assay; IL: interleukin; PCR: polymerase chain reaction; PTB:
preterm birth; PTL: preterm labor; ROC: receiver-operator
characteristic.
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from the 1980s to the mid-1990s (5). One possible
explanation for the difference in PTB incidence
could be a lower number of patients with infection-
related PTB, as the rate of infection in the genito-
urinary tract (e.g. urinary tract infections,
bacterial vaginosis, clinical chorioamnionitis) and
of neonatal sepsis appear to be comparatively
low in Sweden (6–8). Several recent studies have
shown that microbial invasion of the amniotic
ﬂuid (AF) is one important risk factor for PTB
(9,10). Previous studies have indicated a wide
range in the prevalence of microbial invasion of
the AF (3–48%) among women with preterm
labor (PTL) (10,11). This variability in prevalence
is probably because of differences in the deﬁn-
tions of PTL, including gestational age groups,
microbiological techniques and studied popula-
tions (11). It has also been shown in several stud-
ies that proinﬂammatory cytokines such as
interleukin (IL)-6 and chemokines such as IL-8
are elevated in AF preceding PTB (12–14). There
are, however, no studies from northern Europe
based on transabdominal AF retrieval and focus-
ing on the relationship between microbial inva-
sion of the amniotic cavity, intra-amniotic
inﬂammation and PTL. Such basic information
is required in order to develop strategies for the
prevention and treatment of PTL and its conse-
quences in this region. In addition, it may be
beneﬁcial to compare mechanisms of PTL in
regions with high and low incidences of PTB/
perinatal infections.
The aim of this study was to examine the rela-
tionship between the intra-amniotic occurrence of
microorganisms and the levels of IL-6 and IL-8,
and their relationship with PTB (delivery within
7 days and delivery at <34weeks of gestation,
respectively) in a Swedish population of women
in PTL.
Methods
The study population consisted of 66 women in
PTL, with singleton pregnancies, who presented
at two delivery wards in Go¨teborg (Sahlgrenska
Hospital, 1996–97, n¼ 7; Sahlgrenska University
Hospital/East, 1997–2001, n¼ 59) at a gestational
age of less than 34weeks. Preterm labor was
deﬁned as regular uterine contractions (at least
two uterine contractions/10min during 30min) in
combination with cervical changes: (one,  2 cm
in length and 1 cm in dilatation; two,  2 cm in
length and cervical softening; three,  1 cm in
dilatation and cervical softening; or four, cervical
length <30mm at endovaginal ultrasound).
Women with preterm prelabor rupture of
membranes, known uterine abnormalities, fetal
malformations, signiﬁcant vaginal bleeding,
imminent delivery or fetal distress were not
included.
Gestational age was determined in 64 pregnan-
cies by routine ultrasound in the second trimester
(16th to 19th weeks of gestation) and in two
patients by the date of their last menstrual period.
Tocolytic therapy (intravenous terbutaline and/or
indomethacin, the latter if the pregnancy was
<28weeks of gestation) was used according to
department protocol.
An ultrasound-guided transabdominal amnio-
centesis was performed under antiseptic condi-
tions within 12 h after admittance. A 0.8-mm
diameter needle was used and 30–50mL amniotic
ﬂuid (AF) was aspirated. After sampling, the
AF was immediately placed in a refrigerator
(þ 4 C) and processed within 5 h. It was
centrifuged at 855 g (3000 r.p.m.) in þ 4 C for
10min and stored at 80 C until the time of
analysis.
A sample of uncentrifuged AF was immedi-
ately transported to the microbiological labora-
tory for polymerase chain reaction (PCR)
analysis of Ureaplasma urealyticum and Myco-
plasma hominis and for aerobic and anaerobic
culture. Microbial invasion was defined as positive
PCR and/or growth of any bacteria in the AF,
except for coagulase negativeStaphylococcus, which
was considered to be a skin contamination. Bac-
terial isolates were characterized biochemically
by using the API Rapid ID32STREP, Rapid
ID32A, ID32STAPH, ID32E, API ZYM, API
Coryne, API50CHL, ID32C according to the
manufacturer’s instructions (API bioMe´rieux
Marcy-Etoile, France). These identification systems
identified anaerobes, coryneformbacterium, yeasts,
streptococci, Enterobacteriaceae and other Gram-
negative rods, the genera Staphylococcus, Micro-
coccus and the genus Lactobacillus, and related
organisms. PAGE analysis of whole-cell proteins
was performed as described by Pot et al. (15).
For densitometric analysis, normalization and
interpretation of protein patterns, the GelCompar
4.1 software package (Applied Maths, Gent,
Belgium) was used. Anaerobic bacteria were
further analyzed by fatty acid analysis using the
MIDI specifications (16). Some of the difficult
bacterial isolates were identified by DNA sequen-
cing. The 16S rRNA genes of the isolates were
amplified by PCR and directly sequenced using
theBig dye terminator cycle sequencing kit (Applied
Biosystems, Foster City, USA) and an automatic
DNA sequencer (model 310, Applied Biosystems).
IL-6 and IL-8 in the AF were analyzed with
enzyme-linked immunosorbent assay (ELISA) (paired
antibodies from R & D Systems, Minneapolis,
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MN). The AF samples were diluted 1 : 5, 1 : 20
and 1 : 100 and run in duplicates. The interassay
variation was calculated at <10%, based on
analysis of several samples on three separate
occasions. Low values (700 pg/mL) showed
a higher coefficient of variation (29–76%).
The detection limit of the ELISA test was
30 pg/mL for both IL-6 and IL-8, but because
the samples were run at a 1 : 5 dilution, the
lower limit of detection was 150 pg/mL for
both IL-6 and IL-8.
Clinical chorioamnionitis was defined as
fever at 37.8 C if occurring on two occasions
of at least 4 h apart and if at least two or more of
the following criteria were present: uterine tender-
ness,malodorous vaginal discharge, fetal tachycardia
(>160 beats/minute), maternal tachycardia
(>100 beats/minute) and maternal leukocytosis
(>15000 cells/mm3 (17)).
Two investigators (BJ, RMH) scrutinized the
medical records and entered the maternal and
perinatal data into a database.
Ethical approval for the study was obtained
from the local Ethics Committee in Go¨teborg.
The patients gave their informed consent before
enrolment in the study.
Calculations were made using the computer
programs StatView 5.01 (SAS Institute Inc,
Cary, NC) or InStat 2.01 (Graph Pad Software,
San Diego, CA). Continuous variables were ana-
lyzed with the Mann–WhitneyU-test and propor-
tions with Fisher’s exact test. A P-value <0.05
was considered statistically signiﬁcant, as was a
conﬁdence interval not including 1.
Sensitivity, specificity, positive and negative
predictive values were calculated for different
concentrations of IL-6 and IL-8 in relation to
delivery within 7 days. A receiver-operator char-
acteristic (ROC) curve was used to identify the
best cut-off levels for IL-6 and IL-8. A survival
analysis of the amniocentesis-delivery interval
according to best cut-off levels for AF IL-6 and
IL-8 was carried out.
Results
Characteristics of the study population are shown
in Table I. Women who gave birth preterm
(<34weeks or within 7 days) did not differ from
those who delivered later, regarding age, parity,
number of previous gestations, number of pre-
vious PTD, smoking habits or antenatal treatment
with tocolytics, antibiotics or corticosteroids.
Women who delivered within 7 days had a signifi-
cantly higher Bishop’s score at inclusion than
those who gave birth after 7 days. Sixty-six
patients underwent amniocentesis. In five patients,
no or an inadequate amount of AF was obtained
and no analyses could be performed. In one
patient, the AF was only analyzed with PCR for
U. urealyticum andM. hominis, leaving 60 patients
with a sufficient amount of AF to allow the
complete set of analyses. Delivery before 34weeks
of gestation occurred in 44% (27/61) of the
patients and delivery within 7 days occurred in
38% (23/61). Patients were included at a median
of 30weeks þ 6days (range: 22weeks þ 6days –
33weeks þ 5days).
Microbial invasion of the AF was identified in
16% (10/61) (Table II). Different bacterial species
were found in all patients except U. urealyticum,
which was found in two patients. In addition,
there was growth of coagulase negative Staphylo-
coccus in the AF in four cases. No patient had
more than one species isolated in the AF. Nine of
10 patients with microbial invasion of the AF
delivered before 34weeks of gestation and one
patient (Streptococcus mitis) delivered at term.
All patients with coagulase negative Staphylococ-
cus delivered after 34weeks (three between 34 and
37weeks and one at term).
Patients with microbial invasion of the AF had
significantly higher levels of IL-6 and IL-8 than
those without microbial invasion (median IL-6:
33.20 ng/mL vs. 0.72 ng/mL, p¼ 0.01; median
IL-8: 26.39 ng/mL vs. 0.37 ng/mL, p¼ 0.002)
(Fig. 1). The bacterial species and corresponding
levels of IL-6 and IL-8 are presented in Table II.
Patients who delivered within 7 days had
significantly higher levels of IL-6 and IL-8 than
those who delivered after 7 days (Table I and
Fig. 2). Patients who delivered before 34weeks
of gestation had significantly higher levels of
IL-6 and IL-8 than those who delivered at34
weeks (median IL-6 6.21 ng/mL vs. 0.29 ng/mL,
p<0.001; median IL-8 4.87 ng/mL vs. 0.15 ng/
mL; p<0.001) (Fig. 3). A ROC curve analysis of
delivery at 7 days for various cut-off levels of
IL-6 and IL-8 is shown in Fig. 4A,B. An IL-6 level
of 1.5 ng/mL and an IL-8 level of 1.3 ng/mL
were found to be the best cut-off points. The
diagnostic indices for microbial invasion of the
AF, IL-6 (1.5 ng/mL) and IL-8 (1.3 ng/mL) in
cases with delivery at7 days are presented in
Table III. Survival analyses of the amniocent-
esis-delivery interval according to the AF IL-6
and IL-8 cut-off levels are presented in Fig. 5.
An inflammatory response, defined as an IL-6
level of 1.5 ng/mL was found in 39% (24/61)
and an IL-8 level of 1.3 ng/mL was found in
43% (26/61) of the cases. An inflammatory
response, defined as IL-6 1.5 ng/mL and/or
IL-8¼ 1.3 ng/mL was found in 46% (28/61) of the
patients. Of patients who delivered at <34weeks,
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78% (21/27) had an inflammatory response with
an IL-6 level 1.5 ng/mL and 85% (23/27) had an
IL-8 level 1.3 ng/mL.
Two bacterial species have not previously been
identified in AF: Sneathia sanguinegens and Acti-
nomyces odontolyticus. A patient with Sneathia
sanguinegens delivered at 24weeks and 5 days.
She had fever during delivery but did not fulfil
the diagnostic criteria of chorioamnionitis. A
patient with Actinomyces odontolyticus had no
signs of any clinical infection and delivered at
24weeks and 5 days.
None of the 10 patients with microbial invasion
in the AF developed clinical chorioamnionitis.
One other patient did, however, develop clinical
chorioamnionitis, and had a negative cul-
ture/PCR but showed a clear inflammatory res-
ponse (IL-6 23.10 pg/mL, IL-8 8.89 pg/mL); she
delivered at 25weeks of gestation (15 days after
the amniocentesis).
Discussion
The main findings in this study were that in
a Scandinavian population presenting with PTL
Table I. Clinical background variables in women delivering within or after 7 days
Variable Women delivering at 7 days (n¼ 23) Women delivering >7 days (n¼ 38) p-value
Maternal age (year) 30(19–37) 29(19–38) 0.28
(median, range)
Nulliparous (n) 16 22 0.58
Number of previous gestations 1(0–5) 1(0–9) 0.54
(median, range)
Previous preterm delivery (n) 4 7 1.00
Smoking in first trimester (n) 1 6 0.23
Gestational age at amniocentesis (days) 214(167–236) 218.5(160–235) 0.30
(median, range)
Bishops score at inclusion 7(3–10) 4(1–9) <0.001
(median, range)
Use of corticosteroids before delivery (n) 22 28 0.07
Use of antibiotics before delivery (n) 8 8 0.37
Use of tocolysis before delivery (n) 22 33 0.64
Microbial invasion of the amniotic fluid (n) 8 2 0.0042
Interleukin-6, ng/mL (median) 7.15 0.32 <0.001
Interleukin-8, ng/mL (median) 5.57 0.15 <0.001
Table II. Microbes isolated fromamniotic ﬂuid and the corresponding levels of
interleukin-6 and interleukin-8
Organism Interleukin-6
(ng/mL)
Interleukin-8
(ng/mL)
Ureaplasma urealyticum 35.43 17.54
Ureaplasma urealyticum 30.80 35.25
Fusobacterium species 2720 184.8
Corynebacterium 0.84 0.33
Eubacterium species >50.0 866.3
Actinomyces odontolyticus 4166 822.3
Snethia sanguinegens 15080 149.1
Listeria monocytogenes 1.00 2.95
Streptococcus mitis <0.15 <0.15
Difteriodic rods 1.62 2.14
Coagulase negative Staphylococcus 5.69 1.49
Coagulase negative Staphylococcus 0.71 0.38
Coagulase negative Staphylococcus <0.15 <0.15
Coagulase negative Staphylococcus <0.15 <0.15
negative
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Fig. 1. (A) Interleukin (IL)-6 and (B) interleukin-8 levels in
microbe-positive and microbe-negative amniotic fluid tested by
polymerase chain reaction analyses or culture. Horizontal bars
indicate medians. Values on the Y-axis are given on a logarithmic
scale (ng/mL) and statistical significance was evaluated with the
Mann–Whitney U-test.
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16% had detectable levels of microorganisms in
the AF and approximately 49% had intra-
amniotic inflammation. Intra-amniotic inflam-
mation is a good predictor of PTB (<34weeks)
and delivery within 7 days, and is a better marker
of PTB than intra-amniotic infection. These find-
ings concur with those of earlier reports (18).
The rate of microbial invasion of the AF in this
study (16%) in women in PTL is within the wide
range (3–48%; median: 13%) of earlier reports
(9,11,19,20). This is somewhat surprising because
the incidence of PTB is only 5–6% and the rate of
urogenital infections and neonatal sepsis is
usually reported to be low in Sweden (6,7). Com-
parisons are difﬁcult, however, because of differ-
ences in the deﬁnition of PTL, e.g. contractions
and cervical change, gestational age at inclusion
and microbiological technique (13,21–25). In this
study, 90% of the patients with positive cultures
or with PCR-detectable microorganisms in the
AF delivered before 34weeks of gestation. Most
of them delivered within a few days, which is also
highly consistent with previous reports (9,13,
21,26) demonstrating that 70–100% of patients
with microbial invasion deliver shortly after
presenting. In adding the four patients with
coagulase negative Staphylococcus, only one
patient with intra-amniotic growth of S. mitis
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Fig. 2. (A) Interleukin (IL)-6 and (B) interleukin-8 levels in
amnion related to amniocentesis-delivery interval. Horizontal
bars indicate medians. Values on the Y-axis are given on a
logarithmic scale. Statistical significance (delivery at 7days vs.
>7days) was evaluated with the Mann–Whitney U-test.
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Fig. 3. (A) Interleukin (IL)-6 and (B) interleukin-8 levels in
amnion related to birth at <34weeks of gestation. Horizontal
bars indicate medians. Values on the Y-axis are given on a
logarithmic scale (ng/mL) and statistical significance (delivery
at<34weeks vs.34weeks of gestation) was evaluated with the
Mann–Whitney U-test.
Table III. Diagnostic indices for amniotic ﬂuid interleukin-6, interleukin-8 and presence of microbes as
predictors of delivery at 7 days
IL-6
 1.5 ng/mL
IL-8
 1.3 ng/mL
Microbes detected
in amnion
Sensitivity 83% 91% 35%
Specificity 87% 87% 95%
Positive predictive value 79% 81% 80%
Negative predictive value 89% 94% 70%
Relative risk and
95% confidence interval
7.3 (2.8–19) 14 (3.6–55) 2.7 (1.6–4.6)
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delivered after 34weeks. This patient had normal
levels of IL-6 and IL-8.
We have considered coagulase negative Sta-
phylococcus to be a skin contamination because
it is a well-known skin contaminant in blood
cultures. Even if amniocentesis is performed
under sterile conditions, bacteria from the mater-
nal skin can contaminate AF culture. However,
one patient had an inflammatory response, indi-
cating that coagulase negative Staphylococcus
could be related to an intra-amniotic inflamma-
tion. We think that coagulase negative Staphylo-
coccus might, depending on the circumstances, be
both a skin contamination and an ascending bac-
terium from the vagina, initiating an inflamma-
tory response.
Intra-amniotic growth of Sneathia sanguinegens
andActinomyces odontolyticus has not been shown
previously in patients with PTL. Both patients
exhibited a robust inflammatory response with
high levels of IL-6 and IL-8 in the AF. Actino-
myces odontolyticus is a natural habitant of the
oral cavity and an occasional pathogen in humans
(27). This is interesting in light of the fact that
periodontitis seems to correlate with PTB (28).
Sneathia sanguinegens has recently been described
as a gram-negative anaerobic rod; it has been isol-
ated from human blood and now also fromAF (29).
In international studies, more than one micro-
organism has been isolated from the AF in 50%
of patients with microbial invasion (11). No
patient had more than one species in this study.
Previous studies have shown that PTL is
associated with a cytokine response, including
expression of IL-6, IL-8, granulocyte colony-
stimulating factor and tumor necrosis factor-alpha
(10). Preterm birth has been associated with
increased levels of IL-6 in the cervico-vaginal
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Fig. 4. Receiver-operator characteristic curve analysis of
amniotic fluid A) Interleukin (IL)-6 and (B) interleukin-8
concentrations (ng/mL) as a predictor of preterm birth within
7 days. Numbers next to solid or open dots represent some of the
cut-off values of the amniotic fluid concentrations (ng/mL) used
in the analysis. The chosen cut-off value was (A) 1.5 ng/mL for
IL-6 and (B) 1.3 ng/mL for IL-8.
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Fig. 5. Survival analysis of the elapsed time between
amniocentesis and delivery, according to levels of (A)
interleukin-6 (cut-off level 1.5 ng/mL) and (B) interleukin-8
(cut-off level 1.3 ng/mL) in amniotic fluid.
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fluid (30,31), AF (26) and fetal blood (32). We
found that nearly 80% of women in PTL leading
to PTB had an elevated IL-6 level (1.5 ng/mL)
compared with 11% of those who did not deliver
preterm. Our data agree with the fact that intra-
amniotic IL-6 is one of the best predictors of PTB
(26). We also found that the alpha-chemokine
IL-8, which induces neutrophil attracting and
activating responses, was highly expressed in the
AF in PTL and was also an excellent predictor of
PTB (18). Other researchers have found the best
cut-off level for IL-6 in amniotic fluid to be
2.6 ng/mL (33) or 2.0 ng/mL (34). Even if these
calculations have been made in relation to differ-
ent outcome variables [microbes present in the
amniotic fluid (33) and IL-6 elevation over the
70th percentile (34), respectively], they are com-
parable to our cut-off level. Our calculations
regarding these outcome variables yield similar
values [microbes present in the amniotic fluid
(2.5 ng/mL) and IL-6 elevation over the 70th per-
centile (4.8 ng/mL)].
Interestingly, only half of the patients with an
inflammatory response (indicated by IL-6
1.5 ng/mL or IL-8 1.3 ng/mL) had detectable
levels of microorganisms in the AF, although
PCR was used for U. urealyticum and M. hominis
(35). This is in agreement with previous reports
(33), and most likely indicates that some micro-
organisms cannot be detected with the techniques
presently employed or that PTB could result from
noninfectious inflammation.
In a recent study, Hebisch et al. showed that
both IL-6 and IL-8 increase in AF with increased
cervical dilatation as part of the normal delivery
process (36). Yoon et al. also found that patients
in PTL with high IL-6 levels had a more
advanced cervical dilatation at inclusion (33).
This might also be the case regarding PTB in
this study, as the patients delivering within
7 days and before 34weeks of gestation had a
higher Bishop’s score at inclusion. It is feasible
that the process involved in uterine contractions
contributed to the elevations of amniotic cyto-
kines in our study. It is important to make the
point, however, that most of these women were
not in actual labor at the time of amniocentesis as
they did not deliver until a few days later.
Amniocentesis has been used for decades to
handle patients with threatening PTB. Analysis
of the lecithin/sphingomyelin-ratio in AF pro-
vides information about the lung maturity of the
fetus and is used worldwide but rarely in the
Nordic countries. Our amniocentesis success rate
was 91%. No complications to the procedure
occurred in this study, but several have been
described in the literature, such as fetal bradycar-
dia requiring immediate delivery, as well as risk
of bacterial contamination of the AF (37). The-
oretically, detection of bacteria in the AF/or intra-
amniotic inflammation may offer guidance for
administration of appropriate antibiotics to
mother and neonate, withdrawal of tocolytics
and timing of corticosteroid administration and
delivery. Nevertheless, no clinical studies have
shown that amniocentesis and analysis of AF
lead to improved neonatal outcome. However,
amniocentesis may serve as an important
research tool, e.g. to identify different subgroups
of PTL that may have different etiologies. Infec-
tion/inflammation-related PTB can be separated
from PTB resulting from cervical insufficiency,
stress, bleeding or disturbances in hydroxypros-
taglandin dehydrogenase metabolism (38). It is
also of great importance to examine whether cer-
vical IL-6 and IL-8 are good indicators of the
presence of microbes in the amniotic fluid, intra-
amniotic inflammation and neonatal outcome in
a Scandinavian population, as a cervical sample
is less invasive than amniocentesis (30,34).
In conclusion, a significant proportion of
women in PTL, in a Scandinavian population,
had microbial invasion (16%) and/or a cytokine
inflammatory response (46%) in the AF. High
levels of IL-6 and IL-8 were excellent predictors
of PTB (delivery at 7 days, delivery <34weeks)
irrespective of the presence of microbes in the
AF. These data may have clinical implications
and are of importance in understanding the
mechanisms involved in PTB. It will serve as
background information for future studies on
strategies to predict and reduce PTB, perinatal
mortality and long-term morbidity in the Scandi-
navian context.
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 Microbial invasion and cytokine response in amniotic fluid in
a Swedish population of women with preterm prelabor
rupture of membranes
Bo Jacobsson1 M.D., Inger Mattsby-Baltzer2 Ph.D., Björn Andersch1 M.D., Ph.D, Hans
Bokström1 M.D., Ph.D, Rose-Marie Holst1 M.D., Natalia Nikolaitchouk2 M.D., Ulla-Britt
Wennerholm1 M.D., Ph.D, Henrik Hagberg1 M.D., Ph.D
Göteborg, Sweden
Background. Previous studies have shown an association between intra-amniotic microbial
invasion and/or inflammation and spontaneous preterm birth. The aim of this study was to
investigate the occurrence of intra-amniotic microorganisms and cytokines (interleukin-6 and
interleukin-8) in a Swedish population, with low incidence of preterm birth, of women with
preterm prelabor rupture of membranes and their correlation to preterm birth.
Methods. Amniotic fluid was retrieved transabdominally from 58 patients with preterm prelabor
rupture of membranes before 34 weeks of gestation. Polymerase chain reaction analyses for
Ureaplasma urealyticum
and Mycoplasma hominis and culture for aerobic and anaerobic bacteria were performed.
Interleukin-6 and interleukin-8 were analyzed with enzyme-linked immunosorbent assay.
Results. Microorganisms in amniotic fluid were detected in 13 patients (25 %).  Patients with
bacteria detected in the amniotic fluid had significantly higher levels of interleukin-6 and
interleukin-8. An amniotic fluid concentration of interleukin-6 ≥ 0.80 ng/mL (relative risk 1.93,
95 % confidence interval: 1.13-3.29, sensitivity 63 %, specificity 75 %) was associated with an
increased risk of delivery within 7 days. There was also an association between interleukin-8 and
preterm birth (< 34 weeks).
Conclusions. Intra-amniotic microbial invasion and inflammation in this population of Swedish
women with preterm prelabor rupture of membranes were similar to data reported from
populations with a higher incidence of preterm delivery. Amniotic interleukin-6 correlated to the
presence of microorganisms and delivery within 7 days and interleukin-8 to delivery before 34
weeks.
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Background
Preterm birth (PTB) is the leading cause of
perinatal mortality, perinatal morbidity,
childhood neurological morbidity and is
associated with suboptimal school
achievements
(1-5). Despite advances in obstetric care during
the last decades the incidence of PTB has not
decreased (6). In Sweden, the incidence of PTB
has been 5-6 % since the beginning of the
seventies, but in the United States and many
other countries, the incidence of PTB is much
higher (12 %) (2, 6). The cause of PTB seems
to be multifactorial but several studies indicate
that microbial invasion of the amniotic fluid
(AF) is an important risk factor for PTB (7).
One possible explanation for the difference in
PTB incidence in the Scandinavian countries
and USA could be a lower number of patients
with infection-related PTB, since the rate of
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infections in the reproductive tract and of
neonatal sepsis appears to be comparatively low
in Sweden (8-10).There are two forms of
spontaneous PTB: preterm labor (PTL) and
preterm prelabor rupture of membranes
(pPROM). In a previous study, we have not
been able to confirm the hypothesis of less
infection-related PTB in a Swedish population
of patients in preterm labor (11).
Microbial invasion of the AF occurs in
approximately one third of patients with
pPROM (7, 12).  Previous studies have
indicated a wide range in the prevalence (15 -
57 %) and is probably due to differences in
population characteristics, gestational age and
microbiological techniques (7, 12). It has also
been shown that proinflammatory cytokines
like interleukin (IL)-6 and chemokines like IL-
8 are elevated in AF preceding PTB (13, 14).
There is, however, only one study available
from northern Europe concerning the
relationship between microbial invasion of the
amniotic cavity in patients with pPROM (15)
and no study regarding intra-amniotic
inflammation and PTB using transabdominal
technique for retrieval of AF. Such basic
information is important in order to develop
strategies for prevention and treatment of
pPROM and its consequences in this region.
The aim of this study was to examine the
relationship between intra-amniotic occurrence
of microorganisms and the levels of IL-6 and
IL-8 and their relationship to PTB (delivery
within 7 days and delivery at < 34 weeks of
gestation) in a Swedish population of women
with pPROM.
Methods
The study population was recruited
prospectively and consisted of 58 women with
singleton pregnancies with pPROM, who
presented at 2 delivery wards in Göteborg
(Sahlgrenska Hospital (1996-1997; n=14) and
Sahlgrenska University Hospital/East (1997-
2001; n=44)) at a gestational age of less than
34 weeks. pPROM was diagnosed by a
speculum examination confirming pooling of
AF in the vagina. Digital examination was not
performed. Women with contractions before
rupture of membranes, known uterine
abnormalities, fetal malformations, significant
vaginal bleeding, imminent delivery or fetal
distress were not included.
Gestational age was determined in all 58
pregnancies by routine ultrasound in the second
trimester (16th to 20th weeks of gestation).
Tocolytic therapy (intravenous terbutaline and/
or indomethacin, the latter if the pregnancy was
< 28 weeks of gestation) was used according
department protocol.
An ultrasound-guided transabdominal
amniocentesis was performed under antiseptic
conditions within 12 hours after admittance and
30 – 50 mL AF was aspirated (needle diameter:
0.8 mm).  After sampling, AF was immediately
placed in a refrigerator  (+4°C) and processed
within 5 hours.  It was centrifuged at 855 g in
+4°C for 10 minutes and stored at –80°C until
time of analysis.
A sample of uncentrifuged AF was immediately
transported to the microbiological laboratory
for polymerase chain reaction (PCR) analysis
of Ureaplasma urealyticum and Mycoplasma
hominis and for aerobic and anaerobic culture.
Microbial invasion was defined as positive
PCR and/or growth of any bacteria in the AF,
except for coagulase negative Staphylococcus,
which was considered to be a skin
contamination.
Bacterial isolates were characterized
biochemically by using the API Rapid
ID32STREP, Rapid ID32A, ID32STAPH,
ID32E, API ZYM, API Coryne, API50CHL,
ID32C according to the manufacturer’s
instructions (API bioMérieux). These
identification systems identified anaerobes,
coryneform bacterium, yeasts, streptococci,
Enterobacteriaceae and other Gram-negative
rods, the genera Staphylococcus, Micrococcus
and the genus Lactobacillus and related
organisms. PAGE analysis of whole-cell
proteins was performed as described by Pot et
al (16). For densitometric analysis,
normalization and interpretation of protein
patterns, the GelCompar 4.1 software package
(Applied Maths) was used. Anaerobic bacteria
were further analyzed by fatty acid analysis
using the MIDI specifications (17). Some of
the difficult bacterial isolates were identified
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by DNA sequencing. The 16S rRNA genes of
the isolates were amplified by PCR and directly
sequenced by using the Big dye terminator
cycle sequencing kit (Applied Biosystems) and
an automatic DNA sequencer (model 310,
Applied Biosystems).
IL-6 and IL–8 in AF were analyzed with
enzyme-linked immunosorbent assay (ELISA)
(paired antibodies from R&D Systems,
Minneapolis, Minn, USA). AF samples were
diluted 1:5, 1:20 and 1:100 and run in
duplicates. An arithmetic mean was calculated.
The interassay variation was calculated at < 10
%, based on analysis of several samples on
three separate occasions. Low values (≤ 700
pg/mL) showed a higher coefficient of variation
(29-76 %).  The detection limit of the ELISA
test was 30 pg/mL for both IL-6 and IL-8, but
because the samples were run at a 1:5 dilution,
the lower limit of detection was 150 pg/mL.
Before amniocentesis, cervico-vaginal fluid
was sampled with a plain cotton-viscose swab.
No bacteriostatic lubricant was used. The swabs
were placed in Stuart’s transport medium for
aerobic and anaerobic standardized culture. If
the laboratory reported an ordinary flora it was
considered to be negative.
Clinical chorioamnionitis was defined as fever
≥ 37.8˚C on two occasions at least 4 hours apart
and ≥ 2 of the following criteria were present:
uterine tenderness, malodorous vaginal
discharge, fetal tachycardia (> 160 beats/
minute), maternal tachycardia (>100 beats/
minute) and maternal leukocytosis (> 15000
cells/mm3) (18).
Two investigators (BJ, RMH) scrutinized the
medical records and entered maternal and
perinatal data into a database.
Ethical approval for the study was obtained
from the local ethic committee in Göteborg.
The patients gave informed consent before
enrollment in the study.
Calculations were made using the computer
programs StatView 5.01 (SAS Institute Inc,
Cary North Carolina, USA) or InStat 2.01
(Graph Pad Software, San Diego, California,
USA). Continuous variables were analyzed
with the Mann-Whitney U test and proportions
with Fisher’s exact test. A p-value < 0.05 was
considered statistically significant, as was a 95
% confidence interval not including 1.00. A
logistic regression analysis was performed for
differences in gestational age at inclusion and
maternal age between patients who gave birth
at ≤ 7 days vs. > 7 days.
Table I. Clinical background variables in women delivering within or after 7 days. 
Women delivering 
≤ 7 days (n=27)
Women delivering
>7 days (n=20)
p-value
Maternal age (year)
(median, SD, range)
32 (6.04)
(20-43)
27 (5.74)
(19-42)
0.01
Nulliparous (n) 11 12 1.00
Previous preterm delivery 
(n)
0 2 0.18
Smoking at the beginning 
of pregnancy (n)
8 5 1.00
Bleeding during 
pregnancy (n)
3 4 0.44
Gestational age at 
amniocentesis (days)
(median, SD, range)
229 (17.91)
(158-236)
204 (22.74)
(162-234)
 < 
0.001
Use of corticosteroids 
before delivery (n)
26 19 1.00
Use of antibiotics before 
delivery (n)
8 5 1.00
Use of tocolysis before 
delivery (n)
23 9 0.005
Microbial invasion of the 
amniotic ﬂ uid (n )
10 2 0.047
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Sensitivity, specificity, positive and negative
predictive values were calculated for different
concentrations of IL-6 and IL-8 in relation to
delivery within 7 days. A receiver-operator
characteristic (ROC) curve was used to identify
the best cut-off levels for IL-6 and IL-8 for
delivery within 7 days. The same cut-off levels
were used to define intra-amniotic
inflammation and to perform survival analysis
of the amniocentesis-delivery interval.
Results
Clinical background information of the study
population is presented in Table I. Women who
gave birth within 7 days where not different
from those who delivered > 7 days except for
gestational age at inclusion and maternal age.
Fifty-eight patients with pPROM, before
uterine contractions started, underwent
amniocentesis. In five patients, no or
inadequate amount of AF was obtained and no
analyses could be performed. In another six
patients, the AF was only analyzed for bacteria
with PCR and culture, leaving 47 patients with
sufficient amount of AF to allow a complete
set of analyses.
Patients were included at a median of 31 weeks
+ 4 days (range: 22weeks+4 days – 33 weeks+5
days). Delivery occurred before 34 weeks of
gestation in 33/47 (70 %) patients and within 7
days in 27/47 (57 %) patients.
Microbial invasion of the AF was identified in
25 % (13/53) (Table II). Ureaplasma
urealyticum was found in nine patients. In
addition, one patient had growth of coagulase
negative Staphylococcus in the AF. Two
patients had 2 species of bacteria isolated from
the AF. All patients with microbial invasion of
the AF delivered prior to 34 weeks of gestation.
The patient with coagulase negative
Staphylococcus delivered at 33 weeks of
gestation.
The strain with anaerobic Gram-negative rods
died during identification at the laboratory, so
no further information of the strain is available.
The strain was associated with a very intense
Table II. 
Microbes isolated from amniotic ﬂ uid and the corresponding levels of interleukin-6 and 
interleukin-8.
Organism Interleukin-6 (ng/mL) Interleukin-8 (ng/mL)
Ureaplasma urealyticum
53.6 21.4
Ureaplasma urealyticum 0.52 0.49
Ureaplasma urealyticum 3.50 3.24
Ureaplasma urealyticum 1.79 3.30
Ureaplasma urealyticum 41.1 22.0
Ureaplasma urealyticum >50.0 6.01
Ureaplasma urealyticum 33.8 13.1
Ureaplasma urealyticum - -
Ureaplasma urealyticum+
    Mycoplasma hominis
1.67 2.26
Haemophilus infl uenzae 1.40 0.43
Streptococcus agalactiae 833 45.0
Bacteroides fragilis + 
   Bifi dobacterium adolecentis
0.21 <0.15
Anaerob gram-negative rods 1736 420
Coagulase negative staphylococcus 4.15 0.65
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inflammatory response in the AF with high
levels of IL-6 and IL-8.
None of the thirteen patients with microbial
invasion in AF developed clinical
chorioamnionitis. The patient with
Haemophilus influenzae was suspected to
suffer from clinical chorioamnionitis but did
not fulfill all the criteria. Clinical
chorioamnionitis developed in one patient with
a negative culture/PCR and no inflammatory
response (IL-6 <0.15 ng/mL, IL-8 <0.15 ng/
mL) and she delivered 7 hours after
amniocentesis at 33 weeks of gestation by
cesarean section due to pathological CTG and
clinical chorioamnionitis.
Patients with microbial invasion of the AF had
significantly higher levels of IL-6 and IL-8 than
those without microbial invasion (median IL-
6 18.6 ng/mL versus 0.42 ng/mL; p<0.001)
(median IL-8 4.66 ng/mL versus 0.25 ng/mL;
p<0.001) (Fig. 1). The bacterial species and
corresponding levels of IL-6 and IL-8 are
presented in Table II.
Patients who delivered within 7 days had
significantly higher levels of IL-6 than those
who delivered after 7 days (median IL-6 1.40
ng/mL versus 0.37 ng/mL; p=0.011) but the IL-
8 levels were not significantly higher (median
IL-8 0.43 ng/mL versus 0.22 ng/mL; p=0.089)
(Fig. 2).  A logistic regression analysis was
performed with correction for gestational age
at inclusion and maternal age without any
significant changes in the results (IL-6 p=0.048,
IL-8 NS). However, three patients had an
induction of labor within 7 days and might
therefore be misclassified as spontaneous
delivery within 7 day. There were no changes
of the results if these patients were excluded,
except for the correlation between IL-8 and
time of delivery that became slightly stronger
(median IL-8 0.54 ng/mL in delivery ≤ 7 days
vs. 0.22 ng/mL in delivery > 7 days; p=0.04).
Patients who delivered before 34 weeks of
gestation had significantly higher levels of IL-
8 than those who delivered ≥ 34 weeks (median
Fig. 1
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Fig. 1. Interleukin (IL)-6 (a) and interleukin-8 (b) levels
in microbe-positive and microbe-negative amniotic fluid
tested by PCR and culture. Horizontal bars indicate
medians. Values on the Y-axis are given on a logarithmic
scale (ng/mL) and statistical significance was evaluated
with the Mann-Whitney U test.
Fig. 2. Interleukin (IL)-6 (a) and interleukin-8 (b) levels
in amniotic fluid related to amniocentesis-delivery
interval. Horizontal bars indicate medians. Values on
the Y-axis are given on a logarithmic scale (ng/mL).
Statistical significance (delivery at ≤ 7 days vs. >7 days)
was evaluated with the Mann-Whitney U test.
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IL-6 1.0 ng/mL versus 0.46 ng/mL; p=0.18)
(median IL-8 0.51 versus 0. 16 ng/mL;
p=0.046) (Fig. 3). There were 3 inductions and
2 cesarean sections performed before onset of
contractions that were included in the group
“spontaneous delivery < 34 weeks”. However,
the results were not affected by exclusion of
these patients.
A ROC curve analysis of delivery at ≤ 7 days
for various cut-off levels of IL-6 and IL-8 is
shown in Fig. 4 a and b. An IL-6 level of 0.80
ng/mL and IL-8 level of 0.42 ng/mL were found
to be the best cut-off points. The diagnostic
indices for microbial invasion of the AF, IL-6
(0.80 ng/mL) and IL-8 (0.42 ng/mL) in cases
with delivery at ≤ 7 days are presented in Table
III. Survival analyses of amniocentesis-delivery
interval according to AF IL-6 (0.80 ng/mL) and
IL-8 (0.42 ng/mL) are presented in Fig 5.
An inflammatory response, defined as an IL-6
level ≥ 0.80 ng/mL was found in 47 % (22/47)
and an IL-8 level ≥ 0.42 ng/mL was found in
44 % (21/47) of the cases. An inflammatory
response, defined as IL-6 ≥ 0.80 ng/mL and/or
IL-8 ≥ 0.42 ng/mL was found in 57 % (27/47)
of the patients.
A positive endocervical culture was found in
19 patients. In 4 patients the result of the
endocervical culture were missing. Bacteria
found in the endocervical culture were
Streptococcus agalactiae (n=12), Candida
albicans (n=6), Gardnerella vaginalis (n=2),
Staphylococcus aureus (n=1), alpha-
Streptococcus (n=1), coagulase negative
Staphylococcus (n=1) and one patient had a
disturbed vaginal flora (gram positive aerobe
and anaerobe mixed flora). One patient with a
positive culture in AF Streptococcus agalactiae
had Streptococcus agalactiae and
Staphylococcus aureus in the endocervical
Fig. 3
IL
-6
, 
n
g
/m
L
a
< 34 weeks≥ 34 weeks
NS
0.1
1
10
100
1000
10000
≥ 34 weeks
0.1
1
10
100
1000
< 34 weeks
b
IL
-8
, 
n
g
/m
L
p = 0.046
Fig. 4
0
0 0.2 0.4 0.6 0.8 1
1 - specificity
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
se
n
si
ti
v
it
y
O ≥ 0.42
.≥ 10
≥ 1.5
b
.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.2 0.4 0.6 0.8 1
1 - specificity
se
n
si
ti
v
it
y
O
≥ 1.4
. ≥ 2.3
.
≥ 0.40
a
.
≥ 0.8
Fig. 3. Interleukin (IL)-6 (a) and interleukin-8 (b) levels
in amniotic fluid related to birth at <34 weeks of
gestation. Horizontal bars indicate medians. Values on
the Y-axis are given on a logarithmic scale (ng/mL) and
statistical significance (delivery at ≤ 34 weeks vs. > 34
weeks of gestation) was evaluated with the Mann-
Whitney U test. Fig. 4. Receiver-operator characteristic curve analysis
of amniotic fluid interleukin-6 (a) and interleukin-8 (b)
concentrations (ng/mL) as a predictor of preterm birth
within 7 days. Numbers next to solid or open dots
represent some of the cut-off values of amniotic fluid
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fluid. Eleven other patients had Streptococcus
agalactiae in endocervix without detectable
levels of the bacteria in AF.
Discussion
The result of this study demonstrates that in
this Swedish population presenting with
pPROM (median gestation: 31 weeks), 25 %
had detectable levels of microorganisms in the
AF and approximately 57 % had amniotic
inflammation  (indicated by IL-6 ≥ 0.80 ng/
mL and IL-8 ≥ 0.42 ng/mL). IL-6, IL-8 and
intra-amniotic inflammation were better
predictors for imminent PTB (Table III) than
intra-amniotic infection, which agrees with
earlier reports (19).
The prevalence of microbial invasion of the AF
found presently (25 %) in women with
pPROM, using PCR for Mycoplasma hominis
and Ureaplasma urealyticum combined with
aerobic and anaerobic cultures, is within the
wide range (15-57 %; median: 34 %) of earlier
reports (12, 15). Although, all studies seem to
underestimate the occurrence of microbial
invasion in women with pPROM since
microbial invasion is related to
oligohydramnios and therefore less accessible
for amniocentesis (20). Comparisons between
different reports are difficult, however, because
of differences in the definition of pPROM with
respect to detection method of AF in the vagina,
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Table III.  
Diagnostic indices for amniotic ﬂ uid interleukin-6, interleukin-8 and presence of microbes in 
the amniotic ﬂ uid as predictors of delivery at ≤ 7 days.
IL-6 
≥0.80 ng/mL
(n=47)
IL-8
≥0.42 ng/mL
(n=47)
IAI
(n=47)
Microbes 
detected in 
amniotic ﬂ uid
(n=53)
Sensitivity 63 % 56 % 70 % 33 %
Speciﬁ city 75 % 70 % 60 % 90 %
Positive predictive value 77 % 71 % 70 % 84 %
Negative predictive value 60 % 54 % 60 % 45 %
Relative risk and 
95% conﬁ dence interval
1.93
(1.14– 3.29)
1.55 
(0.94-2.54)
1.76 
(0.98-3.17)
1.71 
(1.12-2.62)
 IL – interleukin
 IAI – intra-amniotic inﬂ ammation
Fig.  5. Survival analysis of elapsed time between
amniocentesis and delivery, according to levels of
interleukin-6 (a; cut-off level ≥ 0.80 ng/mL) and
interleukin-8 (b; cut-off level ≥ 0.42 ng/mL) in amniotic
fluid.
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gestational age of included patients and
microbiological technique used (19, 21-29).
Our data show that the occurrence of culture-
positive patients in pPROM was not different
from previous studies performed in other
countries (if expressed as percentage of patients
sampled). This is somewhat surprising as the
incidence of birth <37 weeks of gestation is
only 5-6% (and birth <34 weeks 1.5 %) (2) and
the rate of bacterial vaginosis, postpartum
endometritis and neonatal sepsis is reported to
be comparatively low in Sweden (8-10).
Furthermore, all the patients with positive
cultures or with PCR-detectable
microorganisms in the AF delivered prior to
34 weeks of gestation.
Coagulase negative Staphylococcus is a well-
known skin contaminant in blood cultures.
Even if amniocentesis is performed under
sterile conditions, bacteria from the maternal
skin can contaminate the amniotic culture.  It’s
likely that coagulase negative Staphylococcus,
depending on the circumstances, might be a
skin contamination in certain cases and an
ascending bacterium from vagina in other
cases. There was an inflammatory response in
the patient with coagulase negative
Staphylococcus, which might indicate that
coagulase negative Staphylococcus could be
related to the intra-amniotic inflammation in
this case and therefore, should not be regarded
as a skin contamination.
In international studies, fifty percent of patients
with microbial invasion have more than one
microorganism isolated from the AF (12). In
this study we found only two patients (2/13)
with two types of bacteria in the AF. The fact
that Ureaplasma urealyticum and certain
anaerobes predominate in our patients with
pPROM must be taken into consideration when
the type of antibiotic is chosen in cases when
amniocentesis is not performed (which is most
often the case in Sweden). A combination of
e.g. erythromycin and clindamycin is preferable
to cefuroxime that is often used today in the
Scandinavian countries.
Previous studies have shown that pPROM is
associated with a cytokine response, including
expression of IL-1, IL-6, IL-8 and tumor
necrosis factor-alpha (30). PTB has been
associated with increased levels of IL-6 in AF
(19) and fetal blood (31). We presently found
that nearly 53 % of the women with pPROM
leading to PTB (< 34 weeks of gestation) had
an elevated IL-6 level (≥ 0.80 ng/mL) compared
to 31 % of those that delivered > 34 weeks.
Our data agree with the fact that intra-amniotic
IL-6 is one of the best predictors of preterm
delivery (13) even if the sensitivity and
specificity are not as high as in PTL patients
(11). It has previously been shown that IL-6 is
not as good predictor of microbial invasion of
the AF in pPROM as in PTL patients, and
microbial invasion of the AF is related to a short
amniocentesis-delivery interval (19). We also
found that the alpha chemokine IL-8, that
induces neutrophil attractant and activating
responses, was highly expressed in the AF with
pPROM  but did not have as high sensitivity
and specificity as in the PTL group (11). This
difference in prediction of PTB between the
PTL and pPROM groups is not surprising, since
different mechanisms appear to be important
in pPROM as compared to PTL (32).
It is interesting to note that only 37 % (10/27)
of the patients with an inflammatory response
(indicated by IL-6 ≥ 0.80 ng/mL or IL-8 ≥ 0.42
ng/mL) had detectable levels of
microorganisms in the AF in spite of that PCR
was used for Ureaplasma urealyticum and
Mycoplasma hominis (33). This is in agreement
with previous reports (34), and most likely
indicate that some microorganisms cannot be
detected with the techniques presently
employed or that PTB could result from non-
infectious inflammation.
In summary, a significant percentage of women
with pPROM (< 34 weeks), even in a Swedish
population with low prevalence of genital tract
infections, have microbial invasion (25 %) and/
or a cytokine inflammatory response (57 %) in
the AF.
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Objective. To evaluate the relationship between interleukin (IL)-18 in cervical mucus and amniotic
fluid and microbial invasion of amniotic fluid, preterm delivery and intra-amniotic inflammation in
women in preterm labour (PTL), with preterm prelabour rupture of the membranes (pPROM) and
at term.
Design. A prospective follow-up study
Setting. Sahlgrenska University Hospital, Göteborg, Sweden.
Sample. Women with singleton pregnancies (<34 weeks) presenting with PTL (n=87) or
pPROM (n=47) and women, not in labour, at term (n=28).
Methods. Amniotic fluid was retrieved transabdominally. Cervical mucus was taken from the
uterine cervix of women in PTL and at term. IL-18 was analyzed with enzyme-linked
immunosorbent assay.
Main outcome measures: IL-18 in relation to microbial invasion of the amniotic fluid, delivery
within 7 days or <34 weeks of gestation and intra-amniotic inflammation.
Results. The levels of IL-18 in the cervical and amniotic fluid were higher in women with PTL
than in those not in labour at term. In the PTL group, significant associations were found
between elevated IL-18 in amniotic fluid and microbial invasion of the amniotic fluid, as well as
between delivery within 7 days or <34 weeks of gestation and intra-amniotic inflammation.
Delivery was delayed longer in the pPROM sub-group with IL-18 ≥1.0 ng/mL than in that with
IL-18 <1.0 ng/mL.
Conclusions. In the PTL group, high IL-18 in amniotic fluid (but not in the cervix) was
associated with microbial invasion of the amniotic fluid, intra-amniotic inflammation and prompt
delivery. On the other hand, elevated IL-18 in the pPROM group correlated with a longer
interval to delivery.
1Perinatal Center, Department of Obstetrics and
Gynaecology, Institute for the Health of Women and
Children, 2Department of Clinical Bacteriology,
Sahlgrenska University Hospital, Göteborg, Sweden.
Submitted to Br J Obstet Gynecol October
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Introduction
Interleukin (IL)-18 is a recently identified
cytokine (1).  It is considered to have
pleiotrophic qualities that regulate both the
innate and acquired immune responses and it
can stimulate both a T helper 1 and a T helper
2 response depending on the local cytokine
environment (2, 3). IL-18 is synthesized as a
pro-form and is activated through cleavage by
caspase-1 (IL-1β converting enzyme) (4). IL-
18 is important in the host defence against
severe infections via induction of other
cytokines and effector cells and molecules (2).
It is mainly synthesized by macrophages,
monocytes and keratinocytes, but can also be
produced by epithelial cells (4-8). IL-18
enhances the inflammatory process by
stimulating the production of interferon γ ( INF-
γ), tumor necrosis factor (TNF)-α and IL-1β
(2). IL-12 can act synergistically with IL-18 to
provoke a T helper 1 response (4, 9). The IL-
Interleukin-18 in cervical mucus and amniotic fluid:
relationship to microbial invasion of the amniotic cavity,
intra-amniotic inflammation and preterm delivery
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18-receptor in the cell membrane activates the
same intracellular signal pathway as the IL-1-
receptor, through activation of nuclear factor
κ§ (2, 10). Several human epithelial cell lines
express pro-IL-18 and Chlamydia trachomatis
infection has been shown to cause epithelial
cells to produce mature IL-18 through caspase-
1 activation (5). IL-18 can also activate
apoptosis by enhancing Fas ligand and Fas
expression (11).
IL-18 is present in the amniotic fluid (AF) as
well as in maternal and foetal plasma (12-14).
The levels of IL-18 appear to increase with
advancing gestational age (12). Menon et al
detected IL-18 mRNA in chorion and in the
interface between decidua and chorion,
whereas the amniotic epithelium was devoid
of mRNA and protein for IL-18. Higher levels
of IL-18 were found in women with preterm
prelabour rupture of the membranes (pPROM),
no microbial invasion of the AF or contractions,
in comparison with women with preterm labour
(PTL) (13). On the other hand, Pacora et al
found that the concentration of IL-18 in the AF
increases with microbial invasion of the AF in
PTL and in women in labour at term (12). The
elevated level of IL-18 in pPROM was
suggested (13) to initiate apoptosis in the foetal
membranes through the Fas-Fas-ligand
pathway but this has not been confirmed. Thus,
the role of IL-18 in PTL and pPROM remains
uncertain, and no data are available on the
levels of IL-18 in cervical mucus.
Considering its critical role in host defence, IL-
18 may participate in providing a cervical/deci-
dual barrier against microbial invasion of the
AF and might, conceivably, serve as a cervical
marker for intra-amniotic infection. Therefore,
our primary aim was to investigate the
relationship between IL-18 in cervical mucus
and AF in PTL and in AF in pPROM and
microbial invasion of the AF, preterm delivery
(< 34 weeks, ≤ 7 days) and intra-amniotic in-
flammation. Secondly, the intra-amniotic IL-
18 level in PTL was compared with that in
pPROM, as IL-18-induced apoptosis has been
suggested to be important in the rupture of
membranes (13). Third, cervical mucus and AF
levels in women in PTL and in non-labouring
women at term were compared.
Methods
The study population consisted of women with
singleton pregnancies in PTL (n=87) or with
pPROM (n=47) who presented at 2 delivery
wards in Göteborg (Sahlgrenska Hospital
(1996-1997) and Sahlgrenska University
Hospital/East (1997-2001) at a gestational age
less than 34 weeks of gestation. PTL was
defined as regular uterine contractions (at least
2 uterine contractions/10 minutes during ≥ 30
minutes) in combination with cervical changes
at admittance to the clinic: ((1) ≤ 2 cm length
+ ≥ 1 cm dilatation or (2) ≤ 2 cm length +
cervical softening or (3) ≥ 1 cm dilatation +
cervical softening or (4) cervical length < 30
mm at endovaginal ultrasound. pPROM was
defined as amniorrhexis (visible AF in the
vagina) before the onset of spontaneous labour.
Contractions began prior to amniocentesis in
seven women with pPROM.
Women with known uterine abnormalities,
foetal malformations, significant vaginal
bleeding, imminent delivery or foetal distress
were not included. Twenty-eight women at term
(≥ 37 weeks) were included. These women
were scheduled for an elective caesarean
section (CS) with the following indications:
psychosocial, breech presentation or two
previous CS.  None of the women at term had
contractions or rupture of membranes prior to
surgery.
Gestational age was determined in all women
except three by routine ultrasound in the second
trimester (16th to 19th weeks of gestation).
Tocolytic therapy (intravenous terbutaline and/
or indomethacin if the pregnancy was < 28
weeks of gestation) was administered according
to the local protocol at the department.
Cervical mucus was obtained with a Cytobrush
(Cytobrush Plus GT, Medscan Medical AB,
Malmö, Sweden) from the external os of cervix
in all women in PTL (n=87) and in all women
at term (n=28). The cervical mucus was
weighed and kept in a refrigerator (+4°C) until
processed within 5 hours. The Cytobrush with
the cervical mucus was submerged in 1.0 mL
NaCl, shaken for 30 minutes at +4°C, followed
by centrifugation at 855 g at +4°C for 10
minutes and storage at –80°C until analysis.
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Ultrasound-guided transabdominal
amniocentesis, aspirating 30 – 50 mL of AF,
was performed in 59 women in PTL and in 47
women with pPROM under antiseptic
conditions within 12 hours after admittance. In
women at term, AF was retrieved during CS. A
catheter was introduced into the amniotic cavity
and 50 mL of AF was aspirated prior to opening
the membranes. After retrieval, the AF was
immediately placed in a refrigerator  (+4°C)
and was centrifuged within 5 hours of sampling
at 855 g in +4°C for 10 minutes. The
supernatant was stored at –80°C until analysis.
A sample of uncentrifuged AF was immediately
transported to the microbiological laboratory
for polymerase chain reaction (PCR) analysis
of Ureaplasma urealyticum and Mycoplasma
hominis and for aerobic and anaerobic culture.
Microbial invasion was defined as positive
PCR and/or growth of any bacteria in the AF
except Coagulase negative Staphylococcus that
was considered to be skin contamination
IL-18 in AF was analysed with enzyme-linked
immunosorbent assay (ELISA) (paired
antibodies from R&D Systems, Minneapolis,
Minn, USA). AF samples were diluted 1:5, 1:20
and 1:100 and run in duplicates. The inter-assay
variation was calculated to < 25%, based on
analysis of several samples on three separate
occasions. Low values (≤ 400 pg/mL) showed
the highest variation coefficient.  The detection
limit of the ELISA test was 30 pg/mL, but
because the samples were run at 1:5 dilution,
the actual lower limit of detection was 150 pg/
mL.
We have analysed IL-6 and IL-8 in AF in the
same population in previous studies (15, 16)
and calculated the diagnostic indices for
delivery within 7 days. A receiver-operator
characteristic curve was used to identify the
best cut-off levels for IL-6 and IL-8. Intra-
amniotic inflammation was defined as IL-6 ≥
1.5 ng/mL and/or IL-8 ≥ 1.3 ng/mL for women
in PTL and as IL-6 ≥ 0.80 ng/mL and/or IL-8 ≥
0.42 ng/mL for women with pPROM.
Two investigators (BJ, RMH) scrutinised the
medical records and entered maternal and
perinatal data into a database.
Ethical approval for the study was obtained
from the local ethics committee in Göteborg.
The women gave informed consent before
enrolment in the study.
Calculations were made using the computer
programs StatView 5.01 (SAS Institute Inc,
Cary North Carolina, USA) and InStat 2.01
(Graph Pad Software, San Diego California,
USA). Continuous variables were analysed
with the Mann-Whitney U test and proportions
with Fisher’s exact test. A p-value < 0.05 was
considered statistically significant, as was a
confidence interval not including 1.00.
Results
Demographics, presence of bacteria in the AF,
and pregnancy outcome are presented in Table
I. IL-18 was detectable in the cervix in 60%
(52/87) of women with PTL and in 11% (3/28)
of the women at term. IL-18 was detectable in
the amniotic samples in 73% (43/59) of the
women in PTL and in 70% (33/47) of women
with pPROM. In the term group, IL-18 was
detected in AF in 11% (3/28) of the cases.
Microorganisms isolated from the amniotic
cavity were Ureaplasma urealyticum (n=8),
Mycoplasma hominis (n=1), Fusobacterium
species (n=1), Corynebacterium (no intra-
amniotic inflammation) (n=1), Eubacterium
species (n=1), Actinomyces odontolyticus
(n=1), Snethia sanguinegens (n=1), Listeria
monocytogenes (n=1), Streptococcus mitis (no
intra-amniotic inflammation) (n=1),
Haemophilus influenzae  (n=1), Streptococcus
agalactiae  (n=1), Bacteroides fragilis (no intra-
amniotic inflammation)  (n=1),
Bifidobacterium adolecentis (no intra-amniotic
inflammation)  (n=1),  Difteriodic rods (n=1),
Anaerob gram-negative rods  (n=1) and
Coagulase negative Staphylococcus  (no intra-
amniotic inflammation, n=3) (n=5) (15, 16).
None of these women developed clinical
chorioamnionitis.
IL-18 in Cervical mucus
There were higher levels of IL-18 in the
cervical mucus in women in PTL compared
with non-labouring women at term (median
0.51 ng/mL versus <0.15 ng/mL; p<0.001)
(Fig. 1a). In women with PTL, no significant
associations were found between cervical IL-
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18 and microbial invasion in the AF, time of
delivery (≤ 7 days, < 34 weeks) or intra-
correlation was found between IL-18 in cervical
mucus and AF (r=0.30 and p=0.028).
Amniotic fluid IL-18
There were higher levels of IL-18 in the AF of
women in PTL compared with non-labouring
women at term (median 0.59 ng/mL versus <
0.15 ng/mL; p=0.004) (Fig. 1b).
Women in PTL with microbial invasion of the
AF had significantly higher levels of IL-18 in
the AF than those without microbial invasion.
In women with pPROM, this association was
not significant. In the term group, IL-18 was
not detectable in the AF from the woman with
positive PCR for neither Ureaplasma
urealyticum nor the woman with coagulase
negative Staphylococcus.
Women in PTL who delivered within 7 days
after amniocentesis had significantly higher
levels of IL-18 than those who delivered after
7 days (median 1.01 ng/mL versus 0.57 ng/mL,
p=0.046) (Fig. 2b). In the pPROM group, the
levels of IL-18 in women that delivered ≤ 7
days did not differ from those with an interval
> 7days (median 0.24 ng/mL versus median
0.38 ng/mL; p=0.19). However, women with
pPROM and low IL-18 in AF had shorter
interval to delivery than those with high IL-18
levels (< 1.0 ng/mL: median interval 4 days; >
1.0 ng/mL: median latency 36 days; p=0.03).
Table 1. Demographics and pregnancy outcome in women undergoing cesarean section at term, women in 
preterm labour (PTL) and with preterm prelabour rupture of the membranes (pPROM).
Term PTL
(CF)
p-value
term/
PTL 
(CF)
PTL
(AF)
PPROM p-value
(PTL(AF)/
pPROM)
 Number of patients (n) 28 87 59 47
Maternal age (years) 34 
(22-41)
29
(19-43)
0.002 29 
(19-38)
30 
(19-43)
0.49
Nulliparous  (n) 11 (39%) 51 
(59%)
0.09 36 
(62%)
26 
(55%)
0.55
Gestational age at 
sampling (days)
271
(263-288)
216
(160-
237)
0.0003 216 
(160-
236)
221 
(158-
236)
0.07
Gestational age at 
delivery (days) 
271 
(263-288)
252
(168-
299)
0.0003 242 
(168-
288)
232 
(162-
281)
0.04
Patients giving birth at 
<34 weeks (n)
NA NA 25 
(43%)
34 
(72%)
0.003
Birth weight (gram)        3505
(2575-
4340)
2785
(705-
4675)
<0.0001 2550
(705-
4675) 
2170 
(470-
3940)
0.07
Microbial invasion of 
the amniotic ﬂ uid (n)
1 (3.6%) NA NA 9 
(15.5%)
11 
(23.4%)
0.32
Data are presented as median and range except for nulliparity, births < 34 weeks and microbial invasion of the 
amniotic ﬂ uid for which the number (n) and percentage (%) of the women in preterm and term population are 
given, respectively. 
AF – amniotic ﬂ uid
CF – cervical ﬂ uid
NA – not applicable
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Women in PTL that delivered before 34
completed weeks had significantly higher
levels of IL-18 than those who gave birth > 34
weeks of gestation  (median 1.0 ng/mL versus
0.47 ng/mL; p=0.02) (Fig. 2c). In women with
pPROM, there was no association between AF
IL-18 and delivery < 34 weeks (median 0.42
ng/mL versus 0.23 ng/mL; p=0.22).
Intra-amniotic IL-18 correlated to general intra-
amniotic inflammation in women in PTL
(median 0.81 ng/mL versus 0.39 ng/mL;
p=0.02) (Fig. 2d), but no such relationship was
found in the pPROM group (median 0.46 ng/
mL versus 0.28 ng/mL; p=0.13).
No difference was found between IL-18 levels
in the PTL and pPROM groups (median 0.59
ng/mL versus 0.35 ng/mL; p=0.068). Women
with pPROM in the absence of both
contractions and microbial invasion of the AF
(n=31) did not have higher concentrations of
IL-18 than those women with pPROM that had
contractions and/or microbial AF invasion
(n=16) (median 0.39 ng/mL versus 0.35 ng/mL;
p=0.75).
Discussion and Conclusion
This is the first study to document IL-18 in
cervical mucus and its relationship to PTL. The
major finding of this study is that high levels
of AF IL-18 correlated to intra-amniotic
inflammation and prompt delivery in women
presenting with PTL, whereas IL-18 levels ≥
1.0 ng/mL were associated with a longer
interval to delivery in the pPROM group. In
agreement with a previously published study
(12), we found that IL-18 in AF is associated
with microbial invasion of the AF and preterm
delivery in PTL women (12).
The level of IL-18 in cervical mucus and AF
was higher in women in PTL than in non-
labouring women at term. A poor correlation
was observed between the levels of IL-18 in
cervical mucus and AF. Pacora et al have shown
that the levels of IL-18 in AF increases with
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Fig. 1 Interleukin-18 in cervical fluid from women in
PTL and at term (a) and in amniotic fluid from
women in PTL and at term (b). Horizontal bars
indicate medians.
Table 2. Interleukin (IL)- 18 in cervical ﬂ uid in women in preterm labour related to 
different outcome variables
IL-18
(ng/mL)
p-value
MIAC (n=7) / no MIAC (n=47)* 1.72 / 0.42 0.34
Delivery ≤ 7 days  (n=26)  / > 7 days  (n=61) 1.26 / 0.41 0.16
Delivery < 34 weeks  (n=37)  / ≥ 34 weeks  (n=50) 0.92 / 0.40 0.26
IAI (n=25) / No IAI (n=29)* 1.33/0.41 0.51
MIAC – microbial invasion of the amniotic cavity
IAI - Intra-amniotic inﬂ ammation
* cervical sample missing in 5 women
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gestational age (12). Our interpretation of the
differences between women in PTL and non-
labouring at term is that the higher levels of
IL-18 are related to the general inflammatory
response in PTL; this is reflected both in the
cervical mucus and AF.
There was no association between cervical IL-
18 and microbial invasion of the AF, intra-
amniotic inflammation and delivery within 7
days or < 34 weeks, suggesting that this
cytokine is unlikely to be of value as a cervical
marker of preterm birth or infection in women
in PTL.
IL-18 plays a well-documented role in the
development of inflammatory disease, e.g.
rheumatoid arthritis and inflammatory bowel
disease (3, 6). In this study, it is shown that
intra-amniotic IL-18 correlate to the general
intra-amniotic inflammation in women in PTL.
The IL-18 level was also higher in women that
delivered shortly after admission, indicating
that IL-18 is part of the inflammatory response
in PTL.  This is interesting as IL-18 could also
be involved in the foetal inflammatory response
syndrome, which might have
pathophysiological consequences, as this
cytokine could exert adverse effects in the
foetus. A recently published study shows that
preterm infants who later developed
periventricular leukomalacia or cerebral palsy
had elevated concentrations of IL-18 in cord
blood (17). Experimental studies also show that
IL-18 mediates liver cell injury in response to
bacteria (18) and, like IL-1β, induces injury in
the CNS (19).
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Fig. 2. Interleukin-18 in amniotic fluid from women in PTL. The levels are related to microbial invasion in the
amniotic fluid, as defined by a positive culture or PCR (a), to interval between amniocentesis and delivery (> 7 vs.
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IL-18 plays a role in the defence against both
extra- and intracellular bacterial infection (20).
Initially, IL-18 was called INF-γ−inducing
factor and ΙΝF-γ is known to play a central role
in the immune response against infectious
agents (4, 9). This is also supported by data
from several animal studies (21-23). IL-18 has
the capacity to stimulate cytotoxic natural killer
cells and stimulates T-cells to produce INF-γ
and granulocyte/macrophage colony-
stimulating factor (8). Bacteria found in the AF
in women in PTL, e.g. Corynebacteria,
Pseudomonas aeruginosa, Haemophilus
influenzae and Chlamydia tracomatis, have
been shown to provoke a IL-18 response in vivo
in other compartments of the human body (20).
It is therefore interesting that we find, in
agreement with Pacora (12), higher IL-18 levels
in cases of PTL with positive cultures. It is a
tentative hypothesis that IL-18 is part of the
immune response to bacteria within the
amniotic cavity of women in PTL.
Women in PTL who gave birth delivery within
7 days (or <34 weeks) had higher levels of IL-
18 in the AF than those who delivered after 7
days (or >34 weeks). Such a relationship
between IL-18 and interval to delivery was not
found by Pacora et al (12). This discrepancy
could be due to the difference in gestational
age (<34 weeks vs. <37 weeks, respectively)
in our study compared and Pacora’s et al study
(12), since inflammation might be more
important at low gestational ages (24). In
women with pPROM, the opposite relationship
was found, i.e. high IL-18 was associated with
longer interval to delivery. It is also important
to note that the amniotic concentrations of IL-
18 in women with pPROM and microbial
invasion of the AF were not higher than in cases
of pPROM with sterile AF. The response is
different for IL-6 and IL-8, levels of which were
higher in women with microbial invasion both
in the PTL and pPROM groups (15, 16). These
data suggest that IL-18 plays different roles in
PTL and pPROM. A similar dichotomy
between PTL and pPROM has previously been
observed regarding TNF-α and IL-1α (12, 25).
The mechanisms involved are unclear, but IL-
18, TNF-α and IL-1α all possess cytotoxic
properties, in contrast to IL-6 and IL-8 that
seem to be part of the general activation of the
inflammatory response (26).
Neither our study, nor Pacora’s (12), could
confirm the findings by Menon et al (13) of
higher levels of IL-18 in pPROM. On the
contrary, our data indicated a tendency towards
lower values in the pPROM group.
In conclusion, IL-18 is involved in intra-
amniotic inflammation related to PTL and host
defence. IL-18 in cervical mucus cannot serve
as a marker of microbial invasion of the AF or
preterm delivery. Our data supports, the idea
that IL-18 play a different role in pPROM than
in PTL.
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Introduction
Some normal functions of the female
reproductive tract such as parturition and
cervical ripening depend on inflammatory
processes (1). In addition, inflammation
appears to be critical in certain pathological
processes, e.g. in the preterm labor syndrome
(2). Modern understanding of reproductive
functioning indicates the existence of local
paracrine-autocrine regulatory mechanisms (1).
Inflammatory processes are regulated by a
coordinated expression of pro- and anti-
inflammatory cytokines and chemokines.
Chemokines (short for chemoattractant
cytokines) play a crucial role in this process
by regulating the leukocyte traffic. A great deal
of research has identified the chemoattractants
and activators responsible for neutrophil and
lymphocyte traffic but less is known about the
molecules regulating monocyte migration.
Certain chemokines, such as monocyte
chemotactic protein (MCP)-1, have been
demonstrated to recruit monocytes into foci of
active inflammation (3).  MCP-1 is considered
to be a prototypic b-chemokine. It has been
proven that MCP-1 is involved in several
aspects of uterine function and in local
regulation of endometrial processes such as
menstruation and implantation (1).
The preterm labor syndrome has been
characterized as an inflammatory-like
condition (2). Several cytokines with
proinflammatory properties, such as interleukin
(IL)-6, IL-1b,  IL-18 and tumor necrosis factor-
a, are known to be involved in this process (2).
Information on chemokines in pregnancy has
focused on IL-8, macrophage inflammatory
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protein (MIP)-1a, GRO-a and RANTES (4-7).
RANTES and MIP-1a are other b-chemokines
that have been studied in relation to preterm
birth and proven to be increased in patients with
microbial invasion of the amniotic cavity
(MIAC) (4, 6).
Considering its critical role in the traffic of
important cells in inflammatory processes and
the host defense, MCP-1 might participate in
providing a cervical/decidual defense line
against MIAC and might conceivably serve as
a cervical marker for MIAC and intra-amniotic
inflammation. The clinical signs of intra-
amniotic infection are often non-existent, and
it is only by the invasive procedure of
amniocentesis that intra-amniotic conditions
can be revealed. A good cervical marker of
MIAC, intra-amniotic inflammation and
preterm delivery would be clinically important
as cervical sampling is less invasive than
amniocentesis. Preliminary reports indicate that
amniotic MCP-1 may play a role in term
parturition (8) as well as in preterm labor (PTL)
and preterm prelabor rupture of membranes
(pPROM)(9) but no information has been
published on cervical MCP-1 concentrations.
The primary aim was to compare the levels of
MCP-1 in cervical and amniotic fluid (AF) in
women in PTL and in non-laboring women at
term. Secondly, the relationship between MCP-
1 in AF and/or cervical fluid and MIAC, intra-
amniotic inflammation and preterm delivery
was investigated in patients with PTL and
pPROM.
Material and Methods
A prospective cohort study was performed. The
study population consisted of women with
singleton pregnancies in PTL (n=75) or with
pPROM (n=47) who presented at 2 delivery
wards in Göteborg (Sahlgrenska Hospital
(1996-1997) and Sahlgrenska University
Hospital/East (1997-2001)) at a gestational age
less than 34 weeks of gestation. PTL was
defined as regular uterine contractions (at least
2 uterine contractions/10 minutes for ≥ 30
minutes) in combination with cervical changes:
((1) ≤ 2 cm length + ≥ 1 cm dilatation or (2) ≤
2 cm length + cervical softening or (3) ≥ 1 cm
dilatation + cervical softening or (4) cervical
length <30 mm at endovaginal ultrasound).
pPROM was defined as amniorrhexis (visible
AF in the vagina) before the onset of
spontaneous labor. Contractions began prior to
amniocentesis in seven cases of pPROM.
Women with known uterine abnormalities, fetal
malformations, significant vaginal bleeding,
imminent delivery or fetal distress were not
included. Forty-five women at term (≥ 37
weeks) were included. These women were
scheduled for an elective cesarean section (CS)
with the following indications: psychosocial,
breech presentation or two previous CS.  None
of the term patients had contractions or rupture
of membranes prior to surgery.
Gestational age was determined in all patients
except three by routine ultrasound in the second
trimester (16th to 19th weeks of gestation). Date
of last menstruation was used for gestational
length determination when a routine ultrasound
was not available. Tocolytic therapy
(intravenous terbutaline and/or indomethacin,
the latter if the pregnancy was < 28 weeks of
gestation) was administered according to
department protocol.
Cervical fluid was obtained with a Cytobrush
(Cytobrush Plus GT, Medscan Medical AB,
Malmö, Sweden) from the external cervical os
in all patients in PTL (n=75) and in all term
patients (n=45). The cervical mucus was
weighed and kept in a refrigerator (+4°C) until
processed, which occurred within 5 hours. The
Cytobrush with the cervical mucus was
submerged in 1.0 mL NaCl, shaken for 30
minutes at +4°C, followed by centrifugation at
855 g at +4°C for 10 minutes and storage at
–80°C until analysis.
Ultrasound-guided transabdominal amnio-
centesis, aspirating 30-50 ml of AF, was
performed in 61 women in PTL and in 47
women with pPROM under antiseptic
conditions within 12 hours after admission. In
women at term, AF was retrieved during CS. A
catheter was introduced into the amniotic cavity
and 50 mL of AF was aspirated prior to opening
the membranes. After retrieval, the AF was
immediately placed in a refrigerator (+4°C) and
centrifuged, within 5 h of sampling, at 855 g in
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+4°C for 10 minutes. The supernatant was
stored at –80°C until analysis.
A sample of uncentrifuged AF was immediately
transported to the microbiological laboratory
for polymerase chain reaction (PCR) analysis
of Ureaplasma urealyticum and Mycoplasma
hominis and for aerobic and anaerobic culture.
MIAC was defined as positive PCR and/or
growth of any bacteria in the AF except for
coagulase-negative Staphylococcus, which was
considered to be a skin contamination.
However, coagulase-negative Staphylococcus
in AF from patients with an intra-amniotic
inflammation (higher levels of IL-6 and IL-8),
was considered to be MIAC (10, 11).
MCP-1 in cervical fluid and AF was analyzed
with enzyme-linked immunosorbent assay
(ELISA) (paired antibodies from R&D
Systems, Minneapolis, Minn, USA). The
samples were diluted 1:2, 1:3 and 1:6 in
different analysis sets and run in duplicates.
We have analyzed IL-6 and IL-8 in AF in the
same population in previous studies (10, 11)
and calculated the diagnostic indices for
delivery within 7 days. A receiver-operator
characteristic curve (ROC) was used to define
intra-amniotic inflammation. Intra-amniotic
inflammation was defined as IL-6 ≥ 1.5 ng/mL
and/or IL-8 ≥ 1.3 ng/mL for women in PTL
and as IL-6 ≥ 0.80 ng/mL and/or IL-8 ≥ 0.42
ng/mL for women with pPROM.
Table I. Demographics and pregnancy outcome in women undergoing to cesarean section at term, women in 
preterm labor (PTL) and with preterm prelabor rupture of membranes (pPROM). 
Term PTL
(CF)
p-value
term vs.
PTL 
(CF)
PTL
(AF)
pPROM p-value
(PTL(AF) vs.
pPROM)
Number of patients (n) 45 75 61 47
Maternal age (years) 33 
(22-41)
29
(19-43)
<0.001 29 
(19-38)
30 
(19-43)
0.42
Nulliparous  (n) 19 (42%) 45 
(60%)
0.09 38 
(62%)
26 
(55%)
0.55
Gestational age at 
sampling (days)
270
(263-288)
216
(160-
237)
<0.001 216 
(160-
236)
222 
(158-
236)
0.08
Gestational age at 
delivery (days) 
270 
(263-288)
254
(168-
299)
<0.001 242 
(168-
288)
232 
(162-
281)
0.06
Birth weight (gram) 3500
(2575-
4340)
2930
(705-
4675)
<0.001 2425
(705-
4675) 
2175 
(470-
3940)
0.11
Patients giving birth at 
<34 weeks (n)
NA 22 
(29%)
NA 27 
(44%)
34 
(72%)
0.005
Term delivery (≥ 37 
weeks)
45 
(100%)
28 
(37%)
<0.001 22 
(36%)
5 (11%) 0.003
Delivery ≤ 7 days NA 17 NA 23 
(38%)
27 
(57%)
0.05
Microbial invasion of 
the amniotic ﬂ uid (n)
1 (2%) 8/45 
(18%)
0.03 11 
(18%)
13 
(27%)
0.25
Intra-amniotic 
inﬂ ammation
0 (0%) 19/45 
(42%)
<0.001 28 
(46%)
27 
(57%)
0.25
Data are presented as median and range except for nulliparity, births < 34 weeks, term delivery (≥ 37 weeks), 
delivery ≤ 7 days, microbial invasion of the amniotic ﬂ uid and intra-amniotic inﬂ ammation for which the 
number (n) and percentage (%) of the women in the preterm and term population, respectively, are given. 
AF – amniotic ﬂ uid
CF – cervical ﬂ uid
NA – not applicable
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Sensitivity, specificity and positive and
negative predictive values were calculated for
different concentrations of MCP-1 in cervical
fluid and AF in relation to delivery within 7
days after amniocentesis, MIAC and intra-
amniotic inflammation. ROC curves were used
to identify the best cutoff levels of MCP-1 in
cervical fluid and AF for the different outcome
variables of interest.
Two investigators (BJ, RMH) scrutinized the
medical records and entered maternal and
perinatal data into a database. The study was
approved by the local ethics committee in
Göteborg.  The women gave informed consent
before enrollment in the study.
Calculations were made using the computer
programs StatView 5.01 (SAS Institute Inc,
Cary, North Carolina, USA) and InStat 2.01
(Graph Pad Software, San Diego, California,
USA). Continuous variables were analyzed
with the Mann-Whitney U test and proportions
with Fisher’s exact test. Spearman’s rank
correlations test was used for analysis of
correlation between continuous variables. A p-
value < 0.05 or a confidence interval not
including 1 was considered to be statistically
significant.
Results
Demographics, presence of bacteria in the AF,
and pregnancy outcome are presented in Table
I. Analysis of MCP-1 in the cervical sample
was successful in the 75 women in PTL and in
all term patients. A MCP-1 analysis of the AF
was available in all 61 PTL patients, in all 47
patients with pPROM and in 44 of the 45 term
patients. In 45 of the PTL and in 44 of the term
women, MCP-1 analyses were available both
in cervical and AF. MCP-1 was detectable in
cervical fluid in 95% (71/75) of the women in
PTL and in 87% (39/45) of the term women.
MCP-1 was detectable in all AF samples.
Microorganisms isolated from the amniotic
cavity and the corresponding inflammatory
response have been presented in two previous
papers (10, 11).
Fig. 1. Monocyte chemotactic protein (MCP)-1 in cervical fluid from women in preterm labor. The levels are related
to interval between sampleing and delivery (> 7 vs. ≤ 7 days) (a); to gestational age at delivery (≥34 vs. <34 weeks of
gestation) (b); to microbial invasion in the amniotic cavity, defined by a positive or negative culture or PCR (c); and
to inflammatory response in the amniotic fluid, defined as increased levels of IL-6 (≥ 1.5 ng/mL) and/or IL-8 (≥ 1.3
ng/mL) (d). Horizontal bars indicate medians.
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Cervical fluid MCP-1
There were higher levels of MCP-1 in the
cervical fluid in women in PTL compared with
non-laboring women at term (median 0.42 ng/
mL, range 0.016-8.5 ng/mL versus median 0.22
ng/mL, range 0.010-8.5 ng/mL; p=0.016).
There were higher levels of MCP-1 in the
cervical mucus in women in PTL who gave
birth within 7 days than those with a longer
sample-delivery interval (median 1.5 ng/mL,
range 0.41-8.5 ng/mL versus median 0.34 ng/
mL, range 0.016-3.7 ng/mL; p<0.001) (Fig. 1a)
and higher levels of MCP-1 in PTL women who
gave birth before 34 weeks of gestation than in
those ≥ 34 weeks of gestation (median 0.99 ng/
mL, range 0.031-8.5 ng/mL versus 0.34 ng/mL,
range 0.016-3.7 ng/mL; p<0.001) (Fig. 1b).
MCP-1 levels were higher in the cervical mucus
in women in PTL with than in those without
MIAC (median 1.63 ng/mL, range 0.099-8.5
ng/mL versus median 0.50 ng/mL, range 0.031-
3.1 ng/mL; p=0.01) (Fig. 1c). There were also
higher levels of MCP-1 in the cervical mucus
in women in PTL who had intra-amniotic
inflammation (median 0.85, range 0.055-8.5
ng/mL versus median 0.37, range 0.031-2.2 ng/
mL; p=0.02) (Fig. 1d).
Amniotic fluid MCP-1
There were higher levels of MCP-1 in the AF
in women in PTL compared with non-laboring
women at term (median 0.66 ng/mL, range
0.19-12 ng/mL versus median 0.32 ng/mL,
range 0.13-1.3 ng/mL; p<0.001).
Women in PTL with MIAC did not have
significantly higher levels of MCP-1 in the AF
than women without MIAC (median 2.0 ng/
mL, range 0.21-12 ng/mL versus median 0.61
ng/mL, range 0.19-4.0 ng/mL; p=0.063) (Fig.
2a). In women with pPROM, the levels of
MCP-1 were higher in women with than in
those without MIAC (median 2.2 ng/mL, range
0.37-4.0 ng/mL versus median 0.74 ng/mL,
range 0.13-3.9 ng/mL; p=0.0017) (Fig. 2b).
Women in PTL who gave birth within 7 days
after amniocentesis had significantly higher
levels of MCP-1 than those who gave birth after
Fig. 2. Monocyte chemotactic protein (MCP)-1 in amniotic fluid from women in preterm labor (PTL) (a, c, d) or with
preterm prelabor rupture of  membranes (pPROM) (b). The levels are related to microbial invasion in the amniotic
cavity, defined by a positive or negative culture or PCR, in PTL (a); to microbial invasion in the amniotic fluid in
pPROM (b); to time between amniocentesis and delivery (> 7 vs. ≤ 7 days) (c); and to gestational age at delivery (≥34
vs. <34 weeks of gestation) (d). Horizontal bars indicate medians.
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7 days (median 2.0 ng/mL, range 0.23-12 ng/
mL versus median 0.46 ng/mL, range 0.19-2.0
ng/mL; p< 0.001) (Fig. 2c). In the pPROM
group, the levels of MCP-1 in patients that
delivered within 7 days did not differ from those
with an interval > 7 days (median 0.73 ng/mL,
range 0.13-4.0 ng/mL versus median 0.90 ng/
mL, range 0.24-4.0 ng/mL; p=0.65). Three
patients were allocated to the spontaneously
delivered group despite labor being induced.
However, the results were not affected by
exclusion of these cases. We have performed a
log rank survival analysis regarding the best
MCP-1 cut-off level in AF (≥ 2.0 ng/mL) for
delivery within seven days of women in
pPROM, with censor of patients with induction
of labor or cesarean section before delivery had
started (n=12). A significant difference between
the two groups regarding long interval to
delivery  (p=0.01) was found, in contrast to
short interval to delivery (Fig. 3).
Women in PTL who delivered before 34 weeks
had significantly higher levels of MCP-1 than
those who gave birth > 34 weeks of gestation
(median 2.0 ng/mL, range 0.23-12 ng/mL
versus median 0.44 ng/mL, range 0.19-2.0 ng/
mL; p<0.001) (Fig. 2d). In women with
pPROM, there was no association between AF
MCP-1 and delivery < 34 weeks (median 0.94
ng/mL, range 0.13-4.0 ng/mL versus median
0.77 ng/mL, range 0.24-1.9 ng/mL; p=0.21).
There were 3 inductions and 2 cesarean sections
before the onset of contractions; these cases
could be misclassified as spontaneous delivery
< 34 weeks. If these patients were excluded,
no differences were seen in results.
MCP-1 in AF correlated to general intra-
amniotic inflammation both in women in PTL
(median MCP-1 2.0 ng/mL, range 0.23-12 ng/
mL versus median 0.41 ng/mL, range 0.19-1.6
ng/mL; p<0.001) and in women with pPROM
(median MCP-1 1.0 ng/mL, range 0.26-4.0 ng/
mL versus median 0.52 ng/mL, range 0.13-1.9
ng/mL; p=0.006).
MCP-1 in cervical fluid predicted preterm birth
and MIAC with a high negative but low
positive predictive value (Table II, III). The AF
levels of MCP-1 also predicted MIAC and
intra-amniotic inflammation in patients with
pPROM (Table IV).
A correlation was seen between MCP-1 in
cervical fluid and AF (r=0.35 and p=0.02). Data
concerning IL-8 and IL-6 in these patients has
been published previously (13,14) and was used
for comparison in this study. There was a good
correlation between MCP-1, IL-8 and IL-6 in
AF in both the PTL (IL-8 r=0.74 and p<0.001;
IL-6 r=0.70, p<0.001) and the pPROM groups
(IL-8 r=0.64, p<0.001; IL-6 r=0.41, p=0.005).
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Fig.  3. Survival analysis of elapsed time between amniocentesis and delivery in women with pPROM, according
to the best cut-off level of monocyte chemotactic protein (MCP)-1 (≥ 2.0 ng/mL) for delivery within 7 days.
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Comments
This is the first study that documents MCP-1
in cervical fluid and its relationship to MIAC,
intra-amniotic inflammation and preterm
delivery. The cervical level of MCP-1 was a
predictor of delivery within 7 days but with a
low positive predictive value (44 %). MCP-1
in AF was also a predictor for delivery within
7 days. MCP-1 in AF is a marker of intra-
amniotic inflammation and correlating well
with IL-6 and IL-8 in AF. Cervical MCP-1 was
also a predictor of MIAC but with a low
positive predictive value (35%). However,
cervical MCP-1 may not be the ultimate non-
invasive tool to screen for MIAC, intra-
amniotic inflammation and preterm delivery.
Cervical ripening has been described as an
inflammatory process (12). The infiltration of
white blood cells (both neutrophils and
macrophages) into the cervix is known to occur
in women at term (13). Neutrophils are
responsible for most of the connective tissue
changes that take place during cervical
ripening, but macrophages are also involved,
although their specific role is still unclear (14).
There is a tenfold increase of the number of
macrophages in cervical tissue from early to
Table II.  Diagnostic indices for cervical and amniotic ﬂ uid 
monocyte chemotactic protein-1 (MCP-1) as predictor of 
delivery at ≤ 7 days in women in preterm labor.
Cervical ﬂ uid Amniotic ﬂ uid
MCP-1
≥0.60 ng/mL
MCP-1
≥1.0 ng/mL
Sensitivity 76 % 83 %
Speciﬁ city 72 % 79 %
Positive predictive value 45 % 70 %
Negative predictive value 91 % 88 %
Relative risk and 
95% conﬁ dence interval
5.2 (1.9– 14) 6.0 (2.3-16)
Table III. Diagnostic indices for cervical and amniotic ﬂ uid monocyte chemotactic protein-1 (MCP-1) as 
predictor of microbial invasion of the amniotic cavity and inﬂ ammatory response in the amniotic ﬂ uid women 
in preterm labor. 
Cervical ﬂ uid Cervical ﬂ uid Amniotic ﬂ uid Amniotic ﬂ uid
MCP-1
≥0.80 ng/mL
(microbial invasion of 
the amniotic cavity)
MCP-1
≥0.50 ng/mL
(inﬂ ammatory 
response)
MCP-1
≥1.0 ng/mL
(microbial invasion of 
the amniotic cavity)
MCP-1
≥0.70 ng/mL
(inﬂ ammatory response)
Sensitivity 75 % 74 % 73 % 89 %
Speciﬁ city 70 % 54 % 62 %
30 %
85 %
Positive predictive 
value
35 % 54 % 83 %
Negative predictive 
value
93 % 74 % 91 % 90 %
Relative risk and 
95% conﬁ dence interval
4.9 (1.1– 22) 2.0 (0.89– 4.7) 3.4 (0.98-12) 8.6 (2.9-26)
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late pregnancy (13) and they also increase in
number in relation to the final cervical ripening
at birth (15). Chemokines have been proposed
to be involved in cervical ripening via their
chemoattractant and activating effects on
neutrophils and monocytes (1). Although
functional redundancy exists with other
chemokines in vitro, MCP-1 alone is
responsible for mononuclear cell infiltration in
several inflammatory animal models in vivo
(16). It is thus possible that MCP-1 is also
involved in the process of cervical ripening,
since it is a key chemokine in the activation
and recruitment of monocytes and
macrophages.
Further studies are required to determine the
source of MCP-1 in cervical fluid and AF. The
poor correlation between the levels of MCP-1
in cervical fluid and AF in our study may
indicate different production sites. MCP-1 is
known to be produced by term placenta,
decidua and chorion and, to a lesser extent, by
the amniotic epithelium (17). It has been shown
that cell cultures of cervical fibroblasts can
produce MCP-1 (18) and immunohistologically
stained cervical biopsies from pregnant women
are positive for MCP-1 (19). MCP-1 is most
probably produced locally by cervical tissue.
However, the decidua and membranes can be
an alternative source of MCP-1 as the
inflammatory process leads to disruption of the
chorio-decidual interface, leading to its possible
release into the cervical fluid (20). Kent et al
found that AF does not reflect the cytokines
produced by the decidua in case of intact and
non-inflamed fetal membranes (21). As AF
does not reflect the cytokines/chemokines
produced by the decidua and the amniotic
epithelium appears to be a minor producer of
MCP-1, this suggests that the fetus itself may
be a source of MCP-1. There are no reports of
MCP-1 levels in umbilical cord blood but
MCP-1 is present in dried neonatal blood spots
obtained from 3 day old neonates (22) and the
respiratory tract of the preterm baby is a known
producer of MCP-1 (23).
The level of MCP-1 in cervical fluid and AF
was higher in women in PTL than in non-
laboring women at term. MCP-1 in AF
probably reflects the feto-placental
inflammatory response, whereas cervical MCP-
1 reflects both inflammation related to cervical
ripening and the generalized feto-placental
inflammatory response.
Monocytes and macrophages play a critical role
in the immune response, both by being potent
producers of proinflammatory cytokines,
matrix metalloproteinases and prostaglandins
Table IV. Diagnostic indices for amniotic ﬂ uid monocyte chemotactic
 protein-1 (MCP-1) as predictor of microbial invasion of the amniotic 
cavity and inﬂ ammatory response in the amniotic ﬂ uid in women with 
preterm prelabor rupture of membranes.
Amniotic ﬂ uid Amniotic ﬂ uid
MCP-1
≥1.0 ng/mL
(microbial invasion of 
the amniotic cavity)
MCP-1
≥0.90 ng/mL
(inﬂ ammatory 
response)
Sensitivity 77 % 82 %
Speciﬁ city 74 % 73 %
Positive predictive value 53 % 63 %
Negative predictive value 89 % 88 %
Relative risk and
95% conﬁ dence interval
4.9  (1.5-16) 5.3 (1.7-16)
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and by processing and presenting antigens to
T-cells for recognition. In that sense, they
regulate both the innate and the specific
immune systems. It has been proposed that the
b-chemokines are likely to induce chemotaxis
of monocytes and macrophages into the
amniotic cavity and activate them (4). b-
chemokines may be involved in the host
defense against MIAC and in intra-amniotic
inflammation. It was not surprising that there
was a significant association between MCP-1
and MIAC in women with pPROM, which is
in accordance with preliminary data reported
by Esplin et al. (9). MCP-1 is thus the third b-
chemokine (MIP-1-a, RANTES) that has been
shown to increase in response to MIAC (4, 6).
It is also interesting to note that MCP-1 is part
of the intra-amniotic inflammation in both PTL
and pPROM. However, in contrast to the
findings in the PTL group, we found no
correlation between MCP-1 in AF and delivery
within 7 days or before 34 weeks of gestation
in patients with pPROM. A similar result was
recently obtained for IL-18 (24), supporting the
idea that intra-amniotic inflammation has
different characteristics and outcome in
pPROM and PTL, respectively (25).
The major finding of this study is that cervical
MCP-1 correlated to MIAC, intra-amniotic
inflammation and preterm delivery in women
in PTL. In addition, we found that AF MCP-1
is also associated with MIAC in women with
pPROM, with intra-amniotic inflammation in
women in PTL or with pPROM, and preterm
birth in women in PTL.
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Errata paper V
Abstract Page 946, line 11 should be: .. entire group,
clinical chorioamnionitis ....
Table 2 should be: median
Table 3 should be: median
Table 3 line12 should be: 12/146 (8)
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Cerebral palsy in preterm infants: a population-based case–control
study of antenatal and intrapartal risk factors
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Jacobsson B, Hagberg G, Hagberg B, Ladfors L, Niklasson A, Hagberg H. Cerebral palsy in
preterm infants: a population-based case–control study of antenatal and intrapartal risk factors.
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Previous studies have indicated that foetomaternal infection increases the risk of spastic cerebral
palsy (CP) in term infants, whereas this association appears to be less evident in preterm infants.
The aim of this study was to analyse infection-related risk factors for spastic CP in preterm
infants. A population-based series of preterm infants with spastic CP, 91 very preterm (<32 wk)
and 57 moderately preterm (32–36 wk), born in 1983–90, were included and matched with a
control group (n = 296). In total, 154 maternal, antenatal and intrapartal variables were retrieved
from obstetric records. In the entire group, histological chorioamnionitis/pyelonephritis, long
interval between rupture of membranes and birth, admission–delivery interval <4 h and Apgar
scores of <7 at 1 min just signicantly increased the risk of CP, and Apgar scores of <7 at 5 and
10 min were strongly associated with an increased risk. Abruptio placentae, Apgar scores <7 at
1 min and pathological non-stress test (reason for delivery) were signicant risk factors of CP only
in the moderately preterm and hemiplegic groups, whereas fever before delivery was a signicant
risk factor in the very preterm and spastic diplegic groups. Antibiotics during pregnancy was
associated with CP only in the spastic diplegic CP group.
Conclusion: Antenatal infections marginally increased the risk of CP. Low Apgar score and
abruptio placentae were associated with CP, especially in moderately preterm infants with
hemiplegic CP.
Key words: Antenatal risk factors, case–control study, cerebral palsy, pregnancy complications,
preterm infants
B Jacobsson, Department of Obstetrics and Gynecology, Perinatal Center, Sahlgrenska University
Hospital/East, SE-416 85 Go¨teborg, Sweden (Tel. ‡46 31 3434100, fax. ‡46 31 254387, e-mail.
bo.jacobsson@obgyn.gu.se)
Preterm birth is the most important risk factor for
cerebral palsy (CP). The risk of CP is inversely
proportional to gestational age and the relative risk is
60 times higher at <28 wk of gestation than at term
(1, 2). Only 6.1% of infants were born preterm (<37 wk
of gestation) during the period 1983–1990 in western
Sweden, but they accounted for 41.5% of that region’s
CP cases (1, 2). The number of preterm infants with CP
has increased since 1970, mainly related to the parallel
decrease in perinatal mortality (1, 2). Although perina-
tal and neonatal risk factors for CP appear to dominate
in the preterm group, further investigation into antenatal
and intrapartal risk factors is interesting, as they can act
as antecedents to the brain damage resulting in CP. In
previous analyses of antenatal risk factors for CP in
preterm infants no single risk factor has been consistent
across all or even most studies (3–16). Recent studies
suggest that foetoplacental uterine infection/inamma-
tion is important in the initiation of preterm labour and
for the development of central nervous system injury
and CP (16, 17). The western Swedish population is
characterized by a low frequency of perinatal infections
(18, 19) and a low rate of preterm birth. Testing the
hypothesis that infection is a risk factor for CP in this
population as part of the ongoing CP project (1, 2, 20),
applying the uniform and internationally accepted
denition of this condition (21), may thus be interesting
from a pathophysiologica l standpoint.
The aim of this study was to evaluate maternal,
antenatal and intrapartal risk factors for CP, especially
those related to foetomaternal infections (1, 2). A case–
control study was designed, based on the preterm cases
of spastic CP from the birth cohorts 1983–1990 in the
western Swedish CP project. The very preterm group
(<32 wk) and the moderately preterm group
(32–36 wk) were analysed separately, as infection is
considered to be a more common cause of very preterm
birth (22). Furthermore, the moderately preterm group
Ó 2002 Taylor & Francis. ISSN 0803-5253
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has usually not been investigated in previous studies
(4–16), despite its comprising 44% of preterm CP and
18% of all CP (1, 2).
Material and methods
Selection of subjects
This study is part of the CP project in western Sweden;
it is population-based and its geographical area consists
of the western healthcare region of Sweden, with a total
population of 1.7 million inhabitants. The total number
of livebirths was 168 627 during the period 1983–1990.
Of the births, 1063 occurred before 32 wk and 8829
occurred at 32–36 wk of gestation, which corresponds
to a preterm birth rate (<37 wk) of 6.1%.
CP was dened as a group of non-progressive, but
often changing, motor impairment syndromes, second-
ary to lesions or abnormalities of the brain arising in the
early stages of development (21). The internationally
accepted Swedish classication was used in this context
(21). Owing to increasing interest in antecedents of
preterm CP, especially the importance of inammatory
processes in the development of diplegic CP types (12),
the study was restricted to the spastic type of CP in
children born preterm (152 of 159 cases of CP in these
cohorts).
Preterm children with spastic CP were included if
they were born in Sweden and lived in the study region
on 31 December 1990 (for the years 1983–1986) and 31
December 1994 (for the years 1987–1990) and lacked
any obvious postnatal cause of CP. All children were at
least 4 y old at the time of diagnosis (1, 2)
Using the Swedish National Birth Register each case
was matched with two controls. The closest births
occurring before and after the case birth were chosen.
The controls were matched for gestational age, gender,
multiple gestation and delivery ward. In most cases
(97.1%), calculation of gestational age was based on
ultrasound scans performed between gestational weeks
16 and 19. In cases that had not been dated by ultra-
sound, gestational age was estimated from the date of
last menstrual period and clinical assessment of the
child at birth.
The total number of spastic preterm CP cases was
152. Four cases with their respective controls were
excluded: two cases had a proven perinatal cytomegalo-
virus infection and two cases had ultrasound-corrected
gestational age exceeding 37 wk. Subsequently, analy-
sis was performed on 148 CP cases and 296 matched
controls. Matching was complete for gestational age,
gender and multiple gestation. Matching with regard to
delivery ward was complete in only 84.5%, as controls
could not always be recruited from small units. In these
cases, controls were recruited from another unit of
similar level and size.
Subgroup analysis was performed with regard to the
two major types of CP, spastic diplegia and hemiplegia,
and the two gestational age groups, very preterm
(<32 wk) and moderately preterm (32–36 wk).
Approval was obtained from the Ethics Committee in
Go¨teborg.
Data collection
One investigator (BJ), unaware of the paediatric out-
come, examined all 456 records, recording a total of 154
variables including maternal (40), antenatal (63), intra-
partal and immediately postpartal (51) data. Clinical
chorioamnionitis was dened as fever (¶38°C recorded
on two occasions ¶4 h apart) and/or uterine tenderness
and/or foetal tachycardia in the absence of other focus
of infection. Fever before onset of delivery was dened
as fever (¶38°C) prior to the occurrence of regular
contractions and cervical dilation. Postpartum endo-
metritis was dened as fever (¶38°C recorded on two
occasions ¶4 h apart) and uterine tenderness or foul-
smelling cervicovaginal discharge. Histological chorio-
amnionitis was dened as increased inltration of
polymorphonuclear white blood cells in the chorioam-
niotic membranes. Histopathological examination was
performed in 73 of the 444 placentas (18.9% in cases,
15.2% in controls). Clinical chorioamnionitis and
pyelonephritis were grouped together, as previous
studies implied that severe infection in close relation
to the genital tract may be associated with brain injury
(23). Hypertensive disease was used as a compound
diagnostic term including pre-eclampsia (¶140/90 and
¶0.3 g protein in urine), gestational hypertension
(¶140/90 after 20 wk of gestation) and essential hyper-
tension (¶140/90 before the pregnancy or <20 wk of
gestation). Cervical insufciency was dened as open-
ing of the cervix without uterine contractions. The term
“bad obstetric history” was used when one of following
criteria was fullled: more than three subsequent spon-
taneous abortions, one spontaneous abortion after 20 wk
of gestation, intrauterine foetal death or an earlier case
of perinatal death. Maternal disease was dened as the
presence of any of the following diseases at the onset of
the pregnancy: diabetes, hypertension, severe psychia-
tric disease, asthma, active neoplasia, epilepsy and
glomerulonephritis. Antenatal cardiotocographic (CTG)
tracings were classied according to FIGO standards
(24).
Standardization of birthweight according to gesta-
tional age and gender was performed using a recent
study of ultrasonically estimated foetal weights to avoid
underestimating the degree of size deviation in preterm
infants (25). Growth restriction was dened as below
¡24% weight deviation compared with the mean
birthweight for a given gestational age and gender
(25), corresponding to below ¡2 standard deviations
(SD) from the mean; the latter is a more common
denition in paediatric contexts (25).
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Statistical methods
Univariate logistic regression was used to estimate the
odds ratio (OR) with a 95% condence interval (CI) for
correlation between one factor and the outcome.
Statistical signicance was considered to exist if the
95% CI did not include 1.0.
Calculations were made using SAS (SAS Institute,
Cary, NC, USA) and InStat 2.01 (Graph Pad Software,
San Diego, CA, USA). Proportions were compared
using Fisher’s exact test. Wilcoxon’s rank-sum test was
used to test continuous variables for differences
between two groups. A p-value <0.05 was considered
to be statistically signicant.
Results
The distribution of spastic CP types according to
gestational age is shown in Table 1. Most antenatal/
intrapartal factors were unrelated to CP, and the results
are given for the more frequently reported factors and
for variables with signicant or borderline signicant
association to outcome. Maternal characteristics were
comparable in CP and controls (Table 2). The birth-
weight, standardized for gestational age and gender, did
not differ signicantly between cases and controls (12%
cases and 14% controls were below ¡2 SD). Infectious
factors [clinical chorioamnionitis/pyelonephritis, histo-
logical chorioamnionitis and long duration of preterm
prelabour rupture of membranes (pPROM)] were
associated with an increased risk of CP, whereas
treatment with anti-inammatory corticosteroids was
associated with a signicantly lower risk (Table 3).
There was a signicant association between CP and an
admission–delivery interval <4 h (Table 4). Hyper-
tensive disease, cervical insufciency and iatrogenic
reasons for delivery were all associated with a lower
occurrence of CP, whereas no difference was found
between cases and controls with regard to spontaneous
onset of labour [pPROM and preterm labour (PTL)]
(Table 4). Decreased viability at birth (low Apgar scores
at 1, 5 and 10 min) occurred more frequently in CP
cases than in controls (Table 5).
Risk factors for CP were also analysed separately for
very and moderately preterm infants, as well as for
spastic diplegic and hemiplegic forms of CP (Table 6).
Abruptio placentae and low Apgar scores were asso-
Table 1. Distribution of 148 preterm spastic cerebral palsy (CP) cases
by type and gestationa l age group.
Type of CP <32 wka 32–36 wka Total
Spastic diplegia 60 (66) 28 (49) 88 (59.5)
Spastic hemiplegia 11 (12) 20 (35) 31 (21)
Ataxic–spastic diplegia 11 (12) 4 (7) 15 (10)
Spastic tetraplegia 9 (10) 5 (9) 14 (9.5)
Total 91 (00) 57 (00) 148 (00.0)
Data are n (%).
a Weeks of gestation.
Table 2. Selected maternal factors in cerebral palsy (CP) cases and
controls.
CP cases
(n = 148)
Controls
(n = 296)
OR (95% CI) or
p-value
Maternal agea 27 (24–33) 28 (24–33) p = 0.46
Nulliparous 66 (45) 159 (54) 0.83 (0.67–1.02)
Infertility >1 y 13 (9) 32 (11) 0.78 (0.38–1.50)
Maternal disease 10 (7) 19 (6) 1.05 (0.50–2.21)
Bad obstetric history 17 (11) 19 (6) 1.89 (0.94–3.76)
Previous legal abortion 37 (25) 51 (17) 1.60 (0.99–2.58)
Data are a mean (interquartile range), or n (%).
OR: odds ratio; 95% CI: 95% condence interval.
Table 3. Selected factors, related to infection and inammation, in
cerebral palsy (CP) cases and controls .
CP cases
(n = 148)
Control
(n = 296)
OR (95% CI) for
CP or p-value
Clinical
chorioamnionitis
or pyelonephritis
18 (12) 19 (6) 2.02 (1.02–3.99)
Clinical
chorioamnionitis
16 (11) 19 (6) 1.77 (0.88–3.55)
Histological
chorioamnionitis
10/28 (36) 6/45 (13) 3.61 (1.16–12.1)
Fever before onset of
delivery
12/146 (26) 11/289 (4) 2.30 (0.99–5.17)
Fever during delivery 13/147 (9) 25/295 (8) 1.05 (0.52–2.12)
pPROM (h to
delivery)a
63 h (28–252) 37 h (12–90) p = 0.01
Postpartum
endometritis
9 (6) 18 (12) 1.00 (0.44–2.28)
Antenatal
corticosteroids
9 (6) 39 (13) 0.42 (0.20–0.90)
Data are a mean (interquartile range), or n (%).
OR: odds ratio; 95% CI: 95% condence interval; pPROM: preterm
prelabour rupture of membrane.
Table 4. Selected factors related to preterm birth and route of
delivery in cerebral palsy (CP) cases and controls .
CP cases
(n = 148)
Controls
(n = 296) OR (95% CI)
pPROM 42 (28) 104 (35) 0.73 (0.48–1.09)
PTL 60 (41) 119 (40) 1.01 (0.68–1.52)
pPROM or PTL 102 (69) 223 (75) 0.91 (0.81–1.04)
Iatrogenic reason for
delivery
14 (9) 48 (16) 0.54 (0.28–0.99)
Cervical insufciency 2 (1) 16 (5) 0.85 (0.70–0.98)
Hypertensive disease 14 (9) 48 (16) 0.54 (0.28–0.99)
Pre-eclampsia 13 (9) 32 (11) 0.79 (0.40–1.56)
Caesarean section 99 (67) 169 (57) 1.11 (1.00–1.23)
<4 h from admission to
delivery
34 (23) 42 (14) 1.80 (1.09–2.98)
Data are n (%).
OR: odds ratio; 95% CI: 95% condence interval; pPROM: preterm
premature rupture of membrane; PTL: preterm labour.
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ciated with a higher risk of CP, especially in the
hemiplegic and moderately preterm (32–36 wk) group.
Indicators of infection, such as antibiotics during
pregnancy, were associated with diplegic CP. Fever
before onset of delivery was an antecedent of CP in the
very preterm (<32 wk) and the diplegic groups (Table
6).
Discussion
In studies of CP, there is an unavoidable delay of 4–5 y
from birth before a reliable diagnosis can be established
in all cases. In addition, a large number of cases is
required if subgroups of CP types and different gesta-
tional age groups are to be analysed. The strengths of
the present study are that virtually all cases of spastic
CP in a geographically dened area (birth 1983–1990)
were included, the size of the study and the fact that all
children with CP were at least 4 y old at diagnosis. The
problems encountered were some missing information
in the records and, in both cases and controls, the
limited number of histopathologica l examinations of the
placentas (data available in only 73 of the 444 records).
The more frequently observed risk factors for CP in
previous studies are clinical chorioamnionitis (3–5,
7, 11, 26), pPROM of long duration (3, 5, 8, 27), multi-
ple pregnancy (4, 6), maternal antibiotics during preg-
nancy (11, 13), antepartum fever (11), rapid vaginal
delivery lasting <4 h (6, 13), CTG abnormalities/low
Apgar scores at birth (5, 13), vaginal bleeding (6, 13)
and vaginal preterm delivery subsequent to PTL or
pPROM (12). In contrast, delivery without labour
(5, 13) and pre-eclampsia have been found to be
associated with a reduced risk of CP (5, 13). The
variable results obtained may relate to differences in
study design, outcome (all CP or subgroups of CP),
weight/gestational age groups included (most studies
covered the <1500 g group), occurrence of risk factors
in the population and data retrieval methods (records or
birth registers).
In this study, there was an increased occurrence of CP
in infants whose histories reported clinical chorioam-
nionitis/pyelonephritis or histological chorioamnionitis,
and in cases with a delay between pPROM and delivery.
Fever before onset of delivery was a signicant
antecedent of CP in the spastic diplegic and the very
preterm (<32 wk) groups, and the use of antibiotics
during pregnancy was correlated with diplegic CP. This
is in agreement with previous reports demonstrating that
infectious risk factors are, to some extent, associated
with CP in preterm infants (3–5, 7, 8, 10, 11, 13). The
present data support the general concept of foeto-
placental infection as a possible pathogenic factor of
both preterm birth and brain injury (16, 17), even in a
population with a low occurrence of perinatal infections
(18, 19). However, the association between CP and
infectious factors was not particularly strong (Table 3)
and these results differ from those of previous studies,
which demonstrated a markedly increased risk of brain
lesions (28) or a moderately increased risk of CP (12) in
the PTL/pPROM group, compared with groups born
preterm for other reasons. This may reect the fact that
infection was associated with spontaneous delivery (and
CP) in only a minority of cases in the preterm
population (see Table 3). It is important to point out
that the associations found between infection-related
factors and CP are not proof of direct causality; instead,
infection/inammation may play an intermediary role
Table 5. Selected factors related to viability at birth and urgent
delivery in cerebral palsy (CP) cases and controls .
CP cases
(n = 148)
Controls
(n = 296) OR (95% CI)
Apgar <7 at 1 min 66/146 96/289 1.36 (1.06–1.74)
Apgar <7 at 5 min 38/145 30/288 2.52 (1.64–3.85)
Apgar <7 at 10 min 18/140 6/279 5.98 (2.72–13.2)
Maternal bleeding, reason
for delivery
29/148 37/296 1.71 (1.00–2.90)
OR: odds ratio; 95% CI: 95% condence interval.
Table 6. Risk of cerebral palsy (CP) for selected variables, given separately for the two major subgroups of CP (spastic diplegia and
hemiplegia) and for the very preterm (<32 wk) and moderately preterm (32–36 wk) gestational groups. In the subgroup analyses, the cases are
compared to their own matched controls .
All patients Spastic diplegia Hemiplegia <32 wk 32–36 wk
Abruptio placentae 1.64 (0.90–3.02) 1.05 (0.50–2.22) 7.20 (1.63–31.9) 1.31 (0.65–2.63) 4.31 (1.14–16.3)
Pre-eclampsia 0.79 (0.40–1.56) 0.94 (0.41–2.18) 0.17 (0.03–1.16) 1.32 (0.55–3.19) 0.40 (0.13–1.20)
Apgar <7 at 1 min 1.36 (1.06–1.74) 1.30 (0.77–2.21) 3.42 (1.40–8.36) 1.02 (0.61–1.70) 5.48 (2.61–11.5)
Apgar <7 at 5 min 2.52 (1.64–3.85) 2.44 (1.18–5.06) 4.58 (1.46–14.3) 2.30 (1.25–4.26) 7.90 (2.79–22.4)
Apgar <7 at 10 min 5.98 (2.72–13.2) 3.72 (1.06–13.1) 30.9 (1.7–568) 6.12 (2.34–16.0) 10.4 (1.74–62.0)
Antibiotics during pregnancy 1.18 (0.64–2.20) 2.39 (1.12–5.09) 0.47 (0.10–2.29) 1.35 (0.68–2.68) 0.65 (0.13–2.30)
Fever before onset of delivery 2.30 (0.99–5.17) 3.10 (1.14–8.44) 0.66 (0.07–6.56) 2.60 (1.06–6.36) 1.00 (0.09–11.3)
Pathological non-stress test (CTG), reason
for delivery
2.89 (0.95–8.84) 2.04 (0.4–10.0) 4.20 (0.43–40.9) 1.01 (0.09–11.3) 4.3 (1.14–16.3)
Data are odds ratio (95% condence interval).
CTG: cardiotocography .
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between CP and some other, yet unknown, factor (29).
To investigate this further, more detailed information
regarding the presence of microbes and inammatory
mediators in the membranes, amniotic uid and blood
of the newborn is required.
The use of antenatal corticosteroids (betamethasone)
was associated with a decreased risk of CP, which is in
agreement with a recent report indicating that beta-
methasone (but not dexamethasone) reduces periven-
tricular leukomalacia in preterm infants (30), possibly
through its benecial effects on respiration during the
neonatal period, anti-inammatory actions or neuropro-
tective properties. Alternatively, there may have been a
selection bias among cases receiving treatment towards
those delivered for iatrogenic reasons and with a longer
latency between admission and delivery, and this group
may therefore have been at lower risk even without
corticosteroids. This issue is of great importance and
must be addressed in prospective randomized controlled
trials.
Traditionally, preterm birth has been subdivided into
a very preterm (<32 wk) and a moderately preterm
(32–36 wk) group. Periventricular leukomalacia, known
to be strongly correlated with spastic diplegic CP in
preterm children, predominantly occurs in the 24th to
32–34th wk of gestation, whereas cortical/subcortical
insults (which correlate with moderate–severe neonatal
encephalopathy) occur after that time (20). Hence, the
observed rate of CP in low-birthweight infants with low
Apgar at 10–20 min is relatively low, whereas the CP
rate in term babies with low Apgar at 10–20 min is very
high, probably reecting that the immaturity of the
nervous system of preterm infants confers cerebral
resistance to asphyxia, whereas the brain of term infants
is more vulnerable (31). Accordingly, from an aetio-
logical point of view, the moderately preterm group is
an intermediate group between the very preterm and
term groups, which is, to some extent, illustrated in this
study. In the very preterm group, fever before delivery
and low Apgar scores at 5 and 10 min were signicant
risk factors for CP, as in the spastic diplegic group that
dominated the very preterm group. In the moderately
preterm group, abruptio placentae, low Apgar scores at
1, 5 and 10 min and pathological non-stress test (reason
for delivery) were signicant risk factors, as in the
hemiplegic group (Table 4).
These results indicate that foetal distress and pre-
cipitous delivery constitute a risk for CP, not a con-
sistent nding in previous studies, which may be
explained by the exclusion of moderately preterm cases
in most studies (4–14). However, the present data are in
agreement with Cooke, who found an association
between CTG abnormalities and preterm CP (4).
Although the data may indicate that intrapartal distress
is contributory in the aetiology of spastic CP in preterm
infants, drawing a rm conclusion is complicated by the
fact that infants born with low Apgar scores at birth (or
delivered after abruptio) are probably more likely to
have suffered from other adverse events antenatally
and/or neonatally as well. Since adjustment for all of
these possible confounders was not made, the results
must be interpreted with caution.
The risk of CP was lower in infants born to mothers
with hypertensive disease (but not signicantly for pre-
eclampsia as a separate group). Pre-eclampsia appears
to be associated with a reduced risk, irrespective of
whether MgSO4 was used or not (5, 6, 13). It has been
suggested that pre-eclampsia does not decrease the risk
in itself but rather represents a group delivered preterm
in the absence of adverse infectious/inammatory
factors, as opposed to the PTL–pPROM group (5, 12).
As mentioned previously (Table 5), no higher risk of CP
in the PTL/pPROM group was found compared with the
pre-eclamptic group, suggesting that other mechanisms
may be in play.
In summary, among the antenatal variables studied,
infectious factors were signicantly, but weakly, asso-
ciated with CP. Low Apgar scores and abruptio
placentae correlated with hemiplegic CP in moderately
preterm infants, whereas a similar relationship was less
evident in the very preterm diplegic cases. Postpartal
and neonatal variables were not studied, but are known
to be associated with brain damage resulting in CP in
preterm births (1, 26).
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